id	sid	tid	token	lemma	pos
dpc-2669	1	1	dermatology	dermatology	NOUN
dpc-2669	1	2	:	:	PUNCT
dpc-2669	1	3	practical	practical	ADJ
dpc-2669	1	4	and	and	CCONJ
dpc-2669	1	5	conceptual	conceptual	ADJ
dpc-2669	1	6	original	original	ADJ
dpc-2669	1	7	article	article	NOUN
dpc-2669	1	8	|	|	ADV
dpc-2669	1	9	dermatol	dermatol	ADJ
dpc-2669	1	10	pract	pract	NOUN
dpc-2669	1	11	concept	concept	NOUN
dpc-2669	1	12	.	.	PUNCT
dpc-2669	2	1	2023;13(2):e2023116	2023;13(2):e2023116	NUM
dpc-2669	2	2	1	1	NUM
dpc-2669	2	3	the	the	DET
dpc-2669	2	4	relationship	relationship	NOUN
dpc-2669	2	5	of	of	ADP
dpc-2669	2	6	serum	serum	NOUN
dpc-2669	2	7	trimethylamine	trimethylamine	NOUN
dpc-2669	2	8	n	n	CCONJ
dpc-2669	2	9	-	-	PUNCT
dpc-2669	2	10	oxide	oxide	NOUN
dpc-2669	2	11	levels	level	NOUN
dpc-2669	2	12	with	with	ADP
dpc-2669	2	13	carotid	carotid	NOUN
dpc-2669	2	14	intima	intima	ADJ
dpc-2669	2	15	-	-	PUNCT
dpc-2669	2	16	media	medium	NOUN
dpc-2669	2	17	thickness	thickness	NOUN
dpc-2669	2	18	and	and	CCONJ
dpc-2669	2	19	disease	disease	NOUN
dpc-2669	2	20	activity	activity	NOUN
dpc-2669	2	21	in	in	ADP
dpc-2669	2	22	psoriasis	psoriasis	NOUN
dpc-2669	2	23	patients	patient	NOUN
dpc-2669	2	24	emre	emre	PROPN
dpc-2669	2	25	zekey1	zekey1	PROPN
dpc-2669	2	26	,	,	PUNCT
dpc-2669	2	27	fatma	fatma	PROPN
dpc-2669	2	28	tunçez	tunçez	PROPN
dpc-2669	2	29	akyürek2	akyürek2	PROPN
dpc-2669	2	30	,	,	PUNCT
dpc-2669	2	31	abdullah	abdullah	PROPN
dpc-2669	2	32	tunçez3	tunçez3	PROPN
dpc-2669	2	33	,	,	PUNCT
dpc-2669	2	34	fikret	fikret	PROPN
dpc-2669	2	35	akyürek4	akyürek4	PROPN
dpc-2669	2	36	,	,	PUNCT
dpc-2669	2	37	merve	merve	VERB
dpc-2669	2	38	ezgi	ezgi	ADJ
dpc-2669	2	39	doğan5	doğan5	PROPN
dpc-2669	2	40	1	1	NUM
dpc-2669	2	41	department	department	NOUN
dpc-2669	2	42	of	of	ADP
dpc-2669	2	43	dermatology	dermatology	NOUN
dpc-2669	2	44	,	,	PUNCT
dpc-2669	2	45	sivas	sivas	PROPN
dpc-2669	2	46	numune	numune	PROPN
dpc-2669	2	47	hospital	hospital	PROPN
dpc-2669	2	48	,	,	PUNCT
dpc-2669	2	49	sivas	sivas	PROPN
dpc-2669	2	50	,	,	PUNCT
dpc-2669	2	51	turkey	turkey	PROPN
dpc-2669	2	52	2	2	NUM
dpc-2669	2	53	department	department	NOUN
dpc-2669	2	54	of	of	ADP
dpc-2669	2	55	dermatology	dermatology	NOUN
dpc-2669	2	56	,	,	PUNCT
dpc-2669	2	57	selcuk	selcuk	PROPN
dpc-2669	2	58	university	university	PROPN
dpc-2669	2	59	medical	medical	ADJ
dpc-2669	2	60	faculty	faculty	NOUN
dpc-2669	2	61	,	,	PUNCT
dpc-2669	2	62	konya	konya	PROPN
dpc-2669	2	63	,	,	PUNCT
dpc-2669	2	64	turkey	turkey	PROPN
dpc-2669	2	65	3	3	NUM
dpc-2669	2	66	department	department	NOUN
dpc-2669	2	67	of	of	ADP
dpc-2669	2	68	cardiology	cardiology	NOUN
dpc-2669	2	69	,	,	PUNCT
dpc-2669	2	70	selcuk	selcuk	PROPN
dpc-2669	2	71	university	university	PROPN
dpc-2669	2	72	medical	medical	ADJ
dpc-2669	2	73	faculty	faculty	NOUN
dpc-2669	2	74	,	,	PUNCT
dpc-2669	2	75	konya	konya	PROPN
dpc-2669	2	76	,	,	PUNCT
dpc-2669	2	77	turkey	turkey	PROPN
dpc-2669	2	78	4	4	NUM
dpc-2669	2	79	department	department	NOUN
dpc-2669	2	80	of	of	ADP
dpc-2669	2	81	biochemistry	biochemistry	NOUN
dpc-2669	2	82	,	,	PUNCT
dpc-2669	2	83	selcuk	selcuk	PROPN
dpc-2669	2	84	university	university	PROPN
dpc-2669	2	85	medical	medical	ADJ
dpc-2669	2	86	faculty	faculty	NOUN
dpc-2669	2	87	,	,	PUNCT
dpc-2669	2	88	konya	konya	PROPN
dpc-2669	2	89	,	,	PUNCT
dpc-2669	2	90	turkey	turkey	PROPN
dpc-2669	2	91	5	5	NUM
dpc-2669	2	92	department	department	NOUN
dpc-2669	2	93	of	of	ADP
dpc-2669	2	94	public	public	ADJ
dpc-2669	2	95	health	health	NOUN
dpc-2669	2	96	,	,	PUNCT
dpc-2669	2	97	selcuk	selcuk	PROPN
dpc-2669	2	98	university	university	PROPN
dpc-2669	2	99	medical	medical	ADJ
dpc-2669	2	100	faculty	faculty	NOUN
dpc-2669	2	101	,	,	PUNCT
dpc-2669	2	102	konya	konya	PROPN
dpc-2669	2	103	,	,	PUNCT
dpc-2669	2	104	turkey	turkey	PROPN
dpc-2669	2	105	key	key	ADJ
dpc-2669	2	106	words	word	NOUN
dpc-2669	2	107	:	:	PUNCT
dpc-2669	2	108	psoriasis	psoriasis	NOUN
dpc-2669	2	109	,	,	PUNCT
dpc-2669	2	110	trimethylamine	trimethylamine	NOUN
dpc-2669	2	111	n	n	CCONJ
dpc-2669	2	112	-	-	PUNCT
dpc-2669	2	113	oxide	oxide	NOUN
dpc-2669	2	114	,	,	PUNCT
dpc-2669	2	115	gut	gut	NOUN
dpc-2669	2	116	microbiota	microbiota	NOUN
dpc-2669	2	117	,	,	PUNCT
dpc-2669	2	118	atherosclerosis	atherosclerosis	NOUN
dpc-2669	2	119	,	,	PUNCT
dpc-2669	2	120	carotid	carotid	NOUN
dpc-2669	2	121	intima	intima	ADJ
dpc-2669	2	122	-	-	PUNCT
dpc-2669	2	123	media	medium	NOUN
dpc-2669	2	124	thickness	thickness	NOUN
dpc-2669	2	125	citation	citation	NOUN
dpc-2669	2	126	:	:	PUNCT
dpc-2669	2	127	zekey	zekey	VERB
dpc-2669	2	128	e	e	NOUN
dpc-2669	2	129	,	,	PUNCT
dpc-2669	2	130	tunçez	tunçez	NOUN
dpc-2669	2	131	akyürek	akyürek	PROPN
dpc-2669	3	1	f	f	X
dpc-2669	3	2	,	,	PUNCT
dpc-2669	3	3	tunçez	tunçez	NOUN
dpc-2669	3	4	a	a	PRON
dpc-2669	3	5	,	,	PUNCT
dpc-2669	3	6	akyürek	akyürek	PROPN
dpc-2669	3	7	f	f	X
dpc-2669	3	8	,	,	PUNCT
dpc-2669	3	9	doğan	doğan	VERB
dpc-2669	3	10	me	i	PRON
dpc-2669	3	11	.	.	PUNCT
dpc-2669	4	1	the	the	DET
dpc-2669	4	2	relationship	relationship	NOUN
dpc-2669	4	3	of	of	ADP
dpc-2669	4	4	serum	serum	NOUN
dpc-2669	4	5	trimethylamine	trimethylamine	NOUN
dpc-2669	4	6	n	n	CCONJ
dpc-2669	4	7	-	-	PUNCT
dpc-2669	4	8	oxide	oxide	NOUN
dpc-2669	4	9	levels	level	NOUN
dpc-2669	4	10	with	with	ADP
dpc-2669	4	11	carotid	carotid	NOUN
dpc-2669	4	12	intima	intima	ADJ
dpc-2669	4	13	-	-	PUNCT
dpc-2669	4	14	media	medium	NOUN
dpc-2669	4	15	thickness	thickness	NOUN
dpc-2669	4	16	and	and	CCONJ
dpc-2669	4	17	disease	disease	NOUN
dpc-2669	4	18	activity	activity	NOUN
dpc-2669	4	19	in	in	ADP
dpc-2669	4	20	psoriasis	psoriasis	NOUN
dpc-2669	4	21	patients	patient	NOUN
dpc-2669	4	22	.	.	PUNCT
dpc-2669	5	1	dermatol	dermatol	NOUN
dpc-2669	5	2	pract	pract	PROPN
dpc-2669	5	3	concept	concept	NOUN
dpc-2669	5	4	.	.	PUNCT
dpc-2669	6	1	2023;13(2):e2023116	2023;13(2):e2023116	X
dpc-2669	6	2	.	.	PUNCT
dpc-2669	6	3	doi	doi	PROPN
dpc-2669	6	4	:	:	PUNCT
dpc-2669	6	5	https://doi.org/10.5826/dpc.1302a116	https://doi.org/10.5826/dpc.1302a116	PROPN
dpc-2669	6	6	accepted	accept	VERB
dpc-2669	6	7	:	:	PUNCT
dpc-2669	6	8	november	november	PROPN
dpc-2669	6	9	16	16	NUM
dpc-2669	6	10	,	,	PUNCT
dpc-2669	6	11	2022	2022	NUM
dpc-2669	6	12	;	;	PUNCT
dpc-2669	6	13	published	publish	VERB
dpc-2669	6	14	:	:	PUNCT
dpc-2669	7	1	april	april	PROPN
dpc-2669	7	2	2023	2023	NUM
dpc-2669	7	3	copyright	copyright	NOUN
dpc-2669	7	4	:	:	PUNCT
dpc-2669	7	5	©	©	PROPN
dpc-2669	7	6	2023	2023	NUM
dpc-2669	7	7	zekey	zekey	NOUN
dpc-2669	7	8	et	et	PROPN
dpc-2669	7	9	al	al	PROPN
dpc-2669	7	10	.	.	PUNCT
dpc-2669	8	1	this	this	PRON
dpc-2669	8	2	is	be	AUX
dpc-2669	8	3	an	an	DET
dpc-2669	8	4	open	open	ADJ
dpc-2669	8	5	-	-	PUNCT
dpc-2669	8	6	access	access	NOUN
dpc-2669	8	7	article	article	NOUN
dpc-2669	8	8	distributed	distribute	VERB
dpc-2669	8	9	under	under	ADP
dpc-2669	8	10	the	the	DET
dpc-2669	8	11	terms	term	NOUN
dpc-2669	8	12	of	of	ADP
dpc-2669	8	13	the	the	DET
dpc-2669	8	14	creative	creative	ADJ
dpc-2669	8	15	commons	common	NOUN
dpc-2669	8	16	attribution	attribution	NOUN
dpc-2669	8	17	-	-	PUNCT
dpc-2669	8	18	noncommercial	noncommercial	ADJ
dpc-2669	8	19	license	license	NOUN
dpc-2669	8	20	(	(	PUNCT
dpc-2669	8	21	by	by	ADP
dpc-2669	8	22	-	-	PUNCT
dpc-2669	8	23	nc-4.0	nc-4.0	NOUN
dpc-2669	8	24	)	)	PUNCT
dpc-2669	8	25	,	,	PUNCT
dpc-2669	8	26	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-2669	8	27	,	,	PUNCT
dpc-2669	8	28	which	which	PRON
dpc-2669	8	29	permits	permit	VERB
dpc-2669	8	30	unrestricted	unrestricted	ADJ
dpc-2669	8	31	noncommercial	noncommercial	ADJ
dpc-2669	8	32	use	use	NOUN
dpc-2669	8	33	,	,	PUNCT
dpc-2669	8	34	distribution	distribution	NOUN
dpc-2669	8	35	,	,	PUNCT
dpc-2669	8	36	and	and	CCONJ
dpc-2669	8	37	reproduction	reproduction	NOUN
dpc-2669	8	38	in	in	ADP
dpc-2669	8	39	any	any	DET
dpc-2669	8	40	medium	medium	NOUN
dpc-2669	8	41	,	,	PUNCT
dpc-2669	8	42	provided	provide	VERB
dpc-2669	8	43	the	the	DET
dpc-2669	8	44	original	original	ADJ
dpc-2669	8	45	authors	author	NOUN
dpc-2669	8	46	and	and	CCONJ
dpc-2669	8	47	source	source	NOUN
dpc-2669	8	48	are	be	AUX
dpc-2669	8	49	credited	credit	VERB
dpc-2669	8	50	.	.	PUNCT
dpc-2669	9	1	funding	funding	NOUN
dpc-2669	9	2	:	:	PUNCT
dpc-2669	9	3	none	none	NOUN
dpc-2669	9	4	.	.	PUNCT
dpc-2669	10	1	competing	compete	VERB
dpc-2669	10	2	interests	interest	NOUN
dpc-2669	10	3	:	:	PUNCT
dpc-2669	10	4	none	none	NOUN
dpc-2669	10	5	.	.	PUNCT
dpc-2669	11	1	authorship	authorship	NOUN
dpc-2669	11	2	:	:	PUNCT
dpc-2669	11	3	all	all	DET
dpc-2669	11	4	authors	author	NOUN
dpc-2669	11	5	have	have	AUX
dpc-2669	11	6	contributed	contribute	VERB
dpc-2669	11	7	significantly	significantly	ADV
dpc-2669	11	8	to	to	ADP
dpc-2669	11	9	this	this	DET
dpc-2669	11	10	publication	publication	NOUN
dpc-2669	11	11	.	.	PUNCT
dpc-2669	12	1	corresponding	correspond	VERB
dpc-2669	12	2	author	author	NOUN
dpc-2669	12	3	:	:	PUNCT
dpc-2669	12	4	emre	emre	PROPN
dpc-2669	12	5	zekey	zekey	PROPN
dpc-2669	12	6	,	,	PUNCT
dpc-2669	12	7	department	department	NOUN
dpc-2669	12	8	of	of	ADP
dpc-2669	12	9	dermatology	dermatology	NOUN
dpc-2669	12	10	,	,	PUNCT
dpc-2669	12	11	sivas	sivas	PROPN
dpc-2669	12	12	numune	numune	PROPN
dpc-2669	12	13	hospital	hospital	PROPN
dpc-2669	12	14	,	,	PUNCT
dpc-2669	12	15	sivas	sivas	PROPN
dpc-2669	12	16	,	,	PUNCT
dpc-2669	12	17	turkey	turkey	PROPN
dpc-2669	12	18	.	.	PUNCT
dpc-2669	13	1	e	e	X
dpc-2669	13	2	-	-	NOUN
dpc-2669	13	3	mail	mail	NOUN
dpc-2669	13	4	:	:	PUNCT
dpc-2669	13	5	emre.zekey@gmail.com	emre.zekey@gmail.com	X
dpc-2669	13	6	introduction	introduction	NOUN
dpc-2669	13	7	:	:	PUNCT
dpc-2669	13	8	psoriasis	psoriasis	NOUN
dpc-2669	13	9	is	be	AUX
dpc-2669	13	10	an	an	DET
dpc-2669	13	11	inflammatory	inflammatory	ADJ
dpc-2669	13	12	disease	disease	NOUN
dpc-2669	13	13	that	that	PRON
dpc-2669	13	14	can	can	AUX
dpc-2669	13	15	cause	cause	VERB
dpc-2669	13	16	cardiovascular	cardiovascular	ADJ
dpc-2669	13	17	comorbidities	comorbiditie	NOUN
dpc-2669	13	18	.	.	PUNCT
dpc-2669	14	1	some	some	DET
dpc-2669	14	2	recent	recent	ADJ
dpc-2669	14	3	studies	study	NOUN
dpc-2669	14	4	have	have	AUX
dpc-2669	14	5	indicated	indicate	VERB
dpc-2669	14	6	that	that	SCONJ
dpc-2669	14	7	impaired	impaired	ADJ
dpc-2669	14	8	gut	gut	NOUN
dpc-2669	14	9	microbiota	microbiota	NOUN
dpc-2669	14	10	and	and	CCONJ
dpc-2669	14	11	metabolites	metabolite	NOUN
dpc-2669	14	12	may	may	AUX
dpc-2669	14	13	be	be	AUX
dpc-2669	14	14	associated	associate	VERB
dpc-2669	14	15	with	with	ADP
dpc-2669	14	16	inflammatory	inflammatory	ADJ
dpc-2669	14	17	diseases	disease	NOUN
dpc-2669	14	18	.	.	PUNCT
dpc-2669	15	1	objectives	objective	NOUN
dpc-2669	15	2	:	:	PUNCT
dpc-2669	15	3	in	in	ADP
dpc-2669	15	4	this	this	DET
dpc-2669	15	5	study	study	NOUN
dpc-2669	15	6	,	,	PUNCT
dpc-2669	15	7	the	the	DET
dpc-2669	15	8	relationship	relationship	NOUN
dpc-2669	15	9	between	between	ADP
dpc-2669	15	10	serum	serum	NOUN
dpc-2669	15	11	trimethylamine	trimethylamine	NOUN
dpc-2669	15	12	n	n	CCONJ
dpc-2669	15	13	-	-	PUNCT
dpc-2669	15	14	oxide	oxide	NOUN
dpc-2669	15	15	(	(	PUNCT
dpc-2669	15	16	tmao	tmao	PROPN
dpc-2669	15	17	,	,	PUNCT
dpc-2669	15	18	a	a	DET
dpc-2669	15	19	gut	gut	ADJ
dpc-2669	15	20	bacterial	bacterial	ADJ
dpc-2669	15	21	metabolite	metabolite	NOUN
dpc-2669	15	22	)	)	PUNCT
dpc-2669	15	23	level	level	NOUN
dpc-2669	15	24	and	and	CCONJ
dpc-2669	15	25	carotid	carotid	NOUN
dpc-2669	15	26	intima	intima	ADJ
dpc-2669	15	27	-	-	PUNCT
dpc-2669	15	28	media	media	NOUN
dpc-2669	15	29	thickness	thickness	NOUN
dpc-2669	15	30	(	(	PUNCT
dpc-2669	15	31	cimt	cimt	NOUN
dpc-2669	15	32	)	)	PUNCT
dpc-2669	15	33	and	and	CCONJ
dpc-2669	15	34	disease	disease	NOUN
dpc-2669	15	35	severity	severity	NOUN
dpc-2669	15	36	in	in	ADP
dpc-2669	15	37	psoriasis	psoriasis	NOUN
dpc-2669	15	38	patients	patient	NOUN
dpc-2669	15	39	was	be	AUX
dpc-2669	15	40	investigated	investigate	VERB
dpc-2669	15	41	.	.	PUNCT
dpc-2669	16	1	methods	method	NOUN
dpc-2669	16	2	:	:	PUNCT
dpc-2669	16	3	ageand	ageand	NOUN
dpc-2669	16	4	gender	gender	NOUN
dpc-2669	16	5	-	-	PUNCT
dpc-2669	16	6	matched	match	VERB
dpc-2669	16	7	73	73	NUM
dpc-2669	16	8	patients	patient	NOUN
dpc-2669	16	9	and	and	CCONJ
dpc-2669	16	10	72	72	NUM
dpc-2669	16	11	healthy	healthy	ADJ
dpc-2669	16	12	controls	control	NOUN
dpc-2669	16	13	were	be	AUX
dpc-2669	16	14	included	include	VERB
dpc-2669	16	15	in	in	ADP
dpc-2669	16	16	the	the	DET
dpc-2669	16	17	study	study	NOUN
dpc-2669	16	18	.	.	PUNCT
dpc-2669	17	1	in	in	ADP
dpc-2669	17	2	both	both	DET
dpc-2669	17	3	groups	group	NOUN
dpc-2669	17	4	serum	serum	VERB
dpc-2669	17	5	trimethylamine	trimethylamine	NOUN
dpc-2669	17	6	n	n	CCONJ
dpc-2669	17	7	-	-	PUNCT
dpc-2669	17	8	oxide(tmao	oxide(tmao	ADJ
dpc-2669	17	9	)	)	PUNCT
dpc-2669	17	10	,	,	PUNCT
dpc-2669	17	11	oxidized	oxidize	VERB
dpc-2669	17	12	lowdensity	lowdensity	NOUN
dpc-2669	17	13	lipoprotein	lipoprotein	ADJ
dpc-2669	17	14	(	(	PUNCT
dpc-2669	17	15	ox	ox	ADJ
dpc-2669	17	16	-	-	NOUN
dpc-2669	17	17	ldl	ldl	NOUN
dpc-2669	17	18	)	)	PUNCT
dpc-2669	17	19	,	,	PUNCT
dpc-2669	17	20	high	high	ADJ
dpc-2669	17	21	-	-	PUNCT
dpc-2669	17	22	density	density	NOUN
dpc-2669	17	23	lipoprotein	lipoprotein	ADJ
dpc-2669	17	24	cholesterol	cholesterol	NOUN
dpc-2669	17	25	(	(	PUNCT
dpc-2669	17	26	hdl	hdl	NOUN
dpc-2669	17	27	-	-	PUNCT
dpc-2669	17	28	c	c	NOUN
dpc-2669	17	29	)	)	PUNCT
dpc-2669	17	30	,	,	PUNCT
dpc-2669	17	31	low	low	ADJ
dpc-2669	17	32	-	-	PUNCT
dpc-2669	17	33	density	density	NOUN
dpc-2669	17	34	lipoprotein	lipoprotein	ADJ
dpc-2669	17	35	cholesterol	cholesterol	NOUN
dpc-2669	17	36	(	(	PUNCT
dpc-2669	17	37	ldl	ldl	NOUN
dpc-2669	17	38	-	-	PUNCT
dpc-2669	17	39	c	c	NOUN
dpc-2669	17	40	)	)	PUNCT
dpc-2669	17	41	,	,	PUNCT
dpc-2669	17	42	triglyceride	triglyceride	ADJ
dpc-2669	17	43	,	,	PUNCT
dpc-2669	17	44	total	total	ADJ
dpc-2669	17	45	cholesterol	cholesterol	NOUN
dpc-2669	17	46	,	,	PUNCT
dpc-2669	17	47	high	high	ADJ
dpc-2669	17	48	-	-	PUNCT
dpc-2669	17	49	sensitivity	sensitivity	NOUN
dpc-2669	17	50	c	c	NOUN
dpc-2669	17	51	-	-	PUNCT
dpc-2669	17	52	reactive	reactive	ADJ
dpc-2669	17	53	protein	protein	NOUN
dpc-2669	17	54	(	(	PUNCT
dpc-2669	17	55	hs	hs	NOUN
dpc-2669	17	56	-	-	PROPN
dpc-2669	17	57	crp	crp	NOUN
dpc-2669	17	58	)	)	PUNCT
dpc-2669	17	59	,	,	PUNCT
dpc-2669	17	60	creatinine	creatinine	NOUN
dpc-2669	17	61	,	,	PUNCT
dpc-2669	17	62	aspartate	aspartate	NOUN
dpc-2669	17	63	aminotransferase	aminotransferase	NOUN
dpc-2669	17	64	(	(	PUNCT
dpc-2669	17	65	ast	ast	NOUN
dpc-2669	17	66	)	)	PUNCT
dpc-2669	17	67	and	and	CCONJ
dpc-2669	17	68	alanine	alanine	NOUN
dpc-2669	17	69	aminotransferase(alt	aminotransferase(alt	NOUN
dpc-2669	17	70	)	)	PUNCT
dpc-2669	17	71	levels	level	NOUN
dpc-2669	17	72	were	be	AUX
dpc-2669	17	73	recorded	record	VERB
dpc-2669	17	74	and	and	CCONJ
dpc-2669	17	75	the	the	DET
dpc-2669	17	76	carotid	carotid	NOUN
dpc-2669	17	77	intima	intima	ADJ
dpc-2669	17	78	-	-	PUNCT
dpc-2669	17	79	media	media	NOUN
dpc-2669	17	80	thickness	thickness	NOUN
dpc-2669	17	81	(	(	PUNCT
dpc-2669	17	82	cimt	cimt	NOUN
dpc-2669	17	83	)	)	PUNCT
dpc-2669	17	84	was	be	AUX
dpc-2669	17	85	measured	measure	VERB
dpc-2669	17	86	by	by	ADP
dpc-2669	17	87	b	b	NOUN
dpc-2669	17	88	-	-	PUNCT
dpc-2669	17	89	mode	mode	NOUN
dpc-2669	17	90	ultrasonography	ultrasonography	NOUN
dpc-2669	17	91	by	by	ADP
dpc-2669	17	92	a	a	DET
dpc-2669	17	93	cardiologist	cardiologist	NOUN
dpc-2669	17	94	.	.	PUNCT
dpc-2669	18	1	results	result	NOUN
dpc-2669	18	2	:	:	PUNCT
dpc-2669	18	3	tmao	tmao	PROPN
dpc-2669	18	4	,	,	PUNCT
dpc-2669	18	5	hs	hs	PROPN
dpc-2669	18	6	-	-	PROPN
dpc-2669	18	7	crp	crp	NOUN
dpc-2669	18	8	,	,	PUNCT
dpc-2669	18	9	oxidized	oxidize	VERB
dpc-2669	18	10	-	-	PUNCT
dpc-2669	18	11	ldl	ldl	NOUN
dpc-2669	18	12	,	,	PUNCT
dpc-2669	18	13	triglyceride	triglyceride	ADJ
dpc-2669	18	14	and	and	CCONJ
dpc-2669	18	15	cimt	cimt	NOUN
dpc-2669	18	16	levels	level	NOUN
dpc-2669	18	17	were	be	AUX
dpc-2669	18	18	statistically	statistically	ADV
dpc-2669	18	19	higher	high	ADJ
dpc-2669	18	20	in	in	ADP
dpc-2669	18	21	the	the	DET
dpc-2669	18	22	patient	patient	NOUN
dpc-2669	18	23	group	group	NOUN
dpc-2669	18	24	.	.	PUNCT
dpc-2669	19	1	hdl	hdl	PROPN
dpc-2669	19	2	levels	level	NOUN
dpc-2669	19	3	were	be	AUX
dpc-2669	19	4	statistically	statistically	ADV
dpc-2669	19	5	higher	high	ADJ
dpc-2669	19	6	in	in	ADP
dpc-2669	19	7	the	the	DET
dpc-2669	19	8	control	control	NOUN
dpc-2669	19	9	group	group	NOUN
dpc-2669	19	10	.	.	PUNCT
dpc-2669	20	1	there	there	PRON
dpc-2669	20	2	was	be	VERB
dpc-2669	20	3	no	no	DET
dpc-2669	20	4	significant	significant	ADJ
dpc-2669	20	5	abstract	abstract	ADJ
dpc-2669	20	6	2	2	NUM
dpc-2669	20	7	original	original	ADJ
dpc-2669	20	8	article	article	NOUN
dpc-2669	20	9	|	|	ADV
dpc-2669	20	10	dermatol	dermatol	ADJ
dpc-2669	20	11	pract	pract	NOUN
dpc-2669	20	12	concept	concept	NOUN
dpc-2669	20	13	.	.	PUNCT
dpc-2669	21	1	2023;13(2):e2023116	2023;13(2):e2023116	NUM
dpc-2669	21	2	introduction	introduction	NOUN
dpc-2669	21	3	psoriasis	psoriasis	NOUN
dpc-2669	21	4	is	be	AUX
dpc-2669	21	5	a	a	DET
dpc-2669	21	6	chronic	chronic	ADJ
dpc-2669	21	7	inflammatory	inflammatory	ADJ
dpc-2669	21	8	disease	disease	NOUN
dpc-2669	21	9	managed	manage	VERB
dpc-2669	21	10	by	by	ADP
dpc-2669	21	11	the	the	DET
dpc-2669	21	12	immune	immune	ADJ
dpc-2669	21	13	system	system	NOUN
dpc-2669	21	14	.	.	PUNCT
dpc-2669	22	1	systemic	systemic	ADJ
dpc-2669	22	2	inflammation	inflammation	NOUN
dpc-2669	22	3	that	that	SCONJ
dpc-2669	22	4	psoriasis	psoriasis	NOUN
dpc-2669	22	5	causes	cause	VERB
dpc-2669	22	6	can	can	AUX
dpc-2669	22	7	affect	affect	VERB
dpc-2669	22	8	many	many	ADJ
dpc-2669	22	9	organs	organ	NOUN
dpc-2669	22	10	and	and	CCONJ
dpc-2669	22	11	systems	system	NOUN
dpc-2669	23	1	[	[	X
dpc-2669	23	2	1	1	NUM
dpc-2669	23	3	]	]	PUNCT
dpc-2669	23	4	.	.	PUNCT
dpc-2669	24	1	effector	effector	PROPN
dpc-2669	24	2	t	t	PROPN
dpc-2669	24	3	lymphocytes	lymphocyte	VERB
dpc-2669	24	4	such	such	ADJ
dpc-2669	24	5	as	as	ADP
dpc-2669	24	6	th1	th1	PROPN
dpc-2669	24	7	and	and	CCONJ
dpc-2669	24	8	th17	th17	PROPN
dpc-2669	24	9	are	be	AUX
dpc-2669	24	10	involved	involve	VERB
dpc-2669	24	11	in	in	ADP
dpc-2669	24	12	the	the	DET
dpc-2669	24	13	pathogenesis	pathogenesis	NOUN
dpc-2669	24	14	of	of	ADP
dpc-2669	24	15	psoriasis	psoriasis	NOUN
dpc-2669	24	16	and	and	CCONJ
dpc-2669	24	17	atherosclerosis	atherosclerosis	NOUN
dpc-2669	24	18	.	.	PUNCT
dpc-2669	25	1	although	although	SCONJ
dpc-2669	25	2	the	the	DET
dpc-2669	25	3	mechanisms	mechanism	NOUN
dpc-2669	25	4	underlying	underlie	VERB
dpc-2669	25	5	the	the	DET
dpc-2669	25	6	relationship	relationship	NOUN
dpc-2669	25	7	between	between	ADP
dpc-2669	25	8	these	these	DET
dpc-2669	25	9	two	two	NUM
dpc-2669	25	10	diseases	disease	NOUN
dpc-2669	25	11	are	be	AUX
dpc-2669	25	12	still	still	ADV
dpc-2669	25	13	poorly	poorly	ADV
dpc-2669	25	14	understood	understand	VERB
dpc-2669	25	15	,	,	PUNCT
dpc-2669	25	16	the	the	DET
dpc-2669	25	17	inflammatory	inflammatory	ADJ
dpc-2669	25	18	cytokine	cytokine	NOUN
dpc-2669	25	19	profile	profile	NOUN
dpc-2669	25	20	that	that	PRON
dpc-2669	25	21	plays	play	VERB
dpc-2669	25	22	a	a	DET
dpc-2669	25	23	fundamental	fundamental	ADJ
dpc-2669	25	24	role	role	NOUN
dpc-2669	25	25	in	in	ADP
dpc-2669	25	26	both	both	DET
dpc-2669	25	27	diseases	disease	NOUN
dpc-2669	25	28	seems	seem	VERB
dpc-2669	25	29	to	to	PART
dpc-2669	25	30	provide	provide	VERB
dpc-2669	25	31	a	a	DET
dpc-2669	25	32	common	common	ADJ
dpc-2669	25	33	pathogenic	pathogenic	ADJ
dpc-2669	25	34	basis	basis	NOUN
dpc-2669	26	1	[	[	X
dpc-2669	26	2	2	2	NUM
dpc-2669	26	3	]	]	PUNCT
dpc-2669	26	4	.	.	PUNCT
dpc-2669	27	1	tmao	tmao	PROPN
dpc-2669	27	2	(	(	PUNCT
dpc-2669	27	3	oxidized	oxidize	VERB
dpc-2669	27	4	product	product	NOUN
dpc-2669	27	5	of	of	ADP
dpc-2669	27	6	trimethylamine	trimethylamine	NOUN
dpc-2669	27	7	)	)	PUNCT
dpc-2669	27	8	is	be	AUX
dpc-2669	27	9	an	an	DET
dpc-2669	27	10	intestinal	intestinal	ADJ
dpc-2669	27	11	microbial	microbial	ADJ
dpc-2669	27	12	metabolite	metabolite	NOUN
dpc-2669	27	13	.	.	PUNCT
dpc-2669	28	1	most	most	ADJ
dpc-2669	28	2	of	of	ADP
dpc-2669	28	3	the	the	DET
dpc-2669	28	4	trimethylamine	trimethylamine	NOUN
dpc-2669	28	5	produced	produce	VERB
dpc-2669	28	6	from	from	ADP
dpc-2669	28	7	the	the	DET
dpc-2669	28	8	metabolism	metabolism	NOUN
dpc-2669	28	9	of	of	ADP
dpc-2669	28	10	choline	choline	NOUN
dpc-2669	28	11	and	and	CCONJ
dpc-2669	28	12	l	l	NOUN
dpc-2669	28	13	-	-	NOUN
dpc-2669	28	14	carnitine	carnitine	NOUN
dpc-2669	28	15	by	by	ADP
dpc-2669	28	16	intestinal	intestinal	ADJ
dpc-2669	28	17	bacteria	bacteria	NOUN
dpc-2669	28	18	is	be	AUX
dpc-2669	28	19	absorbed	absorb	VERB
dpc-2669	28	20	into	into	ADP
dpc-2669	28	21	the	the	DET
dpc-2669	28	22	bloodstream	bloodstream	NOUN
dpc-2669	28	23	and	and	CCONJ
dpc-2669	28	24	oxidized	oxidize	VERB
dpc-2669	28	25	to	to	ADP
dpc-2669	28	26	tmao	tmao	VERB
dpc-2669	28	27	by	by	ADP
dpc-2669	28	28	the	the	DET
dpc-2669	28	29	flavin	flavin	NOUN
dpc-2669	28	30	-	-	PUNCT
dpc-2669	28	31	containing	contain	VERB
dpc-2669	28	32	monooxygenase-3	monooxygenase-3	PROPN
dpc-2669	28	33	(	(	PUNCT
dpc-2669	28	34	fmo-3	fmo-3	NOUN
dpc-2669	28	35	)	)	PUNCT
dpc-2669	28	36	enzyme	enzyme	NOUN
dpc-2669	28	37	in	in	ADP
dpc-2669	28	38	the	the	DET
dpc-2669	28	39	liver	liver	NOUN
dpc-2669	28	40	[	[	X
dpc-2669	28	41	3	3	NUM
dpc-2669	28	42	]	]	PUNCT
dpc-2669	28	43	.	.	PUNCT
dpc-2669	29	1	increased	increase	VERB
dpc-2669	29	2	serum	serum	PROPN
dpc-2669	29	3	tmao	tmao	PROPN
dpc-2669	29	4	concentration	concentration	NOUN
dpc-2669	29	5	is	be	AUX
dpc-2669	29	6	associated	associate	VERB
dpc-2669	29	7	with	with	ADP
dpc-2669	29	8	intestinal	intestinal	ADJ
dpc-2669	29	9	dysbiosis	dysbiosis	NOUN
dpc-2669	29	10	[	[	X
dpc-2669	29	11	4	4	NUM
dpc-2669	29	12	]	]	PUNCT
dpc-2669	29	13	.	.	PUNCT
dpc-2669	30	1	remarkably	remarkably	ADV
dpc-2669	30	2	,	,	PUNCT
dpc-2669	30	3	a	a	DET
dpc-2669	30	4	dysbiotic	dysbiotic	ADJ
dpc-2669	30	5	microbiome	microbiome	NOUN
dpc-2669	30	6	similar	similar	ADJ
dpc-2669	30	7	to	to	ADP
dpc-2669	30	8	the	the	DET
dpc-2669	30	9	dysbiosis	dysbiosis	NOUN
dpc-2669	30	10	detected	detect	VERB
dpc-2669	30	11	in	in	ADP
dpc-2669	30	12	individuals	individual	NOUN
dpc-2669	30	13	with	with	ADP
dpc-2669	30	14	elevated	elevated	ADJ
dpc-2669	30	15	serum	serum	NOUN
dpc-2669	30	16	tmao	tmao	PROPN
dpc-2669	30	17	levels	level	NOUN
dpc-2669	30	18	has	have	AUX
dpc-2669	30	19	also	also	ADV
dpc-2669	30	20	been	be	AUX
dpc-2669	30	21	demonstrated	demonstrate	VERB
dpc-2669	30	22	in	in	ADP
dpc-2669	30	23	psoriasis	psoriasis	NOUN
dpc-2669	30	24	patients	patient	NOUN
dpc-2669	30	25	[	[	X
dpc-2669	30	26	5,6	5,6	NUM
dpc-2669	30	27	]	]	X
dpc-2669	30	28	.	.	PUNCT
dpc-2669	31	1	cross	cross	ADJ
dpc-2669	31	2	-	-	ADJ
dpc-2669	31	3	sectional	sectional	ADJ
dpc-2669	31	4	and	and	CCONJ
dpc-2669	31	5	prospective	prospective	ADJ
dpc-2669	31	6	studies	study	NOUN
dpc-2669	31	7	show	show	VERB
dpc-2669	31	8	a	a	DET
dpc-2669	31	9	positive	positive	ADJ
dpc-2669	31	10	association	association	NOUN
dpc-2669	31	11	between	between	ADP
dpc-2669	31	12	elevated	elevate	VERB
dpc-2669	31	13	plasma	plasma	NOUN
dpc-2669	31	14	tmao	tmao	NOUN
dpc-2669	31	15	levels	level	NOUN
dpc-2669	31	16	and	and	CCONJ
dpc-2669	31	17	increased	increase	VERB
dpc-2669	31	18	risk	risk	NOUN
dpc-2669	31	19	for	for	ADP
dpc-2669	31	20	major	major	ADJ
dpc-2669	31	21	cardiovascular	cardiovascular	ADJ
dpc-2669	31	22	events	event	NOUN
dpc-2669	31	23	.	.	PUNCT
dpc-2669	32	1	these	these	DET
dpc-2669	32	2	studies	study	NOUN
dpc-2669	32	3	demonstrated	demonstrate	VERB
dpc-2669	32	4	a	a	DET
dpc-2669	32	5	positive	positive	ADJ
dpc-2669	32	6	correlation	correlation	NOUN
dpc-2669	32	7	between	between	ADP
dpc-2669	32	8	circulating	circulate	VERB
dpc-2669	32	9	tmao	tmao	PROPN
dpc-2669	32	10	levels	level	NOUN
dpc-2669	32	11	and	and	CCONJ
dpc-2669	32	12	carotid	carotid	VERB
dpc-2669	32	13	intima	intima	ADJ
dpc-2669	32	14	-	-	PUNCT
dpc-2669	32	15	media	media	NOUN
dpc-2669	32	16	thickness	thickness	NOUN
dpc-2669	32	17	after	after	ADP
dpc-2669	32	18	controlling	control	VERB
dpc-2669	32	19	for	for	ADP
dpc-2669	32	20	strong	strong	ADJ
dpc-2669	32	21	predictors	predictor	NOUN
dpc-2669	32	22	of	of	ADP
dpc-2669	32	23	cardiovascular	cardiovascular	ADJ
dpc-2669	32	24	disease	disease	NOUN
dpc-2669	32	25	including	include	VERB
dpc-2669	32	26	age	age	NOUN
dpc-2669	32	27	,	,	PUNCT
dpc-2669	32	28	sex	sex	NOUN
dpc-2669	32	29	and	and	CCONJ
dpc-2669	32	30	visceral	visceral	ADJ
dpc-2669	32	31	fat	fat	ADJ
dpc-2669	32	32	mass	mass	NOUN
dpc-2669	32	33	[	[	X
dpc-2669	32	34	7,8	7,8	NUM
dpc-2669	32	35	]	]	PUNCT
dpc-2669	32	36	.	.	PUNCT
dpc-2669	33	1	due	due	ADP
dpc-2669	33	2	to	to	ADP
dpc-2669	33	3	similar	similar	ADJ
dpc-2669	33	4	laminar	laminar	ADJ
dpc-2669	33	5	flow	flow	NOUN
dpc-2669	33	6	properties	property	NOUN
dpc-2669	33	7	,	,	PUNCT
dpc-2669	33	8	imaging	imaging	NOUN
dpc-2669	33	9	of	of	ADP
dpc-2669	33	10	the	the	DET
dpc-2669	33	11	carotid	carotid	NOUN
dpc-2669	33	12	arterial	arterial	NOUN
dpc-2669	33	13	system	system	NOUN
dpc-2669	33	14	can	can	AUX
dpc-2669	33	15	provide	provide	VERB
dpc-2669	33	16	information	information	NOUN
dpc-2669	33	17	about	about	ADP
dpc-2669	33	18	coronary	coronary	ADJ
dpc-2669	33	19	atherosclerosis	atherosclerosis	NOUN
dpc-2669	33	20	.	.	PUNCT
dpc-2669	34	1	carotid	carotid	NOUN
dpc-2669	34	2	intima	intima	ADJ
dpc-2669	34	3	-	-	PUNCT
dpc-2669	34	4	media	media	NOUN
dpc-2669	34	5	thickness	thickness	NOUN
dpc-2669	34	6	(	(	PUNCT
dpc-2669	34	7	cimt	cimt	NOUN
dpc-2669	34	8	)	)	PUNCT
dpc-2669	34	9	measured	measure	VERB
dpc-2669	34	10	by	by	ADP
dpc-2669	34	11	b	b	NOUN
dpc-2669	34	12	-	-	PUNCT
dpc-2669	34	13	mode	mode	NOUN
dpc-2669	34	14	ultrasonography	ultrasonography	NOUN
dpc-2669	34	15	can	can	AUX
dpc-2669	34	16	reliably	reliably	ADV
dpc-2669	34	17	demonstrate	demonstrate	VERB
dpc-2669	34	18	changes	change	NOUN
dpc-2669	34	19	in	in	ADP
dpc-2669	34	20	the	the	DET
dpc-2669	34	21	arterial	arterial	ADJ
dpc-2669	34	22	wall	wall	NOUN
dpc-2669	35	1	[	[	X
dpc-2669	35	2	9,10	9,10	NUM
dpc-2669	35	3	]	]	X
dpc-2669	35	4	.	.	PUNCT
dpc-2669	36	1	objectives	objective	NOUN
dpc-2669	36	2	in	in	ADP
dpc-2669	36	3	this	this	DET
dpc-2669	36	4	study	study	NOUN
dpc-2669	36	5	,	,	PUNCT
dpc-2669	36	6	we	we	PRON
dpc-2669	36	7	aimed	aim	VERB
dpc-2669	36	8	to	to	PART
dpc-2669	36	9	compare	compare	VERB
dpc-2669	36	10	serum	serum	PROPN
dpc-2669	36	11	tmao	tmao	PROPN
dpc-2669	36	12	levels	level	NOUN
dpc-2669	36	13	in	in	ADP
dpc-2669	36	14	psoriasis	psoriasis	NOUN
dpc-2669	36	15	patients	patient	NOUN
dpc-2669	36	16	and	and	CCONJ
dpc-2669	36	17	healthy	healthy	ADJ
dpc-2669	36	18	participants	participant	NOUN
dpc-2669	36	19	and	and	CCONJ
dpc-2669	36	20	to	to	PART
dpc-2669	36	21	determine	determine	VERB
dpc-2669	36	22	the	the	DET
dpc-2669	36	23	relationship	relationship	NOUN
dpc-2669	36	24	between	between	ADP
dpc-2669	36	25	tmao	tmao	PROPN
dpc-2669	36	26	levels	level	NOUN
dpc-2669	36	27	and	and	CCONJ
dpc-2669	36	28	cimt	cimt	NOUN
dpc-2669	36	29	and	and	CCONJ
dpc-2669	36	30	other	other	ADJ
dpc-2669	36	31	atherosclerotic	atherosclerotic	ADJ
dpc-2669	36	32	risk	risk	NOUN
dpc-2669	36	33	factors	factor	NOUN
dpc-2669	36	34	in	in	ADP
dpc-2669	36	35	atherosclerotic	atherosclerotic	ADJ
dpc-2669	36	36	disease	disease	NOUN
dpc-2669	36	37	risk	risk	NOUN
dpc-2669	36	38	prediction	prediction	NOUN
dpc-2669	36	39	.	.	PUNCT
dpc-2669	37	1	methods	method	NOUN
dpc-2669	37	2	patients	patient	NOUN
dpc-2669	37	3	and	and	CCONJ
dpc-2669	37	4	controls	control	VERB
dpc-2669	37	5	seventy	seventy	NUM
dpc-2669	37	6	-	-	PUNCT
dpc-2669	37	7	three	three	NUM
dpc-2669	37	8	patients	patient	NOUN
dpc-2669	37	9	diagnosed	diagnose	VERB
dpc-2669	37	10	with	with	ADP
dpc-2669	37	11	plaque	plaque	NOUN
dpc-2669	37	12	psoriasis	psoriasis	NOUN
dpc-2669	37	13	(	(	PUNCT
dpc-2669	37	14	clinically	clinically	ADV
dpc-2669	37	15	and	and	CCONJ
dpc-2669	37	16	histopathologically	histopathologically	ADV
dpc-2669	37	17	)	)	PUNCT
dpc-2669	37	18	and	and	CCONJ
dpc-2669	37	19	72	72	NUM
dpc-2669	37	20	healthy	healthy	ADJ
dpc-2669	37	21	participants	participant	NOUN
dpc-2669	37	22	as	as	SCONJ
dpc-2669	37	23	the	the	DET
dpc-2669	37	24	control	control	NOUN
dpc-2669	37	25	group	group	NOUN
dpc-2669	37	26	were	be	AUX
dpc-2669	37	27	included	include	VERB
dpc-2669	37	28	in	in	ADP
dpc-2669	37	29	the	the	DET
dpc-2669	37	30	study	study	NOUN
dpc-2669	37	31	.	.	PUNCT
dpc-2669	38	1	an	an	DET
dpc-2669	38	2	informed	informed	ADJ
dpc-2669	38	3	consent	consent	NOUN
dpc-2669	38	4	form	form	NOUN
dpc-2669	38	5	was	be	AUX
dpc-2669	38	6	obtained	obtain	VERB
dpc-2669	38	7	from	from	ADP
dpc-2669	38	8	all	all	DET
dpc-2669	38	9	participants	participant	NOUN
dpc-2669	38	10	and	and	CCONJ
dpc-2669	38	11	they	they	PRON
dpc-2669	38	12	were	be	AUX
dpc-2669	38	13	informed	inform	VERB
dpc-2669	38	14	about	about	ADP
dpc-2669	38	15	the	the	DET
dpc-2669	38	16	study	study	NOUN
dpc-2669	38	17	.	.	PUNCT
dpc-2669	39	1	the	the	DET
dpc-2669	39	2	study	study	NOUN
dpc-2669	39	3	was	be	AUX
dpc-2669	39	4	conducted	conduct	VERB
dpc-2669	39	5	between	between	ADP
dpc-2669	39	6	01.06.2020	01.06.2020	NOUN
dpc-2669	39	7	and	and	CCONJ
dpc-2669	39	8	01.06.2021	01.06.2021	NOUN
dpc-2669	39	9	.	.	PUNCT
dpc-2669	40	1	the	the	DET
dpc-2669	40	2	exclusion	exclusion	NOUN
dpc-2669	40	3	criteria	criterion	NOUN
dpc-2669	40	4	were	be	AUX
dpc-2669	40	5	determined	determine	VERB
dpc-2669	40	6	as	as	SCONJ
dpc-2669	40	7	follows	follow	VERB
dpc-2669	40	8	:	:	PUNCT
dpc-2669	41	1	special	special	ADJ
dpc-2669	41	2	dietary	dietary	ADJ
dpc-2669	41	3	practices	practice	NOUN
dpc-2669	41	4	,	,	PUNCT
dpc-2669	41	5	continuous	continuous	ADJ
dpc-2669	41	6	use	use	NOUN
dpc-2669	41	7	of	of	ADP
dpc-2669	41	8	prebiotics	prebiotic	NOUN
dpc-2669	41	9	and	and	CCONJ
dpc-2669	41	10	probiotics	probiotic	NOUN
dpc-2669	41	11	consumption	consumption	NOUN
dpc-2669	41	12	of	of	ADP
dpc-2669	41	13	>	>	SYM
dpc-2669	41	14	2	2	NUM
dpc-2669	41	15	eggs	egg	NOUN
dpc-2669	41	16	per	per	ADP
dpc-2669	41	17	day	day	NOUN
dpc-2669	41	18	,	,	PUNCT
dpc-2669	41	19	meat	meat	NOUN
dpc-2669	41	20	and	and	CCONJ
dpc-2669	41	21	fish	fish	NOUN
dpc-2669	41	22	>	>	SYM
dpc-2669	41	23	3	3	NUM
dpc-2669	41	24	times	time	NOUN
dpc-2669	41	25	per	per	ADP
dpc-2669	41	26	week	week	NOUN
dpc-2669	41	27	use	use	NOUN
dpc-2669	41	28	of	of	ADP
dpc-2669	41	29	any	any	DET
dpc-2669	41	30	medication	medication	NOUN
dpc-2669	41	31	that	that	PRON
dpc-2669	41	32	may	may	AUX
dpc-2669	41	33	adversely	adversely	ADV
dpc-2669	41	34	affect	affect	VERB
dpc-2669	41	35	the	the	DET
dpc-2669	41	36	microbiota	microbiota	NOUN
dpc-2669	41	37	in	in	ADP
dpc-2669	41	38	the	the	DET
dpc-2669	41	39	last	last	ADJ
dpc-2669	41	40	1	1	NUM
dpc-2669	41	41	month	month	NOUN
dpc-2669	41	42	those	those	PRON
dpc-2669	41	43	diagnosed	diagnose	VERB
dpc-2669	41	44	with	with	ADP
dpc-2669	41	45	diseases	disease	NOUN
dpc-2669	41	46	that	that	PRON
dpc-2669	41	47	may	may	AUX
dpc-2669	41	48	affect	affect	VERB
dpc-2669	41	49	the	the	DET
dpc-2669	41	50	microbiome	microbiome	NOUN
dpc-2669	41	51	such	such	ADJ
dpc-2669	41	52	as	as	ADP
dpc-2669	41	53	inflammatory	inflammatory	ADJ
dpc-2669	41	54	bowel	bowel	NOUN
dpc-2669	41	55	diseases	disease	NOUN
dpc-2669	41	56	,	,	PUNCT
dpc-2669	41	57	irritable	irritable	ADJ
dpc-2669	41	58	bowel	bowel	NOUN
dpc-2669	41	59	disease	disease	NOUN
dpc-2669	41	60	those	those	PRON
dpc-2669	41	61	diagnosed	diagnose	VERB
dpc-2669	41	62	with	with	ADP
dpc-2669	41	63	diabetes	diabetes	NOUN
dpc-2669	41	64	mellitus	mellitus	NOUN
dpc-2669	41	65	,	,	PUNCT
dpc-2669	41	66	hypertension	hypertension	NOUN
dpc-2669	41	67	,	,	PUNCT
dpc-2669	41	68	hypercholesterolemia	hypercholesterolemia	NOUN
dpc-2669	41	69	and/or	and/or	CCONJ
dpc-2669	41	70	taking	take	VERB
dpc-2669	41	71	antidiabetic	antidiabetic	ADJ
dpc-2669	41	72	drugs	drug	NOUN
dpc-2669	41	73	,	,	PUNCT
dpc-2669	41	74	antihypertensive	antihypertensive	ADJ
dpc-2669	41	75	drugs	drug	NOUN
dpc-2669	41	76	,	,	PUNCT
dpc-2669	41	77	antihyperlipidemic	antihyperlipidemic	ADJ
dpc-2669	41	78	drugs	drug	NOUN
dpc-2669	41	79	thyroid	thyroid	NOUN
dpc-2669	41	80	disease	disease	NOUN
dpc-2669	41	81	,	,	PUNCT
dpc-2669	41	82	cardiovascular	cardiovascular	ADJ
dpc-2669	41	83	and	and	CCONJ
dpc-2669	41	84	cerebrovascular	cerebrovascular	ADJ
dpc-2669	41	85	diseases	disease	NOUN
dpc-2669	41	86	,	,	PUNCT
dpc-2669	41	87	peripheral	peripheral	ADJ
dpc-2669	41	88	vascular	vascular	ADJ
dpc-2669	41	89	disease	disease	NOUN
dpc-2669	41	90	and	and	CCONJ
dpc-2669	41	91	systemic	systemic	ADJ
dpc-2669	41	92	vasculitis	vasculitis	NOUN
dpc-2669	41	93	,	,	PUNCT
dpc-2669	41	94	chronic	chronic	ADJ
dpc-2669	41	95	kidney	kidney	NOUN
dpc-2669	41	96	/	/	SYM
dpc-2669	41	97	liver	liver	NOUN
dpc-2669	41	98	disease	disease	NOUN
dpc-2669	41	99	,	,	PUNCT
dpc-2669	41	100	systemic	systemic	ADJ
dpc-2669	41	101	infectious	infectious	ADJ
dpc-2669	41	102	disease	disease	NOUN
dpc-2669	41	103	,	,	PUNCT
dpc-2669	41	104	collagen	collagen	NOUN
dpc-2669	41	105	tissue	tissue	NOUN
dpc-2669	41	106	disease	disease	NOUN
dpc-2669	41	107	and/or	and/or	CCONJ
dpc-2669	41	108	antiaggregant/	antiaggregant/	NUM
dpc-2669	41	109	anticoagulant	anticoagulant	ADJ
dpc-2669	41	110	drug	drug	NOUN
dpc-2669	41	111	users	user	NOUN
dpc-2669	41	112	use	use	NOUN
dpc-2669	41	113	of	of	ADP
dpc-2669	41	114	methotrexate	methotrexate	NOUN
dpc-2669	41	115	,	,	PUNCT
dpc-2669	41	116	cyclosporine	cyclosporine	NOUN
dpc-2669	41	117	,	,	PUNCT
dpc-2669	41	118	biologic	biologic	ADJ
dpc-2669	41	119	agents	agent	NOUN
dpc-2669	41	120	,	,	PUNCT
dpc-2669	41	121	systemic	systemic	ADJ
dpc-2669	41	122	steroid	steroid	NOUN
dpc-2669	41	123	and	and	CCONJ
dpc-2669	41	124	hormonal	hormonal	ADJ
dpc-2669	41	125	therapy	therapy	NOUN
dpc-2669	41	126	in	in	ADP
dpc-2669	41	127	the	the	DET
dpc-2669	41	128	last	last	ADJ
dpc-2669	41	129	3	3	NUM
dpc-2669	41	130	months	month	NOUN
dpc-2669	41	131	malignancy	malignancy	NOUN
dpc-2669	41	132	,	,	PUNCT
dpc-2669	41	133	pregnancy	pregnancy	NOUN
dpc-2669	41	134	,	,	PUNCT
dpc-2669	41	135	breastfeeding	breastfeed	VERB
dpc-2669	41	136	patients	patient	NOUN
dpc-2669	41	137	under	under	ADP
dpc-2669	41	138	18	18	NUM
dpc-2669	41	139	years	year	NOUN
dpc-2669	41	140	of	of	ADP
dpc-2669	41	141	age	age	NOUN
dpc-2669	41	142	obesity	obesity	NOUN
dpc-2669	41	143	,	,	PUNCT
dpc-2669	41	144	smokers	smoker	NOUN
dpc-2669	41	145	,	,	PUNCT
dpc-2669	41	146	drinkers	drinker	NOUN
dpc-2669	41	147	difference	difference	NOUN
dpc-2669	41	148	between	between	ADP
dpc-2669	41	149	the	the	DET
dpc-2669	41	150	two	two	NUM
dpc-2669	41	151	groups	group	NOUN
dpc-2669	41	152	in	in	ADP
dpc-2669	41	153	terms	term	NOUN
dpc-2669	41	154	of	of	ADP
dpc-2669	41	155	total	total	ADJ
dpc-2669	41	156	cholesterol	cholesterol	NOUN
dpc-2669	41	157	and	and	CCONJ
dpc-2669	41	158	ldl	ldl	NOUN
dpc-2669	41	159	-	-	PUNCT
dpc-2669	41	160	c	c	NOUN
dpc-2669	41	161	levels	level	NOUN
dpc-2669	41	162	.	.	PUNCT
dpc-2669	42	1	in	in	ADP
dpc-2669	42	2	partial	partial	ADJ
dpc-2669	42	3	correlation	correlation	NOUN
dpc-2669	42	4	analyzes	analyze	VERB
dpc-2669	42	5	in	in	ADP
dpc-2669	42	6	the	the	DET
dpc-2669	42	7	patient	patient	NOUN
dpc-2669	42	8	group	group	NOUN
dpc-2669	42	9	,	,	PUNCT
dpc-2669	42	10	positive	positive	ADJ
dpc-2669	42	11	correlations	correlation	NOUN
dpc-2669	42	12	were	be	AUX
dpc-2669	42	13	observed	observe	VERB
dpc-2669	42	14	between	between	ADP
dpc-2669	42	15	tmao	tmao	PROPN
dpc-2669	42	16	and	and	CCONJ
dpc-2669	42	17	cimt	cimt	NOUN
dpc-2669	42	18	,	,	PUNCT
dpc-2669	42	19	ldl	ldl	NOUN
dpc-2669	42	20	-	-	PUNCT
dpc-2669	42	21	c	c	PROPN
dpc-2669	42	22	and	and	CCONJ
dpc-2669	42	23	total	total	ADJ
dpc-2669	42	24	cholesterol	cholesterol	NOUN
dpc-2669	42	25	levels	level	NOUN
dpc-2669	42	26	.	.	PUNCT
dpc-2669	43	1	linear	linear	ADJ
dpc-2669	43	2	regression	regression	NOUN
dpc-2669	43	3	analysis	analysis	NOUN
dpc-2669	43	4	showed	show	VERB
dpc-2669	43	5	that	that	SCONJ
dpc-2669	43	6	tmao	tmao	PROPN
dpc-2669	43	7	levels	level	NOUN
dpc-2669	43	8	positively	positively	ADV
dpc-2669	43	9	predicted	predict	VERB
dpc-2669	43	10	cimt	cimt	NOUN
dpc-2669	43	11	levels	level	NOUN
dpc-2669	43	12	.	.	PUNCT
dpc-2669	44	1	conclusions	conclusion	NOUN
dpc-2669	44	2	:	:	PUNCT
dpc-2669	44	3	this	this	DET
dpc-2669	44	4	study	study	NOUN
dpc-2669	44	5	confirmed	confirm	VERB
dpc-2669	44	6	that	that	SCONJ
dpc-2669	44	7	psoriasis	psoriasis	NOUN
dpc-2669	44	8	is	be	AUX
dpc-2669	44	9	a	a	DET
dpc-2669	44	10	risk	risk	NOUN
dpc-2669	44	11	factor	factor	NOUN
dpc-2669	44	12	for	for	ADP
dpc-2669	44	13	the	the	DET
dpc-2669	44	14	development	development	NOUN
dpc-2669	44	15	of	of	ADP
dpc-2669	44	16	cardiovascular	cardiovascular	ADJ
dpc-2669	44	17	disease	disease	NOUN
dpc-2669	44	18	and	and	CCONJ
dpc-2669	44	19	that	that	SCONJ
dpc-2669	44	20	elevated	elevated	ADJ
dpc-2669	44	21	serum	serum	NOUN
dpc-2669	44	22	tmao	tmao	PROPN
dpc-2669	44	23	levels	level	NOUN
dpc-2669	44	24	in	in	ADP
dpc-2669	44	25	these	these	DET
dpc-2669	44	26	patients	patient	NOUN
dpc-2669	44	27	indicate	indicate	VERB
dpc-2669	44	28	the	the	DET
dpc-2669	44	29	presence	presence	NOUN
dpc-2669	44	30	of	of	ADP
dpc-2669	44	31	intestinal	intestinal	ADJ
dpc-2669	44	32	dysbiosis	dysbiosis	NOUN
dpc-2669	44	33	.	.	PUNCT
dpc-2669	45	1	furthermore	furthermore	ADV
dpc-2669	45	2	,	,	PUNCT
dpc-2669	45	3	tmao	tmao	PROPN
dpc-2669	45	4	levels	level	NOUN
dpc-2669	45	5	were	be	AUX
dpc-2669	45	6	found	find	VERB
dpc-2669	45	7	to	to	PART
dpc-2669	45	8	be	be	AUX
dpc-2669	45	9	a	a	DET
dpc-2669	45	10	predictor	predictor	NOUN
dpc-2669	45	11	of	of	ADP
dpc-2669	45	12	the	the	DET
dpc-2669	45	13	risk	risk	NOUN
dpc-2669	45	14	of	of	ADP
dpc-2669	45	15	developing	develop	VERB
dpc-2669	45	16	cardiovascular	cardiovascular	ADJ
dpc-2669	45	17	disease	disease	NOUN
dpc-2669	45	18	in	in	ADP
dpc-2669	45	19	psoriasis	psoriasis	NOUN
dpc-2669	45	20	patients	patient	NOUN
dpc-2669	45	21	.	.	PUNCT
dpc-2669	46	1	original	original	ADJ
dpc-2669	46	2	article	article	NOUN
dpc-2669	46	3	|	|	ADV
dpc-2669	46	4	dermatol	dermatol	ADJ
dpc-2669	46	5	pract	pract	NOUN
dpc-2669	46	6	concept	concept	NOUN
dpc-2669	46	7	.	.	PUNCT
dpc-2669	47	1	2023;13(2):e2023116	2023;13(2):e2023116	NUM
dpc-2669	47	2	3	3	NUM
dpc-2669	47	3	demographic	demographic	ADJ
dpc-2669	47	4	information	information	NOUN
dpc-2669	47	5	of	of	ADP
dpc-2669	47	6	all	all	DET
dpc-2669	47	7	participants	participant	NOUN
dpc-2669	47	8	was	be	AUX
dpc-2669	47	9	recorded	record	VERB
dpc-2669	47	10	and	and	CCONJ
dpc-2669	47	11	systolic	systolic	ADJ
dpc-2669	47	12	/	/	SYM
dpc-2669	47	13	diastolic	diastolic	NOUN
dpc-2669	47	14	blood	blood	NOUN
dpc-2669	47	15	pressure	pressure	NOUN
dpc-2669	47	16	was	be	AUX
dpc-2669	47	17	measured	measure	VERB
dpc-2669	47	18	from	from	ADP
dpc-2669	47	19	the	the	DET
dpc-2669	47	20	brachial	brachial	ADJ
dpc-2669	47	21	artery	artery	NOUN
dpc-2669	47	22	after	after	ADP
dpc-2669	47	23	5	5	NUM
dpc-2669	47	24	minutes	minute	NOUN
dpc-2669	47	25	of	of	ADP
dpc-2669	47	26	rest	rest	NOUN
dpc-2669	47	27	.	.	PUNCT
dpc-2669	48	1	body	body	NOUN
dpc-2669	48	2	-	-	PUNCT
dpc-2669	48	3	mass	mass	NOUN
dpc-2669	48	4	index	index	NOUN
dpc-2669	48	5	(	(	PUNCT
dpc-2669	48	6	bmi	bmi	PROPN
dpc-2669	48	7	)	)	PUNCT
dpc-2669	48	8	of	of	ADP
dpc-2669	48	9	all	all	DET
dpc-2669	48	10	participants	participant	NOUN
dpc-2669	48	11	and	and	CCONJ
dpc-2669	48	12	psoriasis	psoriasis	NOUN
dpc-2669	48	13	area	area	NOUN
dpc-2669	48	14	severity	severity	NOUN
dpc-2669	48	15	index	index	NOUN
dpc-2669	48	16	(	(	PUNCT
dpc-2669	48	17	pasi	pasi	NOUN
dpc-2669	48	18	)	)	PUNCT
dpc-2669	48	19	of	of	ADP
dpc-2669	48	20	patients	patient	NOUN
dpc-2669	48	21	were	be	AUX
dpc-2669	48	22	calculated	calculate	VERB
dpc-2669	48	23	and	and	CCONJ
dpc-2669	48	24	recorded	record	VERB
dpc-2669	48	25	.	.	PUNCT
dpc-2669	49	1	tmao	tmao	PROPN
dpc-2669	49	2	,	,	PUNCT
dpc-2669	49	3	oxidized	oxidize	VERB
dpc-2669	49	4	-	-	PUNCT
dpc-2669	49	5	ldl	ldl	NOUN
dpc-2669	49	6	,	,	PUNCT
dpc-2669	49	7	hs	hs	PROPN
dpc-2669	49	8	-	-	PROPN
dpc-2669	49	9	crp	crp	PROPN
dpc-2669	49	10	,	,	PUNCT
dpc-2669	49	11	cholesterol	cholesterol	NOUN
dpc-2669	49	12	panel	panel	NOUN
dpc-2669	49	13	,	,	PUNCT
dpc-2669	49	14	alt	alt	ADJ
dpc-2669	49	15	-	-	PUNCT
dpc-2669	49	16	ast	ast	NOUN
dpc-2669	49	17	,	,	PUNCT
dpc-2669	49	18	creatinine	creatinine	NOUN
dpc-2669	49	19	,	,	PUNCT
dpc-2669	49	20	alt	alt	ADJ
dpc-2669	49	21	-	-	PUNCT
dpc-2669	49	22	ast	ast	ADJ
dpc-2669	49	23	,	,	PUNCT
dpc-2669	49	24	creatinine	creatinine	NOUN
dpc-2669	49	25	levels	level	NOUN
dpc-2669	49	26	were	be	AUX
dpc-2669	49	27	determined	determine	VERB
dpc-2669	49	28	in	in	ADP
dpc-2669	49	29	serum	serum	NOUN
dpc-2669	49	30	samples	sample	NOUN
dpc-2669	49	31	obtained	obtain	VERB
dpc-2669	49	32	after	after	ADP
dpc-2669	49	33	12	12	NUM
dpc-2669	49	34	hours	hour	NOUN
dpc-2669	49	35	of	of	ADP
dpc-2669	49	36	fasting	fasting	NOUN
dpc-2669	49	37	.	.	PUNCT
dpc-2669	50	1	right	right	INTJ
dpc-2669	50	2	and	and	CCONJ
dpc-2669	50	3	left	leave	VERB
dpc-2669	50	4	carotid	carotid	NOUN
dpc-2669	50	5	intima	intima	ADJ
dpc-2669	50	6	-	-	PUNCT
dpc-2669	50	7	media	medium	NOUN
dpc-2669	50	8	thicknesses	thickness	NOUN
dpc-2669	50	9	were	be	AUX
dpc-2669	50	10	measured	measure	VERB
dpc-2669	50	11	and	and	CCONJ
dpc-2669	50	12	recorded	record	VERB
dpc-2669	50	13	in	in	ADP
dpc-2669	50	14	all	all	DET
dpc-2669	50	15	participants	participant	NOUN
dpc-2669	50	16	.	.	PUNCT
dpc-2669	51	1	measurement	measurement	NOUN
dpc-2669	51	2	of	of	ADP
dpc-2669	51	3	biochemical	biochemical	ADJ
dpc-2669	51	4	markers	marker	NOUN
dpc-2669	51	5	blood	blood	NOUN
dpc-2669	51	6	samples	sample	NOUN
dpc-2669	51	7	were	be	AUX
dpc-2669	51	8	collected	collect	VERB
dpc-2669	51	9	from	from	ADP
dpc-2669	51	10	the	the	DET
dpc-2669	51	11	antecubital	antecubital	ADJ
dpc-2669	51	12	regions	region	NOUN
dpc-2669	51	13	of	of	ADP
dpc-2669	51	14	the	the	DET
dpc-2669	51	15	participants	participant	NOUN
dpc-2669	51	16	into	into	ADP
dpc-2669	51	17	gel	gel	NOUN
dpc-2669	51	18	propylene	propylene	NOUN
dpc-2669	51	19	tubes	tube	NOUN
dpc-2669	51	20	using	use	VERB
dpc-2669	51	21	a	a	DET
dpc-2669	51	22	vacutainer	vacutainer	NOUN
dpc-2669	51	23	.	.	PUNCT
dpc-2669	52	1	blood	blood	NOUN
dpc-2669	52	2	samples	sample	NOUN
dpc-2669	52	3	were	be	AUX
dpc-2669	52	4	allowed	allow	VERB
dpc-2669	52	5	to	to	PART
dpc-2669	52	6	clot	clot	VERB
dpc-2669	52	7	for	for	ADP
dpc-2669	52	8	20	20	NUM
dpc-2669	52	9	  	  	SPACE
dpc-2669	52	10	minutes	minute	NOUN
dpc-2669	52	11	,	,	PUNCT
dpc-2669	52	12	centrifuged	centrifuge	VERB
dpc-2669	52	13	at	at	ADP
dpc-2669	52	14	3000	3000	NUM
dpc-2669	52	15	rpm	rpm	NOUN
dpc-2669	52	16	for	for	ADP
dpc-2669	52	17	10	10	NUM
dpc-2669	52	18	minutes	minute	NOUN
dpc-2669	52	19	and	and	CCONJ
dpc-2669	52	20	stored	store	VERB
dpc-2669	52	21	at	at	ADP
dpc-2669	52	22	-80	-80	NOUN
dpc-2669	52	23	°	°	NOUN
dpc-2669	52	24	c	c	NOUN
dpc-2669	52	25	until	until	ADP
dpc-2669	52	26	the	the	DET
dpc-2669	52	27	study	study	NOUN
dpc-2669	52	28	day	day	NOUN
dpc-2669	52	29	.	.	PUNCT
dpc-2669	53	1	frozen	frozen	ADJ
dpc-2669	53	2	serum	serum	NOUN
dpc-2669	53	3	samples	sample	NOUN
dpc-2669	53	4	were	be	AUX
dpc-2669	53	5	kept	keep	VERB
dpc-2669	53	6	at	at	ADP
dpc-2669	53	7	room	room	NOUN
dpc-2669	53	8	temperature	temperature	NOUN
dpc-2669	53	9	on	on	ADP
dpc-2669	53	10	the	the	DET
dpc-2669	53	11	study	study	NOUN
dpc-2669	53	12	day	day	NOUN
dpc-2669	53	13	and	and	CCONJ
dpc-2669	53	14	the	the	DET
dpc-2669	53	15	samples	sample	NOUN
dpc-2669	53	16	were	be	AUX
dpc-2669	53	17	thawed	thaw	VERB
dpc-2669	53	18	.	.	PUNCT
dpc-2669	54	1	mybiosource	mybiosource	PROPN
dpc-2669	54	2	brand	brand	PROPN
dpc-2669	54	3	oxidized	oxidize	VERB
dpc-2669	54	4	ldl	ldl	NOUN
dpc-2669	54	5	(	(	PUNCT
dpc-2669	54	6	catalog	catalog	NOUN
dpc-2669	54	7	no	no	NOUN
dpc-2669	54	8	:	:	PUNCT
dpc-2669	54	9	mbs265658	mbs265658	ADJ
dpc-2669	54	10	)	)	PUNCT
dpc-2669	54	11	commercial	commercial	ADJ
dpc-2669	54	12	kit	kit	NOUN
dpc-2669	54	13	for	for	ADP
dpc-2669	54	14	oxidized	oxidize	VERB
dpc-2669	54	15	-	-	PUNCT
dpc-2669	54	16	ldl	ldl	NOUN
dpc-2669	54	17	analysis	analysis	NOUN
dpc-2669	54	18	and	and	CCONJ
dpc-2669	54	19	mybiosource	mybiosource	PROPN
dpc-2669	54	20	brand	brand	PROPN
dpc-2669	54	21	tmao	tmao	PROPN
dpc-2669	54	22	(	(	PUNCT
dpc-2669	54	23	catalog	catalog	NOUN
dpc-2669	54	24	no	no	NOUN
dpc-2669	54	25	:	:	PUNCT
dpc-2669	54	26	mbs7254766	mbs7254766	ADJ
dpc-2669	54	27	)	)	PUNCT
dpc-2669	54	28	commercial	commercial	ADJ
dpc-2669	54	29	kits	kit	NOUN
dpc-2669	54	30	for	for	ADP
dpc-2669	54	31	tmao	tmao	NOUN
dpc-2669	54	32	analysis	analysis	NOUN
dpc-2669	54	33	were	be	AUX
dpc-2669	54	34	used	use	VERB
dpc-2669	54	35	.	.	PUNCT
dpc-2669	55	1	analyzes	analyze	NOUN
dpc-2669	55	2	were	be	AUX
dpc-2669	55	3	performed	perform	VERB
dpc-2669	55	4	using	use	VERB
dpc-2669	55	5	rayto	rayto	VERB
dpc-2669	55	6	rt-2600microplate	rt-2600microplate	X
dpc-2669	55	7	washer	washer	NOUN
dpc-2669	55	8	and	and	CCONJ
dpc-2669	55	9	bmg	bmg	PROPN
dpc-2669	55	10	labtech	labtech	ADJ
dpc-2669	55	11	enzyme	enzyme	NOUN
dpc-2669	55	12	-	-	PUNCT
dpc-2669	55	13	linked	link	VERB
dpc-2669	55	14	immunosorbent	immunosorbent	NOUN
dpc-2669	55	15	assay	assay	PROPN
dpc-2669	55	16	(	(	PUNCT
dpc-2669	55	17	elisa	elisa	NOUN
dpc-2669	55	18	)	)	PUNCT
dpc-2669	55	19	reader	reader	NOUN
dpc-2669	55	20	.	.	PUNCT
dpc-2669	56	1	the	the	DET
dpc-2669	56	2	quantitation	quantitation	NOUN
dpc-2669	56	3	limits	limit	VERB
dpc-2669	56	4	for	for	ADP
dpc-2669	56	5	the	the	DET
dpc-2669	56	6	oxidized	oxidize	VERB
dpc-2669	56	7	ldl	ldl	NOUN
dpc-2669	56	8	kit	kit	NOUN
dpc-2669	56	9	are	be	AUX
dpc-2669	56	10	31.2	31.2	NUM
dpc-2669	56	11	-	-	SYM
dpc-2669	56	12	2000	2000	NUM
dpc-2669	56	13	pg	pg	NOUN
dpc-2669	56	14	/	/	SYM
dpc-2669	56	15	ml	ml	ADP
dpc-2669	56	16	,	,	PUNCT
dpc-2669	56	17	and	and	CCONJ
dpc-2669	56	18	the	the	DET
dpc-2669	56	19	quantitation	quantitation	NOUN
dpc-2669	56	20	limits	limit	NOUN
dpc-2669	56	21	for	for	ADP
dpc-2669	56	22	tmao	tmao	PROPN
dpc-2669	56	23	are	be	AUX
dpc-2669	56	24	0	0	NUM
dpc-2669	56	25	-	-	SYM
dpc-2669	56	26	100	100	NUM
dpc-2669	56	27	ng	ng	PROPN
dpc-2669	56	28	/	/	SYM
dpc-2669	56	29	ml	ml	NOUN
dpc-2669	56	30	.	.	PUNCT
dpc-2669	57	1	samples	sample	NOUN
dpc-2669	57	2	were	be	AUX
dpc-2669	57	3	diluted	dilute	VERB
dpc-2669	57	4	1/10	1/10	NUM
dpc-2669	57	5	before	before	ADP
dpc-2669	57	6	the	the	DET
dpc-2669	57	7	study	study	NOUN
dpc-2669	57	8	.	.	PUNCT
dpc-2669	58	1	alt	alt	ADJ
dpc-2669	58	2	,	,	PUNCT
dpc-2669	58	3	ast	ast	PROPN
dpc-2669	58	4	,	,	PUNCT
dpc-2669	58	5	creatinine	creatinine	NOUN
dpc-2669	58	6	,	,	PUNCT
dpc-2669	58	7	total	total	ADJ
dpc-2669	58	8	cholesterol	cholesterol	NOUN
dpc-2669	58	9	,	,	PUNCT
dpc-2669	58	10	triglyceride	triglyceride	ADJ
dpc-2669	58	11	,	,	PUNCT
dpc-2669	58	12	hdl	hdl	NOUN
dpc-2669	58	13	-	-	PUNCT
dpc-2669	58	14	cholesterol	cholesterol	NOUN
dpc-2669	58	15	,	,	PUNCT
dpc-2669	58	16	total	total	ADJ
dpc-2669	58	17	cholesterol	cholesterol	NOUN
dpc-2669	58	18	,	,	PUNCT
dpc-2669	58	19	triglyceride	triglyceride	ADJ
dpc-2669	58	20	,	,	PUNCT
dpc-2669	58	21	hdl	hdl	ADJ
dpc-2669	58	22	-	-	PUNCT
dpc-2669	58	23	cholesterol	cholesterol	NOUN
dpc-2669	58	24	levels	level	NOUN
dpc-2669	58	25	were	be	AUX
dpc-2669	58	26	analyzed	analyze	VERB
dpc-2669	58	27	by	by	ADP
dpc-2669	58	28	spectrophotometric	spectrophotometric	ADJ
dpc-2669	58	29	method	method	NOUN
dpc-2669	58	30	on	on	ADP
dpc-2669	58	31	beckman	beckman	PROPN
dpc-2669	58	32	coulter	coulter	PROPN
dpc-2669	58	33	au5800	au5800	PROPN
dpc-2669	58	34	series	series	PROPN
dpc-2669	58	35	using	use	VERB
dpc-2669	58	36	beckman	beckman	PROPN
dpc-2669	58	37	coulter	coulter	PROPN
dpc-2669	58	38	commercial	commercial	PROPN
dpc-2669	58	39	kits	kits	PROPN
dpc-2669	58	40	.	.	PUNCT
dpc-2669	59	1	hs	hs	PROPN
dpc-2669	59	2	-	-	PUNCT
dpc-2669	59	3	crp	crp	PROPN
dpc-2669	59	4	levels	level	NOUN
dpc-2669	59	5	were	be	AUX
dpc-2669	59	6	analyzed	analyze	VERB
dpc-2669	59	7	by	by	ADP
dpc-2669	59	8	immunoturbidimetric	immunoturbidimetric	ADJ
dpc-2669	59	9	method	method	NOUN
dpc-2669	59	10	using	use	VERB
dpc-2669	59	11	beckman	beckman	PROPN
dpc-2669	59	12	coulter	coulter	PROPN
dpc-2669	59	13	brand	brand	PROPN
dpc-2669	59	14	commercial	commercial	PROPN
dpc-2669	59	15	kits	kit	NOUN
dpc-2669	59	16	in	in	ADP
dpc-2669	59	17	beckman	beckman	PROPN
dpc-2669	59	18	coulter	coulter	PROPN
dpc-2669	59	19	au5800	au5800	PROPN
dpc-2669	59	20	series	series	PROPN
dpc-2669	59	21	device	device	NOUN
dpc-2669	59	22	.	.	PUNCT
dpc-2669	60	1	measurement	measurement	NOUN
dpc-2669	60	2	of	of	ADP
dpc-2669	60	3	carotid	carotid	ADJ
dpc-2669	60	4	intima	intima	ADJ
dpc-2669	60	5	-	-	PUNCT
dpc-2669	60	6	media	media	NOUN
dpc-2669	60	7	thickness	thickness	NOUN
dpc-2669	60	8	carotid	carotid	NOUN
dpc-2669	60	9	artery	artery	NOUN
dpc-2669	60	10	ultrasound	ultrasound	NOUN
dpc-2669	60	11	to	to	PART
dpc-2669	60	12	measure	measure	VERB
dpc-2669	60	13	carotid	carotid	NOUN
dpc-2669	60	14	intima	intima	ADJ
dpc-2669	60	15	-	-	PUNCT
dpc-2669	60	16	media	medium	NOUN
dpc-2669	60	17	thickness	thickness	NOUN
dpc-2669	60	18	was	be	AUX
dpc-2669	60	19	performed	perform	VERB
dpc-2669	60	20	by	by	ADP
dpc-2669	60	21	a	a	DET
dpc-2669	60	22	cardiologist	cardiologist	NOUN
dpc-2669	60	23	using	use	VERB
dpc-2669	60	24	a	a	DET
dpc-2669	60	25	commercially	commercially	ADV
dpc-2669	60	26	available	available	ADJ
dpc-2669	60	27	ultrasound	ultrasound	NOUN
dpc-2669	60	28	system	system	NOUN
dpc-2669	60	29	(	(	PUNCT
dpc-2669	60	30	vivid	vivid	PROPN
dpc-2669	60	31	e9	e9	PROPN
dpc-2669	60	32	,	,	PUNCT
dpc-2669	60	33	ge	ge	PROPN
dpc-2669	60	34	vingmed	vingme	VERB
dpc-2669	60	35	)	)	PUNCT
dpc-2669	60	36	and	and	CCONJ
dpc-2669	60	37	a	a	DET
dpc-2669	60	38	linear	linear	ADJ
dpc-2669	60	39	transducer	transducer	NOUN
dpc-2669	60	40	probe	probe	NOUN
dpc-2669	60	41	(	(	PUNCT
dpc-2669	60	42	11l	11l	PROPN
dpc-2669	60	43	-	-	SYM
dpc-2669	60	44	d	d	NOUN
dpc-2669	60	45	,	,	PUNCT
dpc-2669	60	46	5	5	NUM
dpc-2669	60	47	-	-	SYM
dpc-2669	60	48	12	12	NUM
dpc-2669	60	49	mhz	mhz	NOUN
dpc-2669	60	50	)	)	PUNCT
dpc-2669	60	51	.	.	PUNCT
dpc-2669	61	1	participants	participant	NOUN
dpc-2669	61	2	were	be	AUX
dpc-2669	61	3	examined	examine	VERB
dpc-2669	61	4	in	in	ADP
dpc-2669	61	5	the	the	DET
dpc-2669	61	6	supine	supine	ADJ
dpc-2669	61	7	position	position	NOUN
dpc-2669	61	8	after	after	ADP
dpc-2669	61	9	resting	rest	VERB
dpc-2669	61	10	for	for	ADP
dpc-2669	61	11	at	at	ADV
dpc-2669	61	12	least	least	ADV
dpc-2669	61	13	5	5	NUM
dpc-2669	61	14	minutes	minute	NOUN
dpc-2669	61	15	.	.	PUNCT
dpc-2669	62	1	imaging	imaging	NOUN
dpc-2669	62	2	of	of	ADP
dpc-2669	62	3	both	both	DET
dpc-2669	62	4	arteria	arteria	PROPN
dpc-2669	62	5	carotids	carotid	NOUN
dpc-2669	62	6	communis	communis	NOUN
dpc-2669	62	7	was	be	AUX
dpc-2669	62	8	performed	perform	VERB
dpc-2669	62	9	with	with	ADP
dpc-2669	62	10	the	the	DET
dpc-2669	62	11	participants	participant	NOUN
dpc-2669	62	12	'	'	PART
dpc-2669	62	13	head	head	NOUN
dpc-2669	62	14	in	in	ADP
dpc-2669	62	15	a	a	DET
dpc-2669	62	16	slightly	slightly	ADV
dpc-2669	62	17	extended	extended	ADJ
dpc-2669	62	18	and	and	CCONJ
dpc-2669	62	19	slightly	slightly	ADV
dpc-2669	62	20	retracted	retracted	ADJ
dpc-2669	62	21	position	position	NOUN
dpc-2669	62	22	with	with	ADP
dpc-2669	62	23	the	the	DET
dpc-2669	62	24	carotid	carotid	NOUN
dpc-2669	62	25	bifurcation	bifurcation	NOUN
dpc-2669	62	26	as	as	ADP
dpc-2669	62	27	the	the	DET
dpc-2669	62	28	reference	reference	NOUN
dpc-2669	62	29	point	point	NOUN
dpc-2669	62	30	.	.	PUNCT
dpc-2669	63	1	two	two	NUM
dpc-2669	63	2	-	-	PUNCT
dpc-2669	63	3	dimensional	dimensional	ADJ
dpc-2669	63	4	,	,	PUNCT
dpc-2669	63	5	real	real	ADJ
dpc-2669	63	6	-	-	PUNCT
dpc-2669	63	7	time	time	NOUN
dpc-2669	63	8	,	,	PUNCT
dpc-2669	63	9	grayscale	grayscale	NOUN
dpc-2669	63	10	images	image	NOUN
dpc-2669	63	11	in	in	ADP
dpc-2669	63	12	the	the	DET
dpc-2669	63	13	longitudinal	longitudinal	ADJ
dpc-2669	63	14	plane	plane	NOUN
dpc-2669	63	15	were	be	AUX
dpc-2669	63	16	acquired	acquire	VERB
dpc-2669	63	17	at	at	ADP
dpc-2669	63	18	frame	frame	NOUN
dpc-2669	63	19	rates	rate	NOUN
dpc-2669	63	20	of	of	ADP
dpc-2669	63	21	20	20	NUM
dpc-2669	63	22	-	-	SYM
dpc-2669	63	23	50	50	NUM
dpc-2669	63	24	fps	fps	NOUN
dpc-2669	63	25	with	with	ADP
dpc-2669	63	26	focus	focus	NOUN
dpc-2669	63	27	and	and	CCONJ
dpc-2669	63	28	gain	gain	VERB
dpc-2669	63	29	settings	setting	NOUN
dpc-2669	63	30	adjusted	adjust	VERB
dpc-2669	63	31	to	to	PART
dpc-2669	63	32	maximize	maximize	VERB
dpc-2669	63	33	visibility	visibility	NOUN
dpc-2669	63	34	of	of	ADP
dpc-2669	63	35	the	the	DET
dpc-2669	63	36	near	near	ADJ
dpc-2669	63	37	and	and	CCONJ
dpc-2669	63	38	far	far	ADJ
dpc-2669	63	39	wall	wall	NOUN
dpc-2669	63	40	of	of	ADP
dpc-2669	63	41	the	the	DET
dpc-2669	63	42	artery	artery	NOUN
dpc-2669	63	43	.	.	PUNCT
dpc-2669	64	1	statistical	statistical	ADJ
dpc-2669	64	2	method	method	NOUN
dpc-2669	64	3	all	all	DET
dpc-2669	64	4	data	datum	NOUN
dpc-2669	64	5	were	be	AUX
dpc-2669	64	6	analyzed	analyze	VERB
dpc-2669	64	7	in	in	ADP
dpc-2669	64	8	computer	computer	NOUN
dpc-2669	64	9	environment	environment	NOUN
dpc-2669	64	10	using	use	VERB
dpc-2669	64	11	spss	spss	PROPN
dpc-2669	64	12	22.0	22.0	NUM
dpc-2669	64	13	package	package	NOUN
dpc-2669	64	14	program	program	NOUN
dpc-2669	64	15	.	.	PUNCT
dpc-2669	65	1	categorical	categorical	ADJ
dpc-2669	65	2	data	datum	NOUN
dpc-2669	65	3	were	be	AUX
dpc-2669	65	4	evaluated	evaluate	VERB
dpc-2669	65	5	with	with	ADP
dpc-2669	65	6	the	the	DET
dpc-2669	65	7	chi	chi	ADJ
dpc-2669	65	8	-	-	PUNCT
dpc-2669	65	9	square	square	ADJ
dpc-2669	65	10	exact	exact	ADJ
dpc-2669	65	11	test	test	NOUN
dpc-2669	65	12	.	.	PUNCT
dpc-2669	66	1	the	the	DET
dpc-2669	66	2	kolmogorow	kolmogorow	PROPN
dpc-2669	66	3	-	-	PUNCT
dpc-2669	66	4	smirnow	smirnow	PROPN
dpc-2669	66	5	test	test	NOUN
dpc-2669	66	6	was	be	AUX
dpc-2669	66	7	performed	perform	VERB
dpc-2669	66	8	to	to	PART
dpc-2669	66	9	determine	determine	VERB
dpc-2669	66	10	whether	whether	SCONJ
dpc-2669	66	11	the	the	DET
dpc-2669	66	12	continuous	continuous	ADJ
dpc-2669	66	13	data	datum	NOUN
dpc-2669	66	14	showed	show	VERB
dpc-2669	66	15	a	a	DET
dpc-2669	66	16	normal	normal	ADJ
dpc-2669	66	17	distribution	distribution	NOUN
dpc-2669	66	18	.	.	PUNCT
dpc-2669	67	1	continuous	continuous	ADJ
dpc-2669	67	2	data	datum	NOUN
dpc-2669	67	3	that	that	PRON
dpc-2669	67	4	did	do	AUX
dpc-2669	67	5	not	not	PART
dpc-2669	67	6	show	show	VERB
dpc-2669	67	7	normal	normal	ADJ
dpc-2669	67	8	distribution	distribution	NOUN
dpc-2669	67	9	were	be	AUX
dpc-2669	67	10	tested	test	VERB
dpc-2669	67	11	for	for	ADP
dpc-2669	67	12	their	their	PRON
dpc-2669	67	13	conformity	conformity	NOUN
dpc-2669	67	14	to	to	ADP
dpc-2669	67	15	the	the	DET
dpc-2669	67	16	normal	normal	ADJ
dpc-2669	67	17	distribution	distribution	NOUN
dpc-2669	67	18	by	by	ADP
dpc-2669	67	19	data	datum	NOUN
dpc-2669	67	20	transformation	transformation	NOUN
dpc-2669	67	21	.	.	PUNCT
dpc-2669	68	1	in	in	ADP
dpc-2669	68	2	the	the	DET
dpc-2669	68	3	comparison	comparison	NOUN
dpc-2669	68	4	of	of	ADP
dpc-2669	68	5	continuous	continuous	ADJ
dpc-2669	68	6	data	datum	NOUN
dpc-2669	68	7	of	of	ADP
dpc-2669	68	8	two	two	NUM
dpc-2669	68	9	independent	independent	ADJ
dpc-2669	68	10	groups	group	NOUN
dpc-2669	68	11	,	,	PUNCT
dpc-2669	68	12	student	student	NOUN
dpc-2669	68	13	-	-	PUNCT
dpc-2669	68	14	t	t	PROPN
dpc-2669	68	15	test	test	NOUN
dpc-2669	68	16	was	be	AUX
dpc-2669	68	17	used	use	VERB
dpc-2669	68	18	when	when	SCONJ
dpc-2669	68	19	parametric	parametric	ADJ
dpc-2669	68	20	test	test	NOUN
dpc-2669	68	21	conditions	condition	NOUN
dpc-2669	68	22	were	be	AUX
dpc-2669	68	23	met	meet	VERB
dpc-2669	68	24	,	,	PUNCT
dpc-2669	68	25	mann	mann	PROPN
dpc-2669	68	26	whitney	whitney	PROPN
dpc-2669	68	27	u	u	PROPN
dpc-2669	68	28	test	test	NOUN
dpc-2669	68	29	was	be	AUX
dpc-2669	68	30	used	use	VERB
dpc-2669	68	31	when	when	SCONJ
dpc-2669	68	32	parametric	parametric	ADJ
dpc-2669	68	33	test	test	NOUN
dpc-2669	68	34	conditions	condition	NOUN
dpc-2669	68	35	were	be	AUX
dpc-2669	68	36	not	not	PART
dpc-2669	68	37	met	meet	VERB
dpc-2669	68	38	.	.	PUNCT
dpc-2669	69	1	in	in	ADP
dpc-2669	69	2	order	order	NOUN
dpc-2669	69	3	to	to	PART
dpc-2669	69	4	determine	determine	VERB
dpc-2669	69	5	the	the	DET
dpc-2669	69	6	relationship	relationship	NOUN
dpc-2669	69	7	between	between	ADP
dpc-2669	69	8	continuous	continuous	ADJ
dpc-2669	69	9	variables	variable	NOUN
dpc-2669	69	10	,	,	PUNCT
dpc-2669	69	11	pearson	pearson	PROPN
dpc-2669	69	12	correlation	correlation	NOUN
dpc-2669	69	13	test	test	NOUN
dpc-2669	69	14	was	be	AUX
dpc-2669	69	15	used	use	VERB
dpc-2669	69	16	when	when	SCONJ
dpc-2669	69	17	normality	normality	NOUN
dpc-2669	69	18	conditions	condition	NOUN
dpc-2669	69	19	were	be	AUX
dpc-2669	69	20	met	meet	VERB
dpc-2669	69	21	and	and	CCONJ
dpc-2669	69	22	spearman	spearman	NOUN
dpc-2669	69	23	correlation	correlation	NOUN
dpc-2669	69	24	test	test	NOUN
dpc-2669	69	25	was	be	AUX
dpc-2669	69	26	used	use	VERB
dpc-2669	69	27	when	when	SCONJ
dpc-2669	69	28	normality	normality	NOUN
dpc-2669	69	29	conditions	condition	NOUN
dpc-2669	69	30	were	be	AUX
dpc-2669	69	31	not	not	PART
dpc-2669	69	32	met	meet	VERB
dpc-2669	69	33	.	.	PUNCT
dpc-2669	70	1	in	in	ADP
dpc-2669	70	2	order	order	NOUN
dpc-2669	70	3	to	to	PART
dpc-2669	70	4	determine	determine	VERB
dpc-2669	70	5	the	the	DET
dpc-2669	70	6	true	true	ADJ
dpc-2669	70	7	relationship	relationship	NOUN
dpc-2669	70	8	between	between	ADP
dpc-2669	70	9	the	the	DET
dpc-2669	70	10	data	datum	NOUN
dpc-2669	70	11	,	,	PUNCT
dpc-2669	70	12	the	the	DET
dpc-2669	70	13	partial	partial	ADJ
dpc-2669	70	14	correlation	correlation	NOUN
dpc-2669	70	15	test	test	NOUN
dpc-2669	70	16	was	be	AUX
dpc-2669	70	17	used	use	VERB
dpc-2669	70	18	by	by	ADP
dpc-2669	70	19	controlling	control	VERB
dpc-2669	70	20	the	the	DET
dpc-2669	70	21	related	related	ADJ
dpc-2669	70	22	variables	variable	NOUN
dpc-2669	70	23	.	.	PUNCT
dpc-2669	71	1	simple	simple	ADJ
dpc-2669	71	2	and	and	CCONJ
dpc-2669	71	3	multiple	multiple	ADJ
dpc-2669	71	4	linear	linear	ADJ
dpc-2669	71	5	regression	regression	NOUN
dpc-2669	71	6	analysis	analysis	NOUN
dpc-2669	71	7	was	be	AUX
dpc-2669	71	8	applied	apply	VERB
dpc-2669	71	9	to	to	PART
dpc-2669	71	10	determine	determine	VERB
dpc-2669	71	11	the	the	DET
dpc-2669	71	12	risk	risk	NOUN
dpc-2669	71	13	of	of	ADP
dpc-2669	71	14	cardiovascular	cardiovascular	ADJ
dpc-2669	71	15	disease	disease	NOUN
dpc-2669	71	16	.	.	PUNCT
dpc-2669	72	1	regression	regression	NOUN
dpc-2669	72	2	analysis	analysis	NOUN
dpc-2669	72	3	data	datum	NOUN
dpc-2669	72	4	were	be	AUX
dpc-2669	72	5	reported	report	VERB
dpc-2669	72	6	as	as	ADP
dpc-2669	72	7	r	r	PROPN
dpc-2669	72	8	square	square	NOUN
dpc-2669	72	9	,	,	PUNCT
dpc-2669	72	10	adjusted	adjust	VERB
dpc-2669	72	11	r	r	NOUN
dpc-2669	72	12	square	square	NOUN
dpc-2669	72	13	,	,	PUNCT
dpc-2669	72	14	standardized	standardized	ADJ
dpc-2669	72	15	coefficiency	coefficiency	NOUN
dpc-2669	72	16	β	β	NOUN
dpc-2669	72	17	coefficients	coefficient	NOUN
dpc-2669	72	18	.	.	PUNCT
dpc-2669	73	1	in	in	ADP
dpc-2669	73	2	the	the	DET
dpc-2669	73	3	analysis	analysis	NOUN
dpc-2669	73	4	of	of	ADP
dpc-2669	73	5	all	all	DET
dpc-2669	73	6	hypothesis	hypothesis	NOUN
dpc-2669	73	7	tests	test	NOUN
dpc-2669	73	8	,	,	PUNCT
dpc-2669	73	9	the	the	DET
dpc-2669	73	10	level	level	NOUN
dpc-2669	73	11	of	of	ADP
dpc-2669	73	12	significance	significance	NOUN
dpc-2669	73	13	(	(	PUNCT
dpc-2669	73	14	p	p	NOUN
dpc-2669	73	15	value	value	NOUN
dpc-2669	73	16	)	)	PUNCT
dpc-2669	73	17	was	be	AUX
dpc-2669	73	18	accepted	accept	VERB
dpc-2669	73	19	as	as	ADP
dpc-2669	73	20	0.05	0.05	NUM
dpc-2669	73	21	.	.	PUNCT
dpc-2669	74	1	results	result	VERB
dpc-2669	74	2	the	the	DET
dpc-2669	74	3	patient	patient	ADJ
dpc-2669	74	4	and	and	CCONJ
dpc-2669	74	5	control	control	NOUN
dpc-2669	74	6	groups	group	NOUN
dpc-2669	74	7	were	be	AUX
dpc-2669	74	8	similar	similar	ADJ
dpc-2669	74	9	in	in	ADP
dpc-2669	74	10	terms	term	NOUN
dpc-2669	74	11	of	of	ADP
dpc-2669	74	12	gender	gender	NOUN
dpc-2669	74	13	.	.	PUNCT
dpc-2669	75	1	there	there	PRON
dpc-2669	75	2	was	be	VERB
dpc-2669	75	3	no	no	DET
dpc-2669	75	4	significant	significant	ADJ
dpc-2669	75	5	difference	difference	NOUN
dpc-2669	75	6	between	between	ADP
dpc-2669	75	7	the	the	DET
dpc-2669	75	8	patient	patient	ADJ
dpc-2669	75	9	and	and	CCONJ
dpc-2669	75	10	control	control	NOUN
dpc-2669	75	11	groups	group	NOUN
dpc-2669	75	12	in	in	ADP
dpc-2669	75	13	terms	term	NOUN
dpc-2669	75	14	of	of	ADP
dpc-2669	75	15	mean	mean	ADJ
dpc-2669	75	16	age	age	NOUN
dpc-2669	75	17	,	,	PUNCT
dpc-2669	75	18	bmi	bmi	NOUN
dpc-2669	75	19	,	,	PUNCT
dpc-2669	75	20	systolic/	systolic/	DET
dpc-2669	75	21	diastolic	diastolic	ADJ
dpc-2669	75	22	blood	blood	NOUN
dpc-2669	75	23	pressure(p	pressure(p	NOUN
dpc-2669	75	24	>	>	NOUN
dpc-2669	75	25	0.05	0.05	NUM
dpc-2669	75	26	)	)	PUNCT
dpc-2669	75	27	.	.	PUNCT
dpc-2669	76	1	tmao	tmao	PROPN
dpc-2669	76	2	(	(	PUNCT
dpc-2669	76	3	323.34	323.34	NUM
dpc-2669	76	4	±	±	NUM
dpc-2669	76	5	240.36	240.36	NUM
dpc-2669	76	6	ng	ng	NOUN
dpc-2669	76	7	/	/	SYM
dpc-2669	76	8	ml	ml	X
dpc-2669	76	9	versus	versus	ADP
dpc-2669	76	10	220.96	220.96	NUM
dpc-2669	76	11	±	±	NUM
dpc-2669	76	12	85.36	85.36	NUM
dpc-2669	76	13	ng	ng	PROPN
dpc-2669	76	14	/	/	SYM
dpc-2669	76	15	ml	ml	PROPN
dpc-2669	76	16	)	)	PUNCT
dpc-2669	76	17	,	,	PUNCT
dpc-2669	76	18	hs	hs	PROPN
dpc-2669	76	19	-	-	PROPN
dpc-2669	76	20	crp	crp	PROPN
dpc-2669	76	21	(	(	PUNCT
dpc-2669	76	22	2.318	2.318	NUM
dpc-2669	76	23	±	±	NUM
dpc-2669	76	24	2.00	2.00	NUM
dpc-2669	76	25	mg	mg	PROPN
dpc-2669	76	26	/	/	SYM
dpc-2669	76	27	l	l	NOUN
dpc-2669	76	28	versus	versus	ADP
dpc-2669	76	29	1.306	1.306	NUM
dpc-2669	76	30	±	±	NUM
dpc-2669	76	31	0.74	0.74	NUM
dpc-2669	76	32	mg	mg	PROPN
dpc-2669	76	33	/	/	SYM
dpc-2669	76	34	l	l	NOUN
dpc-2669	76	35	)	)	PUNCT
dpc-2669	76	36	,	,	PUNCT
dpc-2669	76	37	oxidized	oxidize	VERB
dpc-2669	76	38	-	-	PUNCT
dpc-2669	76	39	ldl(82.50	ldl(82.50	NOUN
dpc-2669	76	40	±	±	NUM
dpc-2669	76	41	42.03	42.03	NUM
dpc-2669	76	42	pg	pg	NOUN
dpc-2669	76	43	/	/	SYM
dpc-2669	76	44	ml	ml	X
dpc-2669	76	45	versus	versus	ADP
dpc-2669	76	46	61.34	61.34	NUM
dpc-2669	76	47	±	±	NUM
dpc-2669	76	48	31.34	31.34	NUM
dpc-2669	76	49	pg	pg	NOUN
dpc-2669	76	50	/	/	SYM
dpc-2669	76	51	ml	ml	NOUN
dpc-2669	76	52	)	)	PUNCT
dpc-2669	76	53	and	and	CCONJ
dpc-2669	76	54	triglyceride	triglyceride	INTJ
dpc-2669	76	55	(	(	PUNCT
dpc-2669	76	56	150.87	150.87	NUM
dpc-2669	76	57	±	±	NOUN
dpc-2669	76	58	87.85	87.85	NUM
dpc-2669	76	59	mg	mg	PROPN
dpc-2669	76	60	/	/	SYM
dpc-2669	76	61	dl	dl	PROPN
dpc-2669	76	62	versus	versus	ADP
dpc-2669	76	63	119.83	119.83	NUM
dpc-2669	76	64	±	±	NUM
dpc-2669	76	65	70.02	70.02	NUM
dpc-2669	76	66	mg	mg	PROPN
dpc-2669	76	67	/	/	SYM
dpc-2669	76	68	dl	dl	PROPN
dpc-2669	76	69	)	)	PUNCT
dpc-2669	76	70	levels	level	NOUN
dpc-2669	76	71	were	be	AUX
dpc-2669	76	72	higher	high	ADJ
dpc-2669	76	73	in	in	ADP
dpc-2669	76	74	the	the	DET
dpc-2669	76	75	patient	patient	NOUN
dpc-2669	76	76	group	group	NOUN
dpc-2669	76	77	compared	compare	VERB
dpc-2669	76	78	to	to	ADP
dpc-2669	76	79	the	the	DET
dpc-2669	76	80	control	control	NOUN
dpc-2669	76	81	group	group	NOUN
dpc-2669	76	82	(	(	PUNCT
dpc-2669	76	83	figure	figure	NOUN
dpc-2669	76	84	1	1	NUM
dpc-2669	76	85	)	)	PUNCT
dpc-2669	76	86	.	.	PUNCT
dpc-2669	77	1	there	there	PRON
dpc-2669	77	2	was	be	VERB
dpc-2669	77	3	no	no	DET
dpc-2669	77	4	significant	significant	ADJ
dpc-2669	77	5	difference	difference	NOUN
dpc-2669	77	6	in	in	ADP
dpc-2669	77	7	total	total	ADJ
dpc-2669	77	8	cholesterol	cholesterol	NOUN
dpc-2669	77	9	and	and	CCONJ
dpc-2669	77	10	ldl	ldl	NOUN
dpc-2669	77	11	-	-	PUNCT
dpc-2669	77	12	cholesterol	cholesterol	NOUN
dpc-2669	77	13	levels	level	NOUN
dpc-2669	77	14	in	in	ADP
dpc-2669	77	15	the	the	DET
dpc-2669	77	16	patient	patient	NOUN
dpc-2669	77	17	and	and	CCONJ
dpc-2669	77	18	control	control	NOUN
dpc-2669	77	19	groups(p	groups(p	NOUN
dpc-2669	77	20	>	>	X
dpc-2669	77	21	0.05	0.05	NUM
dpc-2669	77	22	)	)	PUNCT
dpc-2669	77	23	.	.	PUNCT
dpc-2669	78	1	hdl	hdl	PROPN
dpc-2669	78	2	-	-	PUNCT
dpc-2669	78	3	cholesterol	cholesterol	NOUN
dpc-2669	78	4	levels	level	NOUN
dpc-2669	78	5	were	be	AUX
dpc-2669	78	6	higher	high	ADJ
dpc-2669	78	7	in	in	ADP
dpc-2669	78	8	the	the	DET
dpc-2669	78	9	control	control	NOUN
dpc-2669	78	10	group	group	NOUN
dpc-2669	78	11	compared	compare	VERB
dpc-2669	78	12	to	to	ADP
dpc-2669	78	13	the	the	DET
dpc-2669	78	14	patient	patient	ADJ
dpc-2669	78	15	group	group	NOUN
dpc-2669	78	16	(	(	PUNCT
dpc-2669	78	17	47.75	47.75	NUM
dpc-2669	78	18	±	±	NUM
dpc-2669	78	19	10.12	10.12	NUM
dpc-2669	78	20	mg	mg	PROPN
dpc-2669	78	21	/	/	SYM
dpc-2669	78	22	dl	dl	PROPN
dpc-2669	78	23	versus	versus	ADP
dpc-2669	78	24	39.09	39.09	NUM
dpc-2669	78	25	±	±	NUM
dpc-2669	78	26	9.38	9.38	NUM
dpc-2669	78	27	mg	mg	PROPN
dpc-2669	78	28	/	/	SYM
dpc-2669	78	29	dl	dl	PROPN
dpc-2669	78	30	)	)	PUNCT
dpc-2669	78	31	.	.	PUNCT
dpc-2669	79	1	left	left	ADJ
dpc-2669	79	2	-	-	PUNCT
dpc-2669	79	3	anterior	anterior	NOUN
dpc-2669	79	4	(	(	PUNCT
dpc-2669	79	5	0.598	0.598	NUM
dpc-2669	79	6	±	±	NUM
dpc-2669	79	7	0.129	0.129	NUM
dpc-2669	79	8	nm	nm	NOUN
dpc-2669	79	9	versus	versus	ADP
dpc-2669	79	10	0.534	0.534	NUM
dpc-2669	79	11	±	±	NUM
dpc-2669	79	12	0.068	0.068	NUM
dpc-2669	79	13	nm	nm	NOUN
dpc-2669	79	14	)	)	PUNCT
dpc-2669	79	15	,	,	PUNCT
dpc-2669	79	16	left	left	ADJ
dpc-2669	79	17	-	-	PUNCT
dpc-2669	79	18	posterior	posterior	NOUN
dpc-2669	79	19	(	(	PUNCT
dpc-2669	79	20	0.602	0.602	NUM
dpc-2669	79	21	±	±	NUM
dpc-2669	79	22	0.172	0.172	NUM
dpc-2669	79	23	nm	nm	NOUN
dpc-2669	79	24	versus	versus	ADP
dpc-2669	79	25	0.528	0.528	NUM
dpc-2669	79	26	±	±	NUM
dpc-2669	79	27	0.093	0.093	NUM
dpc-2669	79	28	nm	nm	NOUN
dpc-2669	79	29	)	)	PUNCT
dpc-2669	79	30	and	and	CCONJ
dpc-2669	79	31	right	right	ADJ
dpc-2669	79	32	-	-	PUNCT
dpc-2669	79	33	anterior	anterior	NOUN
dpc-2669	79	34	(	(	PUNCT
dpc-2669	79	35	0.623	0.623	NUM
dpc-2669	79	36	±	±	NUM
dpc-2669	79	37	0.177	0.177	NUM
dpc-2669	79	38	nm	nm	NOUN
dpc-2669	79	39	versus	versus	ADP
dpc-2669	79	40	0.537	0.537	NUM
dpc-2669	79	41	±	±	NUM
dpc-2669	79	42	0.086	0.086	NUM
dpc-2669	79	43	nm	nm	NOUN
dpc-2669	79	44	)	)	PUNCT
dpc-2669	79	45	,	,	PUNCT
dpc-2669	79	46	right	right	ADJ
dpc-2669	79	47	-	-	PUNCT
dpc-2669	79	48	posterior	posterior	NOUN
dpc-2669	79	49	(	(	PUNCT
dpc-2669	79	50	0.605	0.605	NUM
dpc-2669	79	51	±	±	NUM
dpc-2669	79	52	0.164	0.164	NUM
dpc-2669	79	53	nm	nm	NOUN
dpc-2669	79	54	versus	versus	ADP
dpc-2669	79	55	0.520	0.520	NUM
dpc-2669	79	56	±	±	NUM
dpc-2669	79	57	0.075	0.075	NUM
dpc-2669	79	58	nm	nm	NOUN
dpc-2669	79	59	)	)	PUNCT
dpc-2669	79	60	4	4	NUM
dpc-2669	79	61	original	original	ADJ
dpc-2669	79	62	article	article	NOUN
dpc-2669	79	63	|	|	ADV
dpc-2669	79	64	dermatol	dermatol	ADJ
dpc-2669	79	65	pract	pract	NOUN
dpc-2669	79	66	concept	concept	NOUN
dpc-2669	79	67	.	.	PUNCT
dpc-2669	80	1	2023;13(2):e2023116	2023;13(2):e2023116	NUM
dpc-2669	80	2	carotid	carotid	ADJ
dpc-2669	80	3	intima	intima	ADJ
dpc-2669	80	4	-	-	PUNCT
dpc-2669	80	5	media	media	NOUN
dpc-2669	80	6	wall	wall	NOUN
dpc-2669	80	7	thicknesses	thickness	NOUN
dpc-2669	80	8	were	be	AUX
dpc-2669	80	9	significantly	significantly	ADV
dpc-2669	80	10	higher	high	ADJ
dpc-2669	80	11	in	in	ADP
dpc-2669	80	12	the	the	DET
dpc-2669	80	13	patient	patient	NOUN
dpc-2669	80	14	group	group	NOUN
dpc-2669	80	15	compared	compare	VERB
dpc-2669	80	16	to	to	ADP
dpc-2669	80	17	the	the	DET
dpc-2669	80	18	control	control	NOUN
dpc-2669	80	19	group	group	NOUN
dpc-2669	80	20	(	(	PUNCT
dpc-2669	80	21	figures	figure	NOUN
dpc-2669	80	22	2	2	NUM
dpc-2669	80	23	and	and	CCONJ
dpc-2669	80	24	3	3	NUM
dpc-2669	80	25	)	)	PUNCT
dpc-2669	80	26	.	.	PUNCT
dpc-2669	81	1	the	the	DET
dpc-2669	81	2	clinical	clinical	ADJ
dpc-2669	81	3	and	and	CCONJ
dpc-2669	81	4	laboratory	laboratory	NOUN
dpc-2669	81	5	data	datum	NOUN
dpc-2669	81	6	of	of	ADP
dpc-2669	81	7	the	the	DET
dpc-2669	81	8	patient	patient	ADJ
dpc-2669	81	9	and	and	CCONJ
dpc-2669	81	10	control	control	NOUN
dpc-2669	81	11	groups	group	NOUN
dpc-2669	81	12	are	be	AUX
dpc-2669	81	13	given	give	VERB
dpc-2669	81	14	in	in	ADP
dpc-2669	81	15	table	table	NOUN
dpc-2669	81	16	1	1	NUM
dpc-2669	81	17	.	.	PUNCT
dpc-2669	82	1	in	in	ADP
dpc-2669	82	2	the	the	DET
dpc-2669	82	3	partial	partial	ADJ
dpc-2669	82	4	correlation	correlation	NOUN
dpc-2669	82	5	analysis	analysis	NOUN
dpc-2669	82	6	performed	perform	VERB
dpc-2669	82	7	after	after	ADP
dpc-2669	82	8	controlling	control	VERB
dpc-2669	82	9	for	for	ADP
dpc-2669	82	10	age	age	NOUN
dpc-2669	82	11	,	,	PUNCT
dpc-2669	82	12	disease	disease	NOUN
dpc-2669	82	13	duration	duration	NOUN
dpc-2669	82	14	and	and	CCONJ
dpc-2669	82	15	bmi	bmi	NOUN
dpc-2669	82	16	parameters	parameter	NOUN
dpc-2669	82	17	,	,	PUNCT
dpc-2669	82	18	positive	positive	ADJ
dpc-2669	82	19	correlations	correlation	NOUN
dpc-2669	82	20	were	be	AUX
dpc-2669	82	21	observed	observe	VERB
dpc-2669	82	22	at	at	ADP
dpc-2669	82	23	various	various	ADJ
dpc-2669	82	24	levels	level	NOUN
dpc-2669	82	25	between	between	ADP
dpc-2669	82	26	tmao	tmao	PROPN
dpc-2669	82	27	levels	level	NOUN
dpc-2669	82	28	and	and	CCONJ
dpc-2669	82	29	total	total	ADJ
dpc-2669	82	30	cholesterol	cholesterol	NOUN
dpc-2669	82	31	,	,	PUNCT
dpc-2669	82	32	ldl	ldl	NOUN
dpc-2669	82	33	cholesterol	cholesterol	NOUN
dpc-2669	82	34	,	,	PUNCT
dpc-2669	82	35	left	leave	VERB
dpc-2669	82	36	anterior	anterior	ADJ
dpc-2669	82	37	and	and	CCONJ
dpc-2669	82	38	right	right	ADJ
dpc-2669	82	39	posterior	posterior	ADJ
dpc-2669	82	40	cimt	cimt	NOUN
dpc-2669	82	41	(	(	PUNCT
dpc-2669	82	42	table	table	NOUN
dpc-2669	82	43	2	2	NUM
dpc-2669	82	44	)	)	PUNCT
dpc-2669	82	45	.	.	PUNCT
dpc-2669	83	1	when	when	SCONJ
dpc-2669	83	2	parameters	parameter	NOUN
dpc-2669	83	3	that	that	PRON
dpc-2669	83	4	may	may	AUX
dpc-2669	83	5	affect	affect	VERB
dpc-2669	83	6	cimt	cimt	NOUN
dpc-2669	83	7	(	(	PUNCT
dpc-2669	83	8	age	age	NOUN
dpc-2669	83	9	,	,	PUNCT
dpc-2669	83	10	bmi	bmi	NOUN
dpc-2669	83	11	,	,	PUNCT
dpc-2669	83	12	disease	disease	NOUN
dpc-2669	83	13	duration	duration	NOUN
dpc-2669	83	14	,	,	PUNCT
dpc-2669	83	15	pasi	pasi	NOUN
dpc-2669	83	16	score	score	NOUN
dpc-2669	83	17	,	,	PUNCT
dpc-2669	83	18	blood	blood	NOUN
dpc-2669	83	19	cholesterol	cholesterol	NOUN
dpc-2669	83	20	,	,	PUNCT
dpc-2669	83	21	hs	hs	PROPN
dpc-2669	83	22	-	-	PROPN
dpc-2669	83	23	crp	crp	PROPN
dpc-2669	83	24	and	and	CCONJ
dpc-2669	83	25	oxidized	oxidize	VERB
dpc-2669	83	26	-	-	PUNCT
dpc-2669	83	27	ldl	ldl	NOUN
dpc-2669	83	28	)	)	PUNCT
dpc-2669	83	29	were	be	AUX
dpc-2669	83	30	controlled	control	VERB
dpc-2669	83	31	,	,	PUNCT
dpc-2669	83	32	positive	positive	ADJ
dpc-2669	83	33	correlations	correlation	NOUN
dpc-2669	83	34	were	be	AUX
dpc-2669	83	35	found	find	VERB
dpc-2669	83	36	between	between	ADP
dpc-2669	83	37	tmao	tmao	PROPN
dpc-2669	83	38	levels	level	NOUN
dpc-2669	83	39	and	and	CCONJ
dpc-2669	83	40	left	leave	VERB
dpc-2669	83	41	anterior	anterior	ADJ
dpc-2669	83	42	and	and	CCONJ
dpc-2669	83	43	right	right	ADJ
dpc-2669	83	44	posterior	posterior	ADJ
dpc-2669	83	45	cimt	cimt	NOUN
dpc-2669	83	46	at	at	ADP
dpc-2669	83	47	various	various	ADJ
dpc-2669	83	48	levels	level	NOUN
dpc-2669	83	49	(	(	PUNCT
dpc-2669	83	50	table	table	NOUN
dpc-2669	83	51	3	3	NUM
dpc-2669	83	52	)	)	PUNCT
dpc-2669	83	53	.	.	PUNCT
dpc-2669	84	1	simple	simple	ADJ
dpc-2669	84	2	linear	linear	ADJ
dpc-2669	84	3	regression	regression	NOUN
dpc-2669	84	4	analysis	analysis	NOUN
dpc-2669	84	5	was	be	AUX
dpc-2669	84	6	performed	perform	VERB
dpc-2669	84	7	to	to	PART
dpc-2669	84	8	predict	predict	VERB
dpc-2669	84	9	the	the	DET
dpc-2669	84	10	left	left	ADJ
dpc-2669	84	11	cimt	cimt	NOUN
dpc-2669	84	12	variable	variable	NOUN
dpc-2669	84	13	by	by	ADP
dpc-2669	84	14	using	use	VERB
dpc-2669	84	15	tmao	tmao	PROPN
dpc-2669	84	16	levels	level	NOUN
dpc-2669	84	17	.	.	PUNCT
dpc-2669	85	1	a	a	DET
dpc-2669	85	2	significant	significant	ADJ
dpc-2669	85	3	regression	regression	NOUN
dpc-2669	85	4	model	model	NOUN
dpc-2669	85	5	was	be	AUX
dpc-2669	85	6	found	find	VERB
dpc-2669	85	7	in	in	ADP
dpc-2669	85	8	which	which	PRON
dpc-2669	85	9	10	10	NUM
dpc-2669	85	10	%	%	NOUN
dpc-2669	85	11	(	(	PUNCT
dpc-2669	85	12	r	r	NOUN
dpc-2669	85	13	 	 	SPACE
dpc-2669	85	14	square	square	ADJ
dpc-2669	85	15	adjusted	adjust	VERB
dpc-2669	85	16	=	=	NOUN
dpc-2669	85	17	.10	.10	NUM
dpc-2669	85	18	)	)	PUNCT
dpc-2669	85	19	of	of	ADP
dpc-2669	85	20	the	the	DET
dpc-2669	85	21	variance	variance	NOUN
dpc-2669	85	22	in	in	ADP
dpc-2669	85	23	the	the	DET
dpc-2669	85	24	left	left	ADJ
dpc-2669	85	25	cimt	cimt	NOUN
dpc-2669	85	26	was	be	AUX
dpc-2669	85	27	explained	explain	VERB
dpc-2669	85	28	by	by	ADP
dpc-2669	85	29	the	the	DET
dpc-2669	85	30	independent	independent	ADJ
dpc-2669	85	31	variable	variable	NOUN
dpc-2669	85	32	(	(	PUNCT
dpc-2669	85	33	f	f	X
dpc-2669	86	1	[	[	X
dpc-2669	86	2	1	1	NUM
dpc-2669	86	3	,	,	PUNCT
dpc-2669	86	4	71]:8.084	71]:8.084	NOUN
dpc-2669	86	5	,	,	PUNCT
dpc-2669	86	6	p	p	X
dpc-2669	86	7	=	=	NOUN
dpc-2669	86	8	0.006	0.006	NUM
dpc-2669	86	9	)	)	PUNCT
dpc-2669	86	10	.	.	PUNCT
dpc-2669	87	1	accordingly	accordingly	ADV
dpc-2669	87	2	,	,	PUNCT
dpc-2669	87	3	tmao	tmao	PROPN
dpc-2669	87	4	predicted	predict	VERB
dpc-2669	87	5	left	left	ADJ
dpc-2669	87	6	cimt	cimt	NOUN
dpc-2669	87	7	positively	positively	ADV
dpc-2669	87	8	and	and	CCONJ
dpc-2669	87	9	significantly	significantly	ADV
dpc-2669	87	10	,	,	PUNCT
dpc-2669	87	11	ß=	ß=	NOUN
dpc-2669	87	12	.32	.32	NUM
dpc-2669	87	13	,	,	PUNCT
dpc-2669	87	14	t(71	t(71	NOUN
dpc-2669	87	15	)	)	PUNCT
dpc-2669	87	16	=	=	SYM
dpc-2669	87	17	2.843	2.843	NUM
dpc-2669	87	18	,	,	PUNCT
dpc-2669	87	19	p	p	NOUN
dpc-2669	87	20	=	=	PUNCT
dpc-2669	87	21	:	:	PUNCT
dpc-2669	87	22	0.006	0.006	NUM
dpc-2669	87	23	(	(	PUNCT
dpc-2669	87	24	table.4	table.4	ADJ
dpc-2669	87	25	)	)	PUNCT
dpc-2669	87	26	.	.	PUNCT
dpc-2669	88	1	multivariate	multivariate	NOUN
dpc-2669	88	2	linear	linear	PROPN
dpc-2669	88	3	regression	regression	NOUN
dpc-2669	88	4	analysis	analysis	NOUN
dpc-2669	88	5	was	be	AUX
dpc-2669	88	6	performed	perform	VERB
dpc-2669	88	7	to	to	PART
dpc-2669	88	8	predict	predict	VERB
dpc-2669	88	9	the	the	DET
dpc-2669	88	10	left	left	ADJ
dpc-2669	88	11	cimt	cimt	NOUN
dpc-2669	88	12	variable	variable	NOUN
dpc-2669	88	13	by	by	ADP
dpc-2669	88	14	using	use	VERB
dpc-2669	88	15	tmao	tmao	PROPN
dpc-2669	88	16	,	,	PUNCT
dpc-2669	88	17	pasi	pasi	NOUN
dpc-2669	88	18	,	,	PUNCT
dpc-2669	88	19	disease	disease	NOUN
dpc-2669	88	20	duration	duration	NOUN
dpc-2669	88	21	,	,	PUNCT
dpc-2669	88	22	age	age	NOUN
dpc-2669	88	23	,	,	PUNCT
dpc-2669	88	24	ox	ox	ADJ
dpc-2669	88	25	-	-	ADJ
dpc-2669	88	26	ldl	ldl	ADJ
dpc-2669	88	27	,	,	PUNCT
dpc-2669	88	28	total	total	ADJ
dpc-2669	88	29	cholesterole	cholesterole	NOUN
dpc-2669	88	30	,	,	PUNCT
dpc-2669	88	31	triglyceride	triglyceride	ADV
dpc-2669	88	32	,	,	PUNCT
dpc-2669	88	33	bmi	bmi	PROPN
dpc-2669	88	34	variables	variable	NOUN
dpc-2669	88	35	.	.	PUNCT
dpc-2669	89	1	a	a	DET
dpc-2669	89	2	significant	significant	ADJ
dpc-2669	89	3	regression	regression	NOUN
dpc-2669	89	4	model	model	NOUN
dpc-2669	89	5	was	be	AUX
dpc-2669	89	6	found	find	VERB
dpc-2669	89	7	in	in	ADP
dpc-2669	89	8	which	which	PRON
dpc-2669	89	9	41	41	NUM
dpc-2669	89	10	%	%	NOUN
dpc-2669	89	11	(	(	PUNCT
dpc-2669	89	12	r	r	NOUN
dpc-2669	89	13	square	square	NOUN
dpc-2669	89	14	adjusted=	adjusted=	NUM
dpc-2669	89	15	.41	.41	NUM
dpc-2669	89	16	)	)	PUNCT
dpc-2669	89	17	of	of	ADP
dpc-2669	89	18	the	the	DET
dpc-2669	89	19	variance	variance	NOUN
dpc-2669	89	20	in	in	ADP
dpc-2669	89	21	the	the	DET
dpc-2669	89	22	left	left	ADJ
dpc-2669	89	23	cimt	cimt	NOUN
dpc-2669	89	24	was	be	AUX
dpc-2669	89	25	explained	explain	VERB
dpc-2669	89	26	by	by	ADP
dpc-2669	89	27	the	the	DET
dpc-2669	89	28	independent	independent	ADJ
dpc-2669	89	29	variables	variable	NOUN
dpc-2669	89	30	(	(	PUNCT
dpc-2669	89	31	f	f	X
dpc-2669	90	1	[	[	X
dpc-2669	90	2	9	9	NUM
dpc-2669	90	3	,	,	PUNCT
dpc-2669	90	4	63]:6,644	63]:6,644	NOUN
dpc-2669	90	5	,	,	PUNCT
dpc-2669	90	6	p	p	X
dpc-2669	90	7	<	<	X
dpc-2669	90	8	0.001	0.001	NUM
dpc-2669	90	9	)	)	PUNCT
dpc-2669	90	10	.	.	PUNCT
dpc-2669	91	1	accordingly	accordingly	ADV
dpc-2669	91	2	,	,	PUNCT
dpc-2669	91	3	tmao	tmao	PROPN
dpc-2669	91	4	predicted	predict	VERB
dpc-2669	91	5	left	left	ADJ
dpc-2669	91	6	cimt	cimt	NOUN
dpc-2669	91	7	positively	positively	ADV
dpc-2669	91	8	and	and	CCONJ
dpc-2669	91	9	significantly	significantly	ADV
dpc-2669	91	10	(	(	PUNCT
dpc-2669	91	11	ß=	ß=	NOUN
dpc-2669	91	12	.371	.371	NUM
dpc-2669	91	13	,	,	PUNCT
dpc-2669	91	14	t(63)=3.801	t(63)=3.801	PRON
dpc-2669	91	15	,	,	PUNCT
dpc-2669	91	16	control	control	NOUN
dpc-2669	91	17	patient	patient	NOUN
dpc-2669	91	18	0	0	NUM
dpc-2669	91	19	50	50	NUM
dpc-2669	91	20	100	100	NUM
dpc-2669	91	21	150	150	NUM
dpc-2669	91	22	200	200	NUM
dpc-2669	91	23	250	250	NUM
dpc-2669	91	24	300	300	NUM
dpc-2669	91	25	350	350	NUM
dpc-2669	91	26	tmao	tmao	NOUN
dpc-2669	91	27	(	(	PUNCT
dpc-2669	91	28	ng	ng	PROPN
dpc-2669	91	29	/	/	SYM
dpc-2669	91	30	ml	ml	NOUN
dpc-2669	91	31	)	)	PUNCT
dpc-2669	91	32	figure	figure	NOUN
dpc-2669	91	33	1	1	NUM
dpc-2669	91	34	.	.	NOUN
dpc-2669	91	35	trimethylamine	trimethylamine	NOUN
dpc-2669	91	36	 	 	SPACE
dpc-2669	91	37	n	n	CCONJ
dpc-2669	91	38	-	-	PUNCT
dpc-2669	91	39	oxide	oxide	NOUN
dpc-2669	91	40	levels	level	NOUN
dpc-2669	91	41	in	in	ADP
dpc-2669	91	42	patient	patient	ADJ
dpc-2669	91	43	and	and	CCONJ
dpc-2669	91	44	control	control	NOUN
dpc-2669	91	45	groups	group	NOUN
dpc-2669	91	46	.	.	PUNCT
dpc-2669	92	1	p	p	X
dpc-2669	92	2	<	<	X
dpc-2669	92	3	0.001	0.001	NUM
dpc-2669	92	4	)	)	PUNCT
dpc-2669	92	5	.	.	PUNCT
dpc-2669	93	1	in	in	ADP
dpc-2669	93	2	addition	addition	NOUN
dpc-2669	93	3	,	,	PUNCT
dpc-2669	93	4	age	age	NOUN
dpc-2669	93	5	predicted	predict	VERB
dpc-2669	93	6	left	left	ADJ
dpc-2669	93	7	cimt	cimt	NOUN
dpc-2669	93	8	positively	positively	ADV
dpc-2669	93	9	and	and	CCONJ
dpc-2669	93	10	significantly	significantly	ADV
dpc-2669	93	11	(	(	PUNCT
dpc-2669	93	12	ß=	ß=	INTJ
dpc-2669	93	13	.618	.618	NUM
dpc-2669	93	14	,	,	PUNCT
dpc-2669	93	15	t(63)=5.428	t(63)=5.428	NOUN
dpc-2669	93	16	,	,	PUNCT
dpc-2669	93	17	p	p	X
dpc-2669	93	18	<	<	X
dpc-2669	93	19	0.001	0.001	NUM
dpc-2669	93	20	)	)	PUNCT
dpc-2669	93	21	.	.	PUNCT
dpc-2669	94	1	oxidized	oxidize	VERB
dpc-2669	94	2	-	-	PUNCT
dpc-2669	94	3	ldl	ldl	NOUN
dpc-2669	94	4	,	,	PUNCT
dpc-2669	94	5	hs	hs	PROPN
dpc-2669	94	6	-	-	PROPN
dpc-2669	94	7	crp	crp	NOUN
dpc-2669	94	8	,	,	PUNCT
dpc-2669	94	9	triglyceride	triglyceride	ADJ
dpc-2669	94	10	,	,	PUNCT
dpc-2669	94	11	total	total	ADJ
dpc-2669	94	12	cholesterol	cholesterol	NOUN
dpc-2669	94	13	,	,	PUNCT
dpc-2669	94	14	pasi	pasi	NOUN
dpc-2669	94	15	,	,	PUNCT
dpc-2669	94	16	disease	disease	NOUN
dpc-2669	94	17	duration	duration	NOUN
dpc-2669	94	18	and	and	CCONJ
dpc-2669	94	19	bmi	bmi	NOUN
dpc-2669	94	20	did	do	AUX
dpc-2669	94	21	not	not	PART
dpc-2669	94	22	significantly	significantly	ADV
dpc-2669	94	23	predict	predict	VERB
dpc-2669	94	24	left	leave	VERB
dpc-2669	94	25	cimt	cimt	NOUN
dpc-2669	94	26	in	in	ADP
dpc-2669	94	27	this	this	DET
dpc-2669	94	28	model	model	NOUN
dpc-2669	94	29	(	(	PUNCT
dpc-2669	94	30	p	p	X
dpc-2669	94	31	>	>	X
dpc-2669	94	32	0.05	0.05	NUM
dpc-2669	94	33	)	)	PUNCT
dpc-2669	94	34	.	.	PUNCT
dpc-2669	95	1	the	the	DET
dpc-2669	95	2	regression	regression	NOUN
dpc-2669	95	3	model	model	NOUN
dpc-2669	95	4	confirmed	confirm	VERB
dpc-2669	95	5	that	that	SCONJ
dpc-2669	95	6	tmao	tmao	PROPN
dpc-2669	95	7	was	be	AUX
dpc-2669	95	8	a	a	DET
dpc-2669	95	9	positive	positive	ADJ
dpc-2669	95	10	predictor	predictor	NOUN
dpc-2669	95	11	for	for	ADP
dpc-2669	95	12	left	left	ADJ
dpc-2669	95	13	anterior	anterior	ADJ
dpc-2669	95	14	cimt	cimt	NOUN
dpc-2669	95	15	and	and	CCONJ
dpc-2669	95	16	may	may	AUX
dpc-2669	95	17	be	be	AUX
dpc-2669	95	18	a	a	DET
dpc-2669	95	19	predictor	predictor	NOUN
dpc-2669	95	20	for	for	ADP
dpc-2669	95	21	cardiovascular	cardiovascular	ADJ
dpc-2669	95	22	disease	disease	NOUN
dpc-2669	95	23	secondary	secondary	ADJ
dpc-2669	95	24	to	to	ADP
dpc-2669	95	25	these	these	DET
dpc-2669	95	26	outcomes	outcome	NOUN
dpc-2669	95	27	(	(	PUNCT
dpc-2669	95	28	table	table	NOUN
dpc-2669	95	29	5	5	NUM
dpc-2669	95	30	)	)	PUNCT
dpc-2669	95	31	.	.	PUNCT
dpc-2669	96	1	conclusions	conclusion	NOUN
dpc-2669	96	2	psoriasis	psoriasis	NOUN
dpc-2669	96	3	is	be	AUX
dpc-2669	96	4	not	not	PART
dpc-2669	96	5	only	only	ADV
dpc-2669	96	6	a	a	DET
dpc-2669	96	7	skin	skin	NOUN
dpc-2669	96	8	and	and	CCONJ
dpc-2669	96	9	joint	joint	ADJ
dpc-2669	96	10	disease	disease	NOUN
dpc-2669	96	11	,	,	PUNCT
dpc-2669	96	12	but	but	CCONJ
dpc-2669	96	13	also	also	ADV
dpc-2669	96	14	a	a	DET
dpc-2669	96	15	systemic	systemic	ADJ
dpc-2669	96	16	inflammatory	inflammatory	ADJ
dpc-2669	96	17	disease	disease	NOUN
dpc-2669	96	18	that	that	PRON
dpc-2669	96	19	can	can	AUX
dpc-2669	96	20	be	be	AUX
dpc-2669	96	21	associated	associate	VERB
dpc-2669	96	22	with	with	ADP
dpc-2669	96	23	various	various	ADJ
dpc-2669	96	24	comorbidities	comorbiditie	NOUN
dpc-2669	96	25	.	.	PUNCT
dpc-2669	97	1	it	it	PRON
dpc-2669	97	2	is	be	AUX
dpc-2669	97	3	associated	associate	VERB
dpc-2669	97	4	with	with	ADP
dpc-2669	97	5	an	an	DET
dpc-2669	97	6	increased	increase	VERB
dpc-2669	97	7	risk	risk	NOUN
dpc-2669	97	8	of	of	ADP
dpc-2669	97	9	developing	develop	VERB
dpc-2669	97	10	serious	serious	ADJ
dpc-2669	97	11	vascular	vascular	ADJ
dpc-2669	97	12	events	event	NOUN
dpc-2669	97	13	,	,	PUNCT
dpc-2669	97	14	particularly	particularly	ADV
dpc-2669	97	15	myocardial	myocardial	ADJ
dpc-2669	97	16	infarction	infarction	NOUN
dpc-2669	97	17	and	and	CCONJ
dpc-2669	97	18	stroke	stroke	NOUN
dpc-2669	97	19	.	.	PUNCT
dpc-2669	98	1	psoriasis	psoriasis	NOUN
dpc-2669	98	2	and	and	CCONJ
dpc-2669	98	3	atherosclerotic	atherosclerotic	ADJ
dpc-2669	98	4	cardiovascular	cardiovascular	ADJ
dpc-2669	98	5	disease	disease	NOUN
dpc-2669	98	6	share	share	VERB
dpc-2669	98	7	common	common	ADJ
dpc-2669	98	8	genetic	genetic	ADJ
dpc-2669	98	9	and	and	CCONJ
dpc-2669	98	10	pathophysiological	pathophysiological	ADJ
dpc-2669	98	11	pathways	pathway	NOUN
dpc-2669	98	12	,	,	PUNCT
dpc-2669	98	13	including	include	VERB
dpc-2669	98	14	genetic	genetic	ADJ
dpc-2669	98	15	factors	factor	NOUN
dpc-2669	98	16	,	,	PUNCT
dpc-2669	98	17	inflammatory	inflammatory	ADJ
dpc-2669	98	18	pathways	pathway	NOUN
dpc-2669	98	19	,	,	PUNCT
dpc-2669	98	20	secretion	secretion	NOUN
dpc-2669	98	21	of	of	ADP
dpc-2669	98	22	adipokines	adipokine	NOUN
dpc-2669	98	23	,	,	PUNCT
dpc-2669	98	24	insulin	insulin	NOUN
dpc-2669	98	25	resistance	resistance	NOUN
dpc-2669	98	26	,	,	PUNCT
dpc-2669	98	27	lipoprotein	lipoprotein	ADJ
dpc-2669	98	28	composition	composition	NOUN
dpc-2669	98	29	and	and	CCONJ
dpc-2669	98	30	function	function	NOUN
dpc-2669	98	31	,	,	PUNCT
dpc-2669	98	32	angiogenesis	angiogenesis	NOUN
dpc-2669	98	33	,	,	PUNCT
dpc-2669	98	34	oxidative	oxidative	ADJ
dpc-2669	98	35	stress	stress	NOUN
dpc-2669	98	36	and	and	CCONJ
dpc-2669	98	37	hypercoagulation	hypercoagulation	NOUN
dpc-2669	99	1	[	[	X
dpc-2669	99	2	11	11	NUM
dpc-2669	99	3	]	]	PUNCT
dpc-2669	99	4	.	.	PUNCT
dpc-2669	100	1	the	the	DET
dpc-2669	100	2	development	development	NOUN
dpc-2669	100	3	of	of	ADP
dpc-2669	100	4	atherosclerosis	atherosclerosis	NOUN
dpc-2669	100	5	is	be	AUX
dpc-2669	100	6	a	a	DET
dpc-2669	100	7	major	major	ADJ
dpc-2669	100	8	pathological	pathological	ADJ
dpc-2669	100	9	process	process	NOUN
dpc-2669	100	10	that	that	PRON
dpc-2669	100	11	can	can	AUX
dpc-2669	100	12	lead	lead	VERB
dpc-2669	100	13	to	to	ADP
dpc-2669	100	14	myocardial	myocardial	ADJ
dpc-2669	100	15	infarction	infarction	NOUN
dpc-2669	100	16	and	and	CCONJ
dpc-2669	100	17	stroke	stroke	NOUN
dpc-2669	100	18	.	.	PUNCT
dpc-2669	101	1	in	in	ADP
dpc-2669	101	2	the	the	DET
dpc-2669	101	3	literature	literature	NOUN
dpc-2669	101	4	,	,	PUNCT
dpc-2669	101	5	there	there	PRON
dpc-2669	101	6	are	be	VERB
dpc-2669	101	7	studies	study	NOUN
dpc-2669	101	8	showing	show	VERB
dpc-2669	101	9	that	that	SCONJ
dpc-2669	101	10	arterial	arterial	NOUN
dpc-2669	101	11	wall	wall	NOUN
dpc-2669	101	12	thickness	thickness	PROPN
dpc-2669	101	13	is	be	AUX
dpc-2669	101	14	increased	increase	VERB
dpc-2669	101	15	in	in	ADP
dpc-2669	101	16	patients	patient	NOUN
dpc-2669	101	17	with	with	ADP
dpc-2669	101	18	psoriasis	psoriasis	NOUN
dpc-2669	101	19	compared	compare	VERB
dpc-2669	101	20	to	to	ADP
dpc-2669	101	21	healthy	healthy	ADJ
dpc-2669	101	22	controls	control	NOUN
dpc-2669	101	23	and	and	CCONJ
dpc-2669	101	24	this	this	DET
dpc-2669	101	25	increase	increase	NOUN
dpc-2669	101	26	is	be	AUX
dpc-2669	101	27	correlated	correlate	VERB
dpc-2669	101	28	with	with	ADP
dpc-2669	101	29	disease	disease	NOUN
dpc-2669	101	30	severity	severity	NOUN
dpc-2669	101	31	.	.	PUNCT
dpc-2669	102	1	positron	positron	NOUN
dpc-2669	102	2	emission	emission	PROPN
dpc-2669	102	3	tomography	tomography	NOUN
dpc-2669	102	4	/	/	SYM
dpc-2669	102	5	computed	compute	VERB
dpc-2669	102	6	tomography	tomography	NOUN
dpc-2669	102	7	studies	study	NOUN
dpc-2669	102	8	have	have	AUX
dpc-2669	102	9	found	find	VERB
dpc-2669	102	10	that	that	SCONJ
dpc-2669	102	11	aortic	aortic	ADJ
dpc-2669	102	12	wall	wall	NOUN
dpc-2669	102	13	inflammation	inflammation	NOUN
dpc-2669	102	14	is	be	AUX
dpc-2669	102	15	higher	high	ADJ
dpc-2669	102	16	in	in	ADP
dpc-2669	102	17	patients	patient	NOUN
dpc-2669	102	18	with	with	ADP
dpc-2669	102	19	psoriasis	psoriasis	NOUN
dpc-2669	102	20	than	than	ADP
dpc-2669	102	21	in	in	ADP
dpc-2669	102	22	the	the	DET
dpc-2669	102	23	healthy	healthy	ADJ
dpc-2669	102	24	population	population	NOUN
dpc-2669	102	25	and	and	CCONJ
dpc-2669	102	26	that	that	SCONJ
dpc-2669	102	27	there	there	PRON
dpc-2669	102	28	is	be	VERB
dpc-2669	102	29	a	a	DET
dpc-2669	102	30	positive	positive	ADJ
dpc-2669	102	31	correlation	correlation	NOUN
dpc-2669	102	32	between	between	ADP
dpc-2669	102	33	disease	disease	NOUN
dpc-2669	102	34	original	original	ADJ
dpc-2669	102	35	article	article	NOUN
dpc-2669	102	36	|	|	ADV
dpc-2669	102	37	dermatol	dermatol	ADJ
dpc-2669	102	38	pract	pract	NOUN
dpc-2669	102	39	concept	concept	NOUN
dpc-2669	102	40	.	.	PUNCT
dpc-2669	103	1	2023;13(2):e2023116	2023;13(2):e2023116	NUM
dpc-2669	103	2	5	5	NUM
dpc-2669	103	3	left	leave	VERB
dpc-2669	103	4	posterior	posterior	ADJ
dpc-2669	103	5	cimt	cimt	NOUN
dpc-2669	103	6	left	leave	VERB
dpc-2669	103	7	anterior	anterior	ADJ
dpc-2669	103	8	cimt	cimt	NOUN
dpc-2669	103	9	0.48	0.48	NUM
dpc-2669	103	10	0.5	0.5	NUM
dpc-2669	103	11	0.52	0.52	NUM
dpc-2669	103	12	0.54	0.54	NUM
dpc-2669	103	13	0.56	0.56	NUM
dpc-2669	103	14	0.58	0.58	NUM
dpc-2669	103	15	0.6	0.6	NUM
dpc-2669	103	16	0.62	0.62	NUM
dpc-2669	103	17	control(mm	control(mm	NOUN
dpc-2669	103	18	)	)	PUNCT
dpc-2669	103	19	patient(mm	patient(mm	NOUN
dpc-2669	103	20	)	)	PUNCT
dpc-2669	103	21	figure	figure	NOUN
dpc-2669	103	22	2	2	NUM
dpc-2669	103	23	.	.	PUNCT
dpc-2669	103	24	left	leave	VERB
dpc-2669	103	25	carotid	carotid	NOUN
dpc-2669	103	26	intima	intima	ADJ
dpc-2669	103	27	-	-	PUNCT
dpc-2669	103	28	media	medium	NOUN
dpc-2669	103	29	thickness	thickness	NOUN
dpc-2669	103	30	levels	level	NOUN
dpc-2669	103	31	in	in	ADP
dpc-2669	103	32	patient	patient	ADJ
dpc-2669	103	33	and	and	CCONJ
dpc-2669	103	34	control	control	NOUN
dpc-2669	103	35	groups	group	NOUN
dpc-2669	103	36	.	.	PUNCT
dpc-2669	104	1	right	right	ADJ
dpc-2669	104	2	posterior	posterior	ADJ
dpc-2669	104	3	cimt	cimt	NOUN
dpc-2669	104	4	right	right	ADJ
dpc-2669	104	5	anterior	anterior	ADJ
dpc-2669	104	6	cimt	cimt	NOUN
dpc-2669	104	7	0.46	0.46	NUM
dpc-2669	104	8	0.48	0.48	NUM
dpc-2669	104	9	0.5	0.5	NUM
dpc-2669	104	10	0.52	0.52	NUM
dpc-2669	104	11	0.54	0.54	NUM
dpc-2669	104	12	0.56	0.56	NUM
dpc-2669	104	13	0.58	0.58	NUM
dpc-2669	104	14	0.6	0.6	NUM
dpc-2669	104	15	0.62	0.62	NUM
dpc-2669	104	16	0.64	0.64	NUM
dpc-2669	104	17	control(mm	control(mm	NOUN
dpc-2669	104	18	)	)	PUNCT
dpc-2669	104	19	patient(mm	patient(mm	NOUN
dpc-2669	104	20	)	)	PUNCT
dpc-2669	104	21	figure	figure	NOUN
dpc-2669	104	22	3	3	NUM
dpc-2669	104	23	.	.	PUNCT
dpc-2669	105	1	right	right	ADJ
dpc-2669	105	2	carotid	carotid	NOUN
dpc-2669	105	3	intima	intima	ADJ
dpc-2669	105	4	-	-	PUNCT
dpc-2669	105	5	media	medium	NOUN
dpc-2669	105	6	thickness	thickness	NOUN
dpc-2669	105	7	levels	level	NOUN
dpc-2669	105	8	in	in	ADP
dpc-2669	105	9	patient	patient	ADJ
dpc-2669	105	10	and	and	CCONJ
dpc-2669	105	11	control	control	NOUN
dpc-2669	105	12	groups	group	NOUN
dpc-2669	105	13	.	.	PUNCT
dpc-2669	106	1	severity	severity	NOUN
dpc-2669	106	2	and	and	CCONJ
dpc-2669	106	3	inflammation	inflammation	NOUN
dpc-2669	106	4	severity	severity	NOUN
dpc-2669	106	5	.	.	PUNCT
dpc-2669	107	1	furthermore	furthermore	ADV
dpc-2669	107	2	,	,	PUNCT
dpc-2669	107	3	aortic	aortic	ADJ
dpc-2669	107	4	inflammation	inflammation	NOUN
dpc-2669	107	5	decreases	decrease	VERB
dpc-2669	107	6	with	with	ADP
dpc-2669	107	7	healing	healing	NOUN
dpc-2669	107	8	of	of	ADP
dpc-2669	107	9	skin	skin	NOUN
dpc-2669	107	10	lesions	lesion	NOUN
dpc-2669	107	11	[	[	X
dpc-2669	107	12	12,13	12,13	NUM
dpc-2669	107	13	]	]	PUNCT
dpc-2669	107	14	.	.	PUNCT
dpc-2669	108	1	the	the	DET
dpc-2669	108	2	finding	finding	NOUN
dpc-2669	108	3	of	of	ADP
dpc-2669	108	4	higher	high	ADJ
dpc-2669	108	5	cimt	cimt	NOUN
dpc-2669	108	6	levels	level	NOUN
dpc-2669	108	7	in	in	ADP
dpc-2669	108	8	psoriasis	psoriasis	NOUN
dpc-2669	108	9	patients	patient	NOUN
dpc-2669	108	10	compared	compare	VERB
dpc-2669	108	11	to	to	ADP
dpc-2669	108	12	healthy	healthy	ADJ
dpc-2669	108	13	controls	control	NOUN
dpc-2669	108	14	in	in	ADP
dpc-2669	108	15	carotid	carotid	NOUN
dpc-2669	108	16	artery	artery	NOUN
dpc-2669	108	17	ultrasonography	ultrasonography	NOUN
dpc-2669	108	18	studies	study	NOUN
dpc-2669	108	19	clearly	clearly	ADV
dpc-2669	108	20	demonstrates	demonstrate	VERB
dpc-2669	108	21	an	an	DET
dpc-2669	108	22	increased	increased	ADJ
dpc-2669	108	23	risk	risk	NOUN
dpc-2669	108	24	of	of	ADP
dpc-2669	108	25	cardiovascular	cardiovascular	ADJ
dpc-2669	108	26	disease	disease	NOUN
dpc-2669	108	27	in	in	ADP
dpc-2669	108	28	psoriasis	psoriasis	NOUN
dpc-2669	108	29	patients	patient	NOUN
dpc-2669	108	30	[	[	X
dpc-2669	108	31	14	14	NUM
dpc-2669	108	32	-	-	SYM
dpc-2669	108	33	16	16	NUM
dpc-2669	108	34	]	]	PUNCT
dpc-2669	108	35	.	.	PUNCT
dpc-2669	109	1	our	our	PRON
dpc-2669	109	2	study	study	NOUN
dpc-2669	109	3	showed	show	VERB
dpc-2669	109	4	that	that	SCONJ
dpc-2669	109	5	cimt	cimt	NOUN
dpc-2669	109	6	levels	level	NOUN
dpc-2669	109	7	were	be	AUX
dpc-2669	109	8	significantly	significantly	ADV
dpc-2669	109	9	higher	high	ADJ
dpc-2669	109	10	in	in	ADP
dpc-2669	109	11	psoriasis	psoriasis	NOUN
dpc-2669	109	12	patients	patient	NOUN
dpc-2669	109	13	compared	compare	VERB
dpc-2669	109	14	to	to	ADP
dpc-2669	109	15	the	the	DET
dpc-2669	109	16	control	control	NOUN
dpc-2669	109	17	group	group	NOUN
dpc-2669	109	18	.	.	PUNCT
dpc-2669	110	1	there	there	PRON
dpc-2669	110	2	were	be	VERB
dpc-2669	110	3	also	also	ADV
dpc-2669	110	4	positive	positive	ADJ
dpc-2669	110	5	correlations	correlation	NOUN
dpc-2669	110	6	between	between	ADP
dpc-2669	110	7	cimt	cimt	NOUN
dpc-2669	110	8	values	value	NOUN
dpc-2669	110	9	and	and	CCONJ
dpc-2669	110	10	patient	patient	ADJ
dpc-2669	110	11	age	age	NOUN
dpc-2669	110	12	,	,	PUNCT
dpc-2669	110	13	disease	disease	NOUN
dpc-2669	110	14	duration	duration	NOUN
dpc-2669	110	15	,	,	PUNCT
dpc-2669	110	16	tmao	tmao	PROPN
dpc-2669	110	17	,	,	PUNCT
dpc-2669	110	18	hs	hs	PROPN
dpc-2669	110	19	-	-	PROPN
dpc-2669	110	20	crp	crp	NOUN
dpc-2669	110	21	,	,	PUNCT
dpc-2669	110	22	triglyceride	triglyceride	ADJ
dpc-2669	110	23	,	,	PUNCT
dpc-2669	110	24	total	total	ADJ
dpc-2669	110	25	cholesterol	cholesterol	NOUN
dpc-2669	110	26	,	,	PUNCT
dpc-2669	110	27	body	body	NOUN
dpc-2669	110	28	mass	mass	NOUN
dpc-2669	110	29	index	index	NOUN
dpc-2669	110	30	and	and	CCONJ
dpc-2669	110	31	blood	blood	NOUN
dpc-2669	110	32	pressures	pressure	NOUN
dpc-2669	110	33	.	.	PUNCT
dpc-2669	111	1	in	in	ADP
dpc-2669	111	2	the	the	DET
dpc-2669	111	3	light	light	NOUN
dpc-2669	111	4	of	of	ADP
dpc-2669	111	5	these	these	DET
dpc-2669	111	6	data	datum	NOUN
dpc-2669	111	7	,	,	PUNCT
dpc-2669	111	8	cimt	cimt	NOUN
dpc-2669	111	9	measurement	measurement	NOUN
dpc-2669	111	10	can	can	AUX
dpc-2669	111	11	be	be	AUX
dpc-2669	111	12	used	use	VERB
dpc-2669	111	13	6	6	NUM
dpc-2669	111	14	original	original	ADJ
dpc-2669	111	15	article	article	NOUN
dpc-2669	111	16	|	|	ADV
dpc-2669	111	17	dermatol	dermatol	ADJ
dpc-2669	111	18	pract	pract	NOUN
dpc-2669	111	19	concept	concept	NOUN
dpc-2669	111	20	.	.	PUNCT
dpc-2669	112	1	2023;13(2):e2023116	2023;13(2):e2023116	NUM
dpc-2669	112	2	to	to	PART
dpc-2669	112	3	detect	detect	VERB
dpc-2669	112	4	the	the	DET
dpc-2669	112	5	risk	risk	NOUN
dpc-2669	112	6	of	of	ADP
dpc-2669	112	7	early	early	ADJ
dpc-2669	112	8	atherosclerotic	atherosclerotic	ADJ
dpc-2669	112	9	disease	disease	NOUN
dpc-2669	112	10	in	in	ADP
dpc-2669	112	11	patients	patient	NOUN
dpc-2669	112	12	with	with	ADP
dpc-2669	112	13	psoriasis	psoriasis	NOUN
dpc-2669	112	14	,	,	PUNCT
dpc-2669	112	15	which	which	PRON
dpc-2669	112	16	is	be	AUX
dpc-2669	112	17	consistent	consistent	ADJ
dpc-2669	112	18	with	with	ADP
dpc-2669	112	19	previous	previous	ADJ
dpc-2669	112	20	studies	study	NOUN
dpc-2669	112	21	.	.	PUNCT
dpc-2669	113	1	microbiota	microbiota	NOUN
dpc-2669	113	2	related	relate	VERB
dpc-2669	113	3	immunomodulation	immunomodulation	NOUN
dpc-2669	113	4	has	have	AUX
dpc-2669	113	5	shown	show	VERB
dpc-2669	113	6	that	that	SCONJ
dpc-2669	113	7	the	the	DET
dpc-2669	113	8	gut	gut	NOUN
dpc-2669	113	9	microbiome	microbiome	NOUN
dpc-2669	113	10	plays	play	VERB
dpc-2669	113	11	a	a	DET
dpc-2669	113	12	role	role	NOUN
dpc-2669	113	13	in	in	ADP
dpc-2669	113	14	influencing	influence	VERB
dpc-2669	113	15	distant	distant	ADJ
dpc-2669	113	16	organs	organ	NOUN
dpc-2669	113	17	,	,	PUNCT
dpc-2669	113	18	mucosal	mucosal	NOUN
dpc-2669	113	19	and	and	CCONJ
dpc-2669	113	20	hematopoietic	hematopoietic	ADJ
dpc-2669	113	21	immune	immune	ADJ
dpc-2669	113	22	function	function	NOUN
dpc-2669	113	23	.	.	PUNCT
dpc-2669	114	1	disruption	disruption	NOUN
dpc-2669	114	2	in	in	ADP
dpc-2669	114	3	the	the	DET
dpc-2669	114	4	composition	composition	NOUN
dpc-2669	114	5	and	and	CCONJ
dpc-2669	114	6	function	function	NOUN
dpc-2669	114	7	of	of	ADP
dpc-2669	114	8	the	the	DET
dpc-2669	114	9	intestinal	intestinal	ADJ
dpc-2669	114	10	microbiota	microbiota	NOUN
dpc-2669	114	11	is	be	AUX
dpc-2669	114	12	associated	associate	VERB
dpc-2669	114	13	with	with	ADP
dpc-2669	114	14	a	a	DET
dpc-2669	114	15	variety	variety	NOUN
dpc-2669	114	16	of	of	ADP
dpc-2669	114	17	chronic	chronic	ADJ
dpc-2669	114	18	diseases	disease	NOUN
dpc-2669	114	19	,	,	PUNCT
dpc-2669	114	20	from	from	ADP
dpc-2669	114	21	gastrointestinal	gastrointestinal	ADJ
dpc-2669	114	22	inflammatory	inflammatory	ADJ
dpc-2669	114	23	and	and	CCONJ
dpc-2669	114	24	metabolic	metabolic	NOUN
dpc-2669	114	25	diseases	disease	NOUN
dpc-2669	114	26	to	to	ADP
dpc-2669	114	27	neurological	neurological	ADJ
dpc-2669	114	28	,	,	PUNCT
dpc-2669	114	29	cardiovascular	cardiovascular	ADJ
dpc-2669	114	30	and	and	CCONJ
dpc-2669	114	31	respiratory	respiratory	ADJ
dpc-2669	114	32	system	system	NOUN
dpc-2669	114	33	diseases	disease	NOUN
dpc-2669	114	34	.	.	PUNCT
dpc-2669	115	1	the	the	DET
dpc-2669	115	2	changes	change	NOUN
dpc-2669	115	3	observed	observe	VERB
dpc-2669	115	4	in	in	ADP
dpc-2669	115	5	the	the	DET
dpc-2669	115	6	composition	composition	NOUN
dpc-2669	115	7	of	of	ADP
dpc-2669	115	8	the	the	DET
dpc-2669	115	9	gut	gut	NOUN
dpc-2669	115	10	microbiome	microbiome	NOUN
dpc-2669	115	11	in	in	ADP
dpc-2669	115	12	studies	study	NOUN
dpc-2669	115	13	with	with	ADP
dpc-2669	115	14	psoriasis	psoriasis	NOUN
dpc-2669	115	15	patients	patient	NOUN
dpc-2669	115	16	have	have	AUX
dpc-2669	115	17	prompted	prompt	VERB
dpc-2669	115	18	researchers	researcher	NOUN
dpc-2669	115	19	to	to	PART
dpc-2669	115	20	investigate	investigate	VERB
dpc-2669	115	21	the	the	DET
dpc-2669	115	22	molecular	molecular	ADJ
dpc-2669	115	23	mechanisms	mechanism	NOUN
dpc-2669	115	24	associated	associate	VERB
dpc-2669	115	25	with	with	ADP
dpc-2669	115	26	the	the	DET
dpc-2669	115	27	microbiome	microbiome	NOUN
dpc-2669	115	28	and	and	CCONJ
dpc-2669	115	29	its	its	PRON
dpc-2669	115	30	possible	possible	ADJ
dpc-2669	115	31	impact	impact	NOUN
dpc-2669	115	32	on	on	ADP
dpc-2669	115	33	the	the	DET
dpc-2669	115	34	disease	disease	NOUN
dpc-2669	115	35	[	[	X
dpc-2669	115	36	17	17	NUM
dpc-2669	115	37	-	-	SYM
dpc-2669	115	38	19	19	NUM
dpc-2669	115	39	]	]	PUNCT
dpc-2669	115	40	.	.	PUNCT
dpc-2669	116	1	in	in	ADP
dpc-2669	116	2	recent	recent	ADJ
dpc-2669	116	3	years	year	NOUN
dpc-2669	116	4	,	,	PUNCT
dpc-2669	116	5	the	the	DET
dpc-2669	116	6	tmao	tmao	PROPN
dpc-2669	116	7	molecule	molecule	NOUN
dpc-2669	116	8	formed	form	VERB
dpc-2669	116	9	by	by	ADP
dpc-2669	116	10	the	the	DET
dpc-2669	116	11	oxidation	oxidation	NOUN
dpc-2669	116	12	in	in	ADP
dpc-2669	116	13	the	the	DET
dpc-2669	116	14	liver	liver	NOUN
dpc-2669	116	15	of	of	ADP
dpc-2669	116	16	tma	tma	PROPN
dpc-2669	116	17	produced	produce	VERB
dpc-2669	116	18	from	from	ADP
dpc-2669	116	19	choline	choline	NOUN
dpc-2669	116	20	and	and	CCONJ
dpc-2669	116	21	l	l	NOUN
dpc-2669	116	22	-	-	NOUN
dpc-2669	116	23	carnitine	carnitine	NOUN
dpc-2669	116	24	by	by	ADP
dpc-2669	116	25	the	the	DET
dpc-2669	116	26	gut	gut	NOUN
dpc-2669	116	27	microbiome	microbiome	NOUN
dpc-2669	116	28	is	be	AUX
dpc-2669	116	29	thought	think	VERB
dpc-2669	116	30	to	to	PART
dpc-2669	116	31	be	be	AUX
dpc-2669	116	32	associated	associate	VERB
dpc-2669	116	33	with	with	ADP
dpc-2669	116	34	increased	increase	VERB
dpc-2669	116	35	cardiovascular	cardiovascular	ADJ
dpc-2669	116	36	risk	risk	NOUN
dpc-2669	116	37	and	and	CCONJ
dpc-2669	116	38	atherosclerosis	atherosclerosis	NOUN
dpc-2669	116	39	,	,	PUNCT
dpc-2669	116	40	but	but	CCONJ
dpc-2669	116	41	there	there	PRON
dpc-2669	116	42	are	be	VERB
dpc-2669	116	43	also	also	ADV
dpc-2669	116	44	conflicting	conflicting	ADJ
dpc-2669	116	45	results	result	NOUN
dpc-2669	116	46	.	.	PUNCT
dpc-2669	117	1	the	the	DET
dpc-2669	117	2	dysbiotic	dysbiotic	ADJ
dpc-2669	117	3	gut	gut	NOUN
dpc-2669	117	4	microbiome	microbiome	NOUN
dpc-2669	117	5	observed	observe	VERB
dpc-2669	117	6	in	in	ADP
dpc-2669	117	7	psoriasis	psoriasis	NOUN
dpc-2669	117	8	patients	patient	NOUN
dpc-2669	117	9	is	be	AUX
dpc-2669	117	10	similar	similar	ADJ
dpc-2669	117	11	to	to	ADP
dpc-2669	117	12	the	the	DET
dpc-2669	117	13	composition	composition	NOUN
dpc-2669	117	14	of	of	ADP
dpc-2669	117	15	the	the	DET
dpc-2669	117	16	dysbiotic	dysbiotic	ADJ
dpc-2669	117	17	microbiome	microbiome	NOUN
dpc-2669	117	18	,	,	PUNCT
dpc-2669	117	19	which	which	PRON
dpc-2669	117	20	is	be	AUX
dpc-2669	117	21	involved	involve	VERB
dpc-2669	117	22	in	in	ADP
dpc-2669	117	23	tmao	tmao	PROPN
dpc-2669	117	24	production	production	NOUN
dpc-2669	117	25	[	[	X
dpc-2669	117	26	5,6,17	5,6,17	NUM
dpc-2669	117	27	]	]	PUNCT
dpc-2669	117	28	.	.	PUNCT
dpc-2669	118	1	tmao	tmao	PROPN
dpc-2669	118	2	table	table	NOUN
dpc-2669	118	3	1	1	NUM
dpc-2669	118	4	.	.	PUNCT
dpc-2669	119	1	data	datum	NOUN
dpc-2669	119	2	for	for	ADP
dpc-2669	119	3	patients	patient	NOUN
dpc-2669	119	4	and	and	CCONJ
dpc-2669	119	5	healthy	healthy	ADJ
dpc-2669	119	6	controls	control	NOUN
dpc-2669	119	7	.	.	PUNCT
dpc-2669	120	1	patient	patient	NOUN
dpc-2669	120	2	(	(	PUNCT
dpc-2669	120	3	n	n	NOUN
dpc-2669	120	4	=	=	SYM
dpc-2669	120	5	73	73	NUM
dpc-2669	120	6	)	)	PUNCT
dpc-2669	120	7	mean	mean	VERB
dpc-2669	120	8	±	±	NUM
dpc-2669	120	9	sd	sd	NOUN
dpc-2669	120	10	control	control	NOUN
dpc-2669	120	11	(	(	PUNCT
dpc-2669	120	12	n	n	NOUN
dpc-2669	120	13	=	=	SYM
dpc-2669	120	14	72	72	NUM
dpc-2669	120	15	)	)	PUNCT
dpc-2669	120	16	mean	mean	VERB
dpc-2669	120	17	±	±	NUM
dpc-2669	120	18	sd	sd	ADP
dpc-2669	120	19	pa	pa	PROPN
dpc-2669	120	20	disease	disease	PROPN
dpc-2669	120	21	type	type	NOUN
dpc-2669	120	22	type-1(%86.30	type-1(%86.30	NOUN
dpc-2669	120	23	)	)	PUNCT
dpc-2669	120	24	type-2(%13.70	type-2(%13.70	NOUN
dpc-2669	120	25	)	)	PUNCT
dpc-2669	120	26	age	age	NOUN
dpc-2669	120	27	(	(	PUNCT
dpc-2669	120	28	year	year	NOUN
dpc-2669	120	29	)	)	PUNCT
dpc-2669	120	30	41.57	41.57	NUM
dpc-2669	120	31	±	±	NUM
dpc-2669	120	32	12.98	12.98	NUM
dpc-2669	120	33	41.22	41.22	NUM
dpc-2669	120	34	±	±	NUM
dpc-2669	120	35	9.25	9.25	NUM
dpc-2669	120	36	0.851	0.851	NUM
dpc-2669	120	37	bmi	bmi	NOUN
dpc-2669	120	38	(	(	PUNCT
dpc-2669	120	39	kg	kg	NOUN
dpc-2669	120	40	/	/	SYM
dpc-2669	120	41	m2	m2	PROPN
dpc-2669	120	42	)	)	PUNCT
dpc-2669	120	43	26.14	26.14	NUM
dpc-2669	120	44	±	±	NUM
dpc-2669	120	45	4.20	4.20	NUM
dpc-2669	120	46	25.63	25.63	NUM
dpc-2669	120	47	±	±	NUM
dpc-2669	120	48	3.35	3.35	NUM
dpc-2669	120	49	0.420	0.420	NUM
dpc-2669	120	50	systolic	systolic	ADJ
dpc-2669	120	51	blood	blood	NOUN
dpc-2669	120	52	pressure	pressure	NOUN
dpc-2669	120	53	(	(	PUNCT
dpc-2669	120	54	mmhg	mmhg	NOUN
dpc-2669	120	55	)	)	PUNCT
dpc-2669	120	56	121.34	121.34	NUM
dpc-2669	120	57	±	±	NUM
dpc-2669	120	58	10.05	10.05	NUM
dpc-2669	120	59	122,06	122,06	NUM
dpc-2669	120	60	±	±	NUM
dpc-2669	120	61	10.50	10.50	NUM
dpc-2669	120	62	0.676	0.676	NUM
dpc-2669	120	63	diastolic	diastolic	NOUN
dpc-2669	120	64	blood	blood	NOUN
dpc-2669	120	65	pressure	pressure	NOUN
dpc-2669	120	66	(	(	PUNCT
dpc-2669	120	67	mmhg	mmhg	PROPN
dpc-2669	120	68	)	)	PUNCT
dpc-2669	120	69	79.74	79.74	NUM
dpc-2669	120	70	±	±	NUM
dpc-2669	120	71	7.27	7.27	NUM
dpc-2669	120	72	81.26	81.26	NUM
dpc-2669	120	73	±	±	NUM
dpc-2669	120	74	7.62	7.62	NUM
dpc-2669	120	75	0.187	0.187	NUM
dpc-2669	120	76	tmao	tmao	PROPN
dpc-2669	120	77	(	(	PUNCT
dpc-2669	120	78	ng	ng	PROPN
dpc-2669	120	79	/	/	SYM
dpc-2669	120	80	ml	ml	NOUN
dpc-2669	120	81	)	)	PUNCT
dpc-2669	120	82	323.34	323.34	NUM
dpc-2669	120	83	±	±	NOUN
dpc-2669	120	84	240.36	240.36	NUM
dpc-2669	120	85	220.96	220.96	NUM
dpc-2669	120	86	±	±	NUM
dpc-2669	120	87	85.36	85.36	NUM
dpc-2669	120	88	0.028	0.028	NUM
dpc-2669	120	89	hscrp	hscrp	NOUN
dpc-2669	120	90	(	(	PUNCT
dpc-2669	120	91	mg	mg	PROPN
dpc-2669	120	92	/	/	SYM
dpc-2669	120	93	l	l	NOUN
dpc-2669	120	94	)	)	PUNCT
dpc-2669	120	95	2.318	2.318	NUM
dpc-2669	120	96	±	±	NUM
dpc-2669	120	97	2.00	2.00	NUM
dpc-2669	120	98	1.306	1.306	NUM
dpc-2669	120	99	±	±	NUM
dpc-2669	120	100	0.74	0.74	NUM
dpc-2669	120	101	0.013	0.013	NUM
dpc-2669	120	102	oxidized	oxidize	VERB
dpc-2669	120	103	-	-	PUNCT
dpc-2669	120	104	ldl	ldl	NOUN
dpc-2669	120	105	(	(	PUNCT
dpc-2669	120	106	pg	pg	NOUN
dpc-2669	120	107	/	/	SYM
dpc-2669	120	108	ml	ml	VERB
dpc-2669	120	109	)	)	PUNCT
dpc-2669	120	110	82.50	82.50	NUM
dpc-2669	120	111	±	±	NUM
dpc-2669	120	112	42.03	42.03	NUM
dpc-2669	120	113	61.34	61.34	NUM
dpc-2669	120	114	±	±	NUM
dpc-2669	120	115	31.34	31.34	NUM
dpc-2669	120	116	0.010	0.010	NUM
dpc-2669	120	117	total	total	ADJ
dpc-2669	120	118	cholesterol	cholesterol	NOUN
dpc-2669	120	119	(	(	PUNCT
dpc-2669	120	120	mg	mg	PROPN
dpc-2669	120	121	/	/	SYM
dpc-2669	120	122	dl	dl	NOUN
dpc-2669	120	123	)	)	PUNCT
dpc-2669	120	124	189.77	189.77	NUM
dpc-2669	120	125	±	±	NUM
dpc-2669	120	126	41.12	41.12	NUM
dpc-2669	120	127	194.29	194.29	NUM
dpc-2669	120	128	±	±	NUM
dpc-2669	120	129	34.71	34.71	NUM
dpc-2669	120	130	0.475	0.475	NUM
dpc-2669	120	131	hdl	hdl	PROPN
dpc-2669	120	132	cholesterol	cholesterol	NOUN
dpc-2669	120	133	(	(	PUNCT
dpc-2669	120	134	mg	mg	PROPN
dpc-2669	120	135	/	/	SYM
dpc-2669	120	136	dl	dl	PROPN
dpc-2669	120	137	)	)	PUNCT
dpc-2669	120	138	39.09	39.09	NUM
dpc-2669	120	139	±	±	NUM
dpc-2669	120	140	9.38	9.38	NUM
dpc-2669	120	141	47.75	47.75	NUM
dpc-2669	120	142	±	±	NUM
dpc-2669	120	143	10.12	10.12	NUM
dpc-2669	120	144	0.001	0.001	NUM
dpc-2669	120	145	ldl	ldl	NOUN
dpc-2669	120	146	cholesterol	cholesterol	NOUN
dpc-2669	120	147	(	(	PUNCT
dpc-2669	120	148	mg	mg	PROPN
dpc-2669	120	149	/	/	SYM
dpc-2669	120	150	dl	dl	NOUN
dpc-2669	120	151	)	)	PUNCT
dpc-2669	120	152	120.74	120.74	NUM
dpc-2669	120	153	±	±	NOUN
dpc-2669	120	154	36.71	36.71	NUM
dpc-2669	120	155	121.99	121.99	NUM
dpc-2669	120	156	±	±	NUM
dpc-2669	120	157	29.68	29.68	NUM
dpc-2669	120	158	0.323	0.323	NUM
dpc-2669	120	159	triglyceride	triglyceride	ADJ
dpc-2669	120	160	(	(	PUNCT
dpc-2669	120	161	mg	mg	PROPN
dpc-2669	120	162	/	/	SYM
dpc-2669	120	163	dl	dl	NOUN
dpc-2669	120	164	)	)	PUNCT
dpc-2669	120	165	150.87	150.87	NUM
dpc-2669	120	166	±	±	NOUN
dpc-2669	120	167	87.85	87.85	NUM
dpc-2669	120	168	119.83	119.83	NUM
dpc-2669	120	169	±	±	NUM
dpc-2669	120	170	70.02	70.02	NUM
dpc-2669	120	171	0.025	0.025	NUM
dpc-2669	120	172	ast	ast	NOUN
dpc-2669	120	173	(	(	PUNCT
dpc-2669	120	174	iu	iu	PROPN
dpc-2669	120	175	/	/	SYM
dpc-2669	120	176	l	l	NOUN
dpc-2669	120	177	)	)	PUNCT
dpc-2669	120	178	20.50	20.50	NUM
dpc-2669	120	179	±	±	NUM
dpc-2669	120	180	5.53	5.53	NUM
dpc-2669	120	181	20.93	20.93	NUM
dpc-2669	120	182	±	±	NUM
dpc-2669	120	183	4.27	4.27	NUM
dpc-2669	120	184	0.291	0.291	NUM
dpc-2669	120	185	alt	alt	NOUN
dpc-2669	120	186	(	(	PUNCT
dpc-2669	120	187	iu	iu	PROPN
dpc-2669	120	188	/	/	SYM
dpc-2669	120	189	l	l	NOUN
dpc-2669	120	190	)	)	PUNCT
dpc-2669	120	191	17.13	17.13	NUM
dpc-2669	120	192	±	±	NUM
dpc-2669	120	193	8.18	8.18	NUM
dpc-2669	120	194	17.82	17.82	NUM
dpc-2669	120	195	±	±	NUM
dpc-2669	120	196	7.95	7.95	NUM
dpc-2669	120	197	0.523	0.523	NUM
dpc-2669	120	198	creatinine	creatinine	NOUN
dpc-2669	120	199	(	(	PUNCT
dpc-2669	120	200	mg	mg	PROPN
dpc-2669	120	201	/	/	SYM
dpc-2669	120	202	dl	dl	NOUN
dpc-2669	120	203	)	)	PUNCT
dpc-2669	120	204	0.75	0.75	NUM
dpc-2669	120	205	±	±	NUM
dpc-2669	120	206	0.14	0.14	NUM
dpc-2669	120	207	0.75	0.75	NUM
dpc-2669	120	208	±	±	NUM
dpc-2669	120	209	0.20	0.20	NUM
dpc-2669	120	210	0.948	0.948	NUM
dpc-2669	120	211	left	leave	VERB
dpc-2669	120	212	anterior	anterior	ADJ
dpc-2669	120	213	cimt	cimt	NOUN
dpc-2669	120	214	(	(	PUNCT
dpc-2669	120	215	mm	mm	NOUN
dpc-2669	120	216	)	)	PUNCT
dpc-2669	120	217	0.598	0.598	NUM
dpc-2669	120	218	±	±	NUM
dpc-2669	120	219	0.129	0.129	NUM
dpc-2669	120	220	0.534	0.534	NUM
dpc-2669	120	221	±	±	NUM
dpc-2669	120	222	0.068	0.068	NUM
dpc-2669	120	223	0.010	0.010	NUM
dpc-2669	120	224	left	leave	VERB
dpc-2669	120	225	posterior	posterior	ADJ
dpc-2669	120	226	cimt	cimt	NOUN
dpc-2669	120	227	(	(	PUNCT
dpc-2669	120	228	mm	mm	NOUN
dpc-2669	120	229	)	)	PUNCT
dpc-2669	120	230	0.602	0.602	NUM
dpc-2669	120	231	±	±	NUM
dpc-2669	120	232	0.172	0.172	NUM
dpc-2669	120	233	0.528	0.528	NUM
dpc-2669	120	234	±	±	NUM
dpc-2669	120	235	0.093	0.093	NUM
dpc-2669	120	236	0.030	0.030	NUM
dpc-2669	120	237	right	right	ADJ
dpc-2669	120	238	anterior	anterior	ADJ
dpc-2669	120	239	cimt	cimt	NOUN
dpc-2669	120	240	(	(	PUNCT
dpc-2669	120	241	mm	mm	NOUN
dpc-2669	120	242	)	)	PUNCT
dpc-2669	120	243	0.623	0.623	NUM
dpc-2669	120	244	±	±	NUM
dpc-2669	120	245	0.177	0.177	NUM
dpc-2669	120	246	0.537	0.537	NUM
dpc-2669	120	247	±	±	NOUN
dpc-2669	120	248	0.086	0.086	NUM
dpc-2669	120	249	<	<	X
dpc-2669	120	250	0.001	0.001	NUM
dpc-2669	120	251	right	right	ADJ
dpc-2669	120	252	posterior	posterior	ADJ
dpc-2669	120	253	cimt	cimt	NOUN
dpc-2669	120	254	(	(	PUNCT
dpc-2669	120	255	mm	mm	NOUN
dpc-2669	120	256	)	)	PUNCT
dpc-2669	120	257	0.605	0.605	NUM
dpc-2669	120	258	±	±	NUM
dpc-2669	120	259	0.164	0.164	NUM
dpc-2669	120	260	0.520	0.520	NUM
dpc-2669	120	261	±	±	NUM
dpc-2669	120	262	0.075	0.075	NUM
dpc-2669	120	263	0.020	0.020	NUM
dpc-2669	120	264	alt	alt	ADJ
dpc-2669	120	265	=	=	SYM
dpc-2669	120	266	alanine	alanine	NOUN
dpc-2669	120	267	aminotransferase	aminotransferase	NOUN
dpc-2669	120	268	;	;	PUNCT
dpc-2669	120	269	ast	ast	NOUN
dpc-2669	120	270	=	=	SYM
dpc-2669	120	271	aspartate	aspartate	NOUN
dpc-2669	120	272	aminotransferase	aminotransferase	NOUN
dpc-2669	120	273	;	;	PUNCT
dpc-2669	120	274	bmi	bmi	NOUN
dpc-2669	120	275	=	=	SYM
dpc-2669	120	276	body	body	PROPN
dpc-2669	120	277	mass	mass	PROPN
dpc-2669	120	278	index	index	NOUN
dpc-2669	120	279	;	;	PUNCT
dpc-2669	120	280	cimt	cimt	NOUN
dpc-2669	120	281	=	=	SYM
dpc-2669	120	282	carotid	carotid	NOUN
dpc-2669	120	283	intima	intima	ADJ
dpc-2669	120	284	-	-	PUNCT
dpc-2669	120	285	media	medium	NOUN
dpc-2669	120	286	thickness	thickness	NOUN
dpc-2669	120	287	;	;	PUNCT
dpc-2669	120	288	hscrp	hscrp	NOUN
dpc-2669	120	289	=	=	PUNCT
dpc-2669	120	290	high	high	ADJ
dpc-2669	120	291	sensitivity	sensitivity	NOUN
dpc-2669	120	292	c	c	NOUN
dpc-2669	120	293	-	-	PUNCT
dpc-2669	120	294	reactive	reactive	ADJ
dpc-2669	120	295	protein	protein	NOUN
dpc-2669	120	296	;	;	PUNCT
dpc-2669	121	1	hdl	hdl	PROPN
dpc-2669	121	2	=	=	PUNCT
dpc-2669	121	3	high	high	ADJ
dpc-2669	121	4	density	density	NOUN
dpc-2669	121	5	lipoprotein	lipoprotein	ADJ
dpc-2669	121	6	;	;	PUNCT
dpc-2669	121	7	ldl	ldl	NOUN
dpc-2669	121	8	=	=	PUNCT
dpc-2669	121	9	low	low	ADJ
dpc-2669	121	10	density	density	NOUN
dpc-2669	121	11	lipoprotein	lipoprotein	ADJ
dpc-2669	121	12	;	;	PUNCT
dpc-2669	121	13	sd	sd	NOUN
dpc-2669	121	14	=	=	SYM
dpc-2669	121	15	standard	standard	ADJ
dpc-2669	121	16	deviation	deviation	NOUN
dpc-2669	121	17	;	;	PUNCT
dpc-2669	121	18	tmao	tmao	PROPN
dpc-2669	121	19	=	=	PUNCT
dpc-2669	121	20	trimethylamine	trimethylamine	NOUN
dpc-2669	121	21	 	 	SPACE
dpc-2669	121	22	n	n	CCONJ
dpc-2669	121	23	-	-	PUNCT
dpc-2669	121	24	oxide	oxide	NOUN
dpc-2669	121	25	.	.	PUNCT
dpc-2669	122	1	athe	athe	ADJ
dpc-2669	122	2	level	level	NOUN
dpc-2669	122	3	of	of	ADP
dpc-2669	122	4	significance	significance	NOUN
dpc-2669	122	5	(	(	PUNCT
dpc-2669	122	6	p	p	NOUN
dpc-2669	122	7	value	value	NOUN
dpc-2669	122	8	)	)	PUNCT
dpc-2669	122	9	was	be	AUX
dpc-2669	122	10	accepted	accept	VERB
dpc-2669	122	11	as	as	ADP
dpc-2669	122	12	0.05	0.05	NUM
dpc-2669	122	13	.	.	PUNCT
dpc-2669	122	14	plays	play	VERB
dpc-2669	122	15	an	an	DET
dpc-2669	122	16	important	important	ADJ
dpc-2669	122	17	role	role	NOUN
dpc-2669	122	18	in	in	ADP
dpc-2669	122	19	oxidized	oxidize	VERB
dpc-2669	122	20	-	-	PUNCT
dpc-2669	122	21	ldl	ldl	NOUN
dpc-2669	122	22	accumulation	accumulation	NOUN
dpc-2669	122	23	and	and	CCONJ
dpc-2669	122	24	foam	foam	NOUN
dpc-2669	122	25	cell	cell	NOUN
dpc-2669	122	26	formation	formation	NOUN
dpc-2669	122	27	within	within	ADP
dpc-2669	122	28	macrophages	macrophage	NOUN
dpc-2669	122	29	by	by	ADP
dpc-2669	122	30	increasing	increase	VERB
dpc-2669	122	31	the	the	DET
dpc-2669	122	32	expression	expression	NOUN
dpc-2669	122	33	of	of	ADP
dpc-2669	122	34	cd36	cd36	PROPN
dpc-2669	122	35	and	and	CCONJ
dpc-2669	122	36	macrophage	macrophage	ADJ
dpc-2669	122	37	scavenger	scavenger	NOUN
dpc-2669	122	38	receptors	receptor	NOUN
dpc-2669	122	39	(	(	PUNCT
dpc-2669	122	40	sr	sr	NOUN
dpc-2669	122	41	-	-	PUNCT
dpc-2669	122	42	a1	a1	NOUN
dpc-2669	122	43	)	)	PUNCT
dpc-2669	122	44	.	.	PUNCT
dpc-2669	123	1	it	it	PRON
dpc-2669	123	2	enhances	enhance	VERB
dpc-2669	123	3	macrophage	macrophage	ADJ
dpc-2669	123	4	chemotaxis	chemotaxis	ADJ
dpc-2669	123	5	,	,	PUNCT
dpc-2669	123	6	expression	expression	NOUN
dpc-2669	123	7	of	of	ADP
dpc-2669	123	8	inflammatory	inflammatory	ADJ
dpc-2669	123	9	cytokines	cytokine	NOUN
dpc-2669	123	10	including	include	VERB
dpc-2669	123	11	tnf	tnf	PROPN
dpc-2669	123	12	-	-	PUNCT
dpc-2669	123	13	alpha	alpha	NOUN
dpc-2669	123	14	and	and	CCONJ
dpc-2669	123	15	il-6	il-6	NOUN
dpc-2669	123	16	,	,	PUNCT
dpc-2669	123	17	and	and	CCONJ
dpc-2669	123	18	may	may	AUX
dpc-2669	123	19	exacerbate	exacerbate	VERB
dpc-2669	123	20	inflammation	inflammation	NOUN
dpc-2669	123	21	via	via	ADP
dpc-2669	123	22	mapk	mapk	NOUN
dpc-2669	123	23	and	and	CCONJ
dpc-2669	123	24	nf	nf	NOUN
dpc-2669	123	25	-	-	PUNCT
dpc-2669	123	26	κb	κb	NOUN
dpc-2669	123	27	.	.	PUNCT
dpc-2669	124	1	it	it	PRON
dpc-2669	124	2	also	also	ADV
dpc-2669	124	3	decreases	decrease	VERB
dpc-2669	124	4	the	the	DET
dpc-2669	124	5	expression	expression	NOUN
dpc-2669	124	6	of	of	ADP
dpc-2669	124	7	the	the	DET
dpc-2669	124	8	anti	anti	ADJ
dpc-2669	124	9	-	-	ADJ
dpc-2669	124	10	inflammatory	inflammatory	ADJ
dpc-2669	124	11	cytokine	cytokine	NOUN
dpc-2669	124	12	il-10	il-10	PRON
dpc-2669	124	13	[	[	X
dpc-2669	124	14	20	20	NUM
dpc-2669	124	15	-	-	SYM
dpc-2669	124	16	23	23	NUM
dpc-2669	124	17	]	]	PUNCT
dpc-2669	124	18	.	.	PUNCT
dpc-2669	125	1	studies	study	NOUN
dpc-2669	125	2	investigating	investigate	VERB
dpc-2669	125	3	serum	serum	NOUN
dpc-2669	125	4	tmao	tmao	PROPN
dpc-2669	125	5	levels	level	NOUN
dpc-2669	125	6	and	and	CCONJ
dpc-2669	125	7	their	their	PRON
dpc-2669	125	8	relationship	relationship	NOUN
dpc-2669	125	9	with	with	ADP
dpc-2669	125	10	comorbidities	comorbiditie	NOUN
dpc-2669	125	11	in	in	ADP
dpc-2669	125	12	patients	patient	NOUN
dpc-2669	125	13	with	with	ADP
dpc-2669	125	14	psoriasis	psoriasis	NOUN
dpc-2669	125	15	are	be	AUX
dpc-2669	125	16	still	still	ADV
dpc-2669	125	17	very	very	ADV
dpc-2669	125	18	limited	limited	ADJ
dpc-2669	125	19	.	.	PUNCT
dpc-2669	126	1	sikora	sikora	NOUN
dpc-2669	126	2	et	et	PROPN
dpc-2669	126	3	al	al	PROPN
dpc-2669	126	4	.	.	PROPN
dpc-2669	126	5	found	find	VERB
dpc-2669	126	6	that	that	SCONJ
dpc-2669	126	7	tmao	tmao	PROPN
dpc-2669	126	8	levels	level	NOUN
dpc-2669	126	9	were	be	AUX
dpc-2669	126	10	significantly	significantly	ADV
dpc-2669	126	11	higher	high	ADJ
dpc-2669	126	12	in	in	ADP
dpc-2669	126	13	psoriasis	psoriasis	NOUN
dpc-2669	126	14	patients	patient	NOUN
dpc-2669	126	15	than	than	ADP
dpc-2669	126	16	in	in	ADP
dpc-2669	126	17	controls	control	NOUN
dpc-2669	126	18	and	and	CCONJ
dpc-2669	126	19	this	this	DET
dpc-2669	126	20	elevation	elevation	NOUN
dpc-2669	126	21	was	be	AUX
dpc-2669	126	22	in	in	ADP
dpc-2669	126	23	parallel	parallel	NOUN
dpc-2669	126	24	with	with	ADP
dpc-2669	126	25	the	the	DET
dpc-2669	126	26	increased	increase	VERB
dpc-2669	126	27	cardiovascular	cardiovascular	ADJ
dpc-2669	126	28	risk	risk	NOUN
dpc-2669	126	29	[	[	X
dpc-2669	126	30	24	24	NUM
dpc-2669	126	31	]	]	PUNCT
dpc-2669	126	32	.	.	PUNCT
dpc-2669	127	1	in	in	ADP
dpc-2669	127	2	this	this	DET
dpc-2669	127	3	study	study	NOUN
dpc-2669	127	4	,	,	PUNCT
dpc-2669	127	5	we	we	PRON
dpc-2669	127	6	found	find	VERB
dpc-2669	127	7	that	that	SCONJ
dpc-2669	127	8	serum	serum	NOUN
dpc-2669	127	9	tmao	tmao	PROPN
dpc-2669	127	10	levels	level	NOUN
dpc-2669	127	11	were	be	AUX
dpc-2669	127	12	significantly	significantly	ADV
dpc-2669	127	13	higher	high	ADJ
dpc-2669	127	14	in	in	ADP
dpc-2669	127	15	psoriasis	psoriasis	NOUN
dpc-2669	127	16	patients	patient	NOUN
dpc-2669	127	17	compared	compare	VERB
dpc-2669	127	18	to	to	ADP
dpc-2669	127	19	the	the	DET
dpc-2669	127	20	control	control	NOUN
dpc-2669	127	21	group	group	NOUN
dpc-2669	127	22	.	.	PUNCT
dpc-2669	128	1	in	in	ADP
dpc-2669	128	2	the	the	DET
dpc-2669	128	3	patient	patient	NOUN
dpc-2669	128	4	group	group	NOUN
dpc-2669	128	5	,	,	PUNCT
dpc-2669	128	6	there	there	PRON
dpc-2669	128	7	were	be	VERB
dpc-2669	128	8	positive	positive	ADJ
dpc-2669	128	9	correlations	correlation	NOUN
dpc-2669	128	10	between	between	ADP
dpc-2669	128	11	serum	serum	NOUN
dpc-2669	128	12	tmao	tmao	PROPN
dpc-2669	128	13	concentrations	concentration	NOUN
dpc-2669	128	14	and	and	CCONJ
dpc-2669	128	15	cimt	cimt	VERB
dpc-2669	128	16	values	value	NOUN
dpc-2669	128	17	when	when	SCONJ
dpc-2669	128	18	other	other	ADJ
dpc-2669	128	19	cardiovascular	cardiovascular	ADJ
dpc-2669	128	20	risk	risk	NOUN
dpc-2669	128	21	markers	marker	NOUN
dpc-2669	128	22	were	be	AUX
dpc-2669	128	23	controlled	control	VERB
dpc-2669	128	24	.	.	PUNCT
dpc-2669	129	1	the	the	DET
dpc-2669	129	2	results	result	NOUN
dpc-2669	129	3	support	support	VERB
dpc-2669	129	4	the	the	DET
dpc-2669	129	5	presence	presence	NOUN
dpc-2669	129	6	of	of	ADP
dpc-2669	129	7	gut	gut	NOUN
dpc-2669	129	8	dysbiosis	dysbiosis	NOUN
dpc-2669	129	9	in	in	ADP
dpc-2669	129	10	psoriasis	psoriasis	NOUN
dpc-2669	129	11	patients	patient	NOUN
dpc-2669	129	12	,	,	PUNCT
dpc-2669	129	13	and	and	CCONJ
dpc-2669	129	14	these	these	DET
dpc-2669	129	15	data	datum	NOUN
dpc-2669	129	16	support	support	VERB
dpc-2669	129	17	the	the	DET
dpc-2669	129	18	idea	idea	NOUN
dpc-2669	129	19	that	that	SCONJ
dpc-2669	129	20	original	original	ADJ
dpc-2669	129	21	article	article	NOUN
dpc-2669	129	22	|	|	ADV
dpc-2669	129	23	dermatol	dermatol	ADJ
dpc-2669	129	24	pract	pract	NOUN
dpc-2669	129	25	concept	concept	NOUN
dpc-2669	129	26	.	.	PUNCT
dpc-2669	130	1	2023;13(2):e2023116	2023;13(2):e2023116	NUM
dpc-2669	130	2	7	7	NUM
dpc-2669	130	3	ta	ta	PART
dpc-2669	130	4	b	b	PROPN
dpc-2669	130	5	le	le	X
dpc-2669	130	6	2	2	NUM
dpc-2669	130	7	.	.	PUNCT
dpc-2669	131	1	c	c	NOUN
dpc-2669	131	2	or	or	CCONJ
dpc-2669	131	3	re	re	ADJ
dpc-2669	131	4	la	la	X
dpc-2669	131	5	ti	ti	NOUN
dpc-2669	131	6	on	on	ADP
dpc-2669	131	7	s	s	PRON
dpc-2669	131	8	w	w	VERB
dpc-2669	131	9	he	he	PRON
dpc-2669	131	10	n	n	CCONJ
dpc-2669	131	11	co	co	VERB
dpc-2669	131	12	nt	not	PART
dpc-2669	131	13	ro	ro	PROPN
dpc-2669	131	14	lli	lli	PROPN
dpc-2669	131	15	ng	ng	PROPN
dpc-2669	131	16	f	f	PROPN
dpc-2669	131	17	or	or	CCONJ
dpc-2669	131	18	a	a	DET
dpc-2669	131	19	ge	ge	PROPN
dpc-2669	131	20	,	,	PUNCT
dpc-2669	131	21	b	b	X
dpc-2669	131	22	m	m	VERB
dpc-2669	131	23	i	i	PRON
dpc-2669	131	24	,	,	PUNCT
dpc-2669	131	25	an	an	DET
dpc-2669	131	26	d	d	X
dpc-2669	131	27	di	di	X
dpc-2669	131	28	se	se	PROPN
dpc-2669	131	29	as	as	ADP
dpc-2669	131	30	e	e	PROPN
dpc-2669	131	31	du	du	PROPN
dpc-2669	131	32	ra	ra	PROPN
dpc-2669	131	33	ti	ti	NOUN
dpc-2669	131	34	on	on	ADP
dpc-2669	131	35	in	in	ADP
dpc-2669	131	36	t	t	PROPN
dpc-2669	131	37	he	he	PRON
dpc-2669	131	38	p	p	X
dpc-2669	131	39	at	at	ADP
dpc-2669	131	40	ie	ie	PROPN
dpc-2669	131	41	nt	not	PART
dpc-2669	131	42	g	g	PROPN
dpc-2669	131	43	ro	ro	X
dpc-2669	131	44	up	up	ADP
dpc-2669	131	45	.	.	PUNCT
dpc-2669	132	1	tm	tm	PROPN
dpc-2669	132	2	a	a	DET
dpc-2669	132	3	o	o	X
dpc-2669	133	1	o	o	X
dpc-2669	133	2	xi	xi	INTJ
dpc-2669	134	1	d	d	NOUN
dpc-2669	134	2	iz	iz	INTJ
dpc-2669	135	1	ed	ed	NOUN
dpc-2669	135	2	-l	-l	PROPN
dpc-2669	136	1	d	d	NOUN
dpc-2669	136	2	l	l	NOUN
dpc-2669	136	3	h	h	NOUN
dpc-2669	136	4	sc	sc	PROPN
dpc-2669	136	5	r	r	NOUN
dpc-2669	136	6	p	p	NOUN
dpc-2669	136	7	tr	tr	VERB
dpc-2669	136	8	ig	ig	PROPN
dpc-2669	136	9	ly	ly	NUM
dpc-2669	136	10	ce	ce	PROPN
dpc-2669	136	11	ri	ri	PROPN
dpc-2669	137	1	d	d	X
dpc-2669	137	2	e	e	X
dpc-2669	137	3	to	to	ADP
dpc-2669	137	4	ta	ta	PROPN
dpc-2669	137	5	lc	lc	PROPN
dpc-2669	137	6	h	h	PROPN
dpc-2669	138	1	d	d	PROPN
dpc-2669	138	2	lc	lc	PROPN
dpc-2669	138	3	ld	ld	PROPN
dpc-2669	138	4	lc	lc	PROPN
dpc-2669	138	5	pa	pa	PROPN
dpc-2669	138	6	si	si	PROPN
dpc-2669	138	7	le	le	PROPN
dpc-2669	138	8	ft	ft	PROPN
dpc-2669	138	9	a	a	PRON
dpc-2669	138	10	n	n	NOUN
dpc-2669	138	11	t	t	NOUN
dpc-2669	138	12	c	c	NOUN
dpc-2669	139	1	i	i	PRON
dpc-2669	139	2	m	m	VERB
dpc-2669	139	3	t	t	X
dpc-2669	139	4	le	le	X
dpc-2669	139	5	ft	ft	ADP
dpc-2669	139	6	p	p	X
dpc-2669	139	7	o	o	PROPN
dpc-2669	139	8	st	st	PROPN
dpc-2669	140	1	c	c	X
dpc-2669	140	2	i	i	PRON
dpc-2669	140	3	m	m	VERB
dpc-2669	140	4	t	t	NOUN
dpc-2669	140	5	r	r	NOUN
dpc-2669	141	1	ig	ig	PROPN
dpc-2669	142	1	h	h	NOUN
dpc-2669	142	2	t	t	PROPN
dpc-2669	142	3	an	an	DET
dpc-2669	142	4	t	t	NOUN
dpc-2669	142	5	c	c	PROPN
dpc-2669	143	1	i	i	PRON
dpc-2669	143	2	m	m	VERB
dpc-2669	143	3	t	t	NOUN
dpc-2669	143	4	r	r	NOUN
dpc-2669	143	5	ig	ig	PROPN
dpc-2669	144	1	h	h	NOUN
dpc-2669	144	2	t	t	NOUN
dpc-2669	144	3	p	p	X
dpc-2669	145	1	o	o	X
dpc-2669	145	2	st	st	PROPN
dpc-2669	146	1	c	c	X
dpc-2669	146	2	i	i	PRON
dpc-2669	146	3	m	m	VERB
dpc-2669	146	4	t	t	PROPN
dpc-2669	146	5	t	t	PROPN
dpc-2669	146	6	m	m	VERB
dpc-2669	146	7	a	a	DET
dpc-2669	146	8	o	o	NOUN
dpc-2669	146	9	p	p	ADJ
dpc-2669	146	10	1	1	NUM
dpc-2669	146	11	.	.	PUNCT
dpc-2669	146	12	00	00	NUM
dpc-2669	146	13	0	0	NUM
dpc-2669	147	1	r	r	NOUN
dpc-2669	147	2	0	0	NUM
dpc-2669	147	3	.	.	PUNCT
dpc-2669	147	4	00	00	NUM
dpc-2669	147	5	0	0	NUM
dpc-2669	148	1	o	o	NOUN
dpc-2669	148	2	xi	xi	X
dpc-2669	148	3	di	di	PROPN
dpc-2669	148	4	ze	ze	PROPN
dpc-2669	148	5	dl	dl	PROPN
dpc-2669	149	1	d	d	PROPN
dpc-2669	149	2	l	l	NOUN
dpc-2669	149	3	p	p	NOUN
dpc-2669	149	4	0	0	PROPN
dpc-2669	149	5	.	.	PUNCT
dpc-2669	149	6	66	66	NUM
dpc-2669	149	7	7	7	NUM
dpc-2669	149	8	1	1	NUM
dpc-2669	149	9	.	.	PUNCT
dpc-2669	149	10	00	00	NUM
dpc-2669	149	11	0	0	NUM
dpc-2669	150	1	r	r	NOUN
dpc-2669	150	2	0	0	NUM
dpc-2669	150	3	.	.	PUNCT
dpc-2669	151	1	05	05	NUM
dpc-2669	151	2	2	2	NUM
dpc-2669	151	3	0	0	NUM
dpc-2669	151	4	.	.	PUNCT
dpc-2669	151	5	00	00	NUM
dpc-2669	151	6	0	0	NUM
dpc-2669	152	1	h	h	NOUN
dpc-2669	152	2	sc	sc	PROPN
dpc-2669	152	3	r	r	NOUN
dpc-2669	152	4	p	p	PROPN
dpc-2669	152	5	p	p	PROPN
dpc-2669	152	6	0	0	NUM
dpc-2669	152	7	.	.	PUNCT
dpc-2669	153	1	51	51	NUM
dpc-2669	153	2	0	0	NUM
dpc-2669	153	3	0	0	NUM
dpc-2669	153	4	.	.	PUNCT
dpc-2669	153	5	84	84	NUM
dpc-2669	153	6	7	7	NUM
dpc-2669	153	7	1	1	NUM
dpc-2669	153	8	.	.	PUNCT
dpc-2669	153	9	00	00	NUM
dpc-2669	153	10	0	0	NUM
dpc-2669	153	11	r	r	NOUN
dpc-2669	153	12	-0	-0	PUNCT
dpc-2669	153	13	.0	.0	NUM
dpc-2669	153	14	80	80	NUM
dpc-2669	153	15	0	0	NUM
dpc-2669	153	16	.	.	PUNCT
dpc-2669	154	1	02	02	NUM
dpc-2669	154	2	3	3	NUM
dpc-2669	154	3	0	0	NUM
dpc-2669	154	4	.	.	PUNCT
dpc-2669	154	5	00	00	NUM
dpc-2669	154	6	0	0	NUM
dpc-2669	155	1	t	t	PROPN
dpc-2669	155	2	ri	ri	NOUN
dpc-2669	155	3	gl	gl	INTJ
dpc-2669	156	1	yc	yc	INTJ
dpc-2669	156	2	er	er	INTJ
dpc-2669	156	3	i	i	PROPN
dpc-2669	156	4	d	d	PROPN
dpc-2669	156	5	e	e	PROPN
dpc-2669	156	6	p	p	PROPN
dpc-2669	156	7	0	0	NUM
dpc-2669	156	8	.	.	PUNCT
dpc-2669	157	1	82	82	NUM
dpc-2669	157	2	1	1	NUM
dpc-2669	157	3	0	0	NUM
dpc-2669	157	4	.	.	PUNCT
dpc-2669	157	5	02	02	NUM
dpc-2669	157	6	2	2	NUM
dpc-2669	157	7	0	0	NUM
dpc-2669	157	8	.	.	PUNCT
dpc-2669	157	9	26	26	NUM
dpc-2669	157	10	5	5	NUM
dpc-2669	157	11	1	1	NUM
dpc-2669	157	12	.	.	PUNCT
dpc-2669	157	13	00	00	NUM
dpc-2669	157	14	0	0	NUM
dpc-2669	158	1	r	r	NOUN
dpc-2669	158	2	-0	-0	PUNCT
dpc-2669	158	3	.0	.0	NUM
dpc-2669	158	4	27	27	NUM
dpc-2669	158	5	0	0	NUM
dpc-2669	158	6	.	.	PUNCT
dpc-2669	159	1	27	27	NUM
dpc-2669	159	2	4	4	NUM
dpc-2669	159	3	0	0	NUM
dpc-2669	159	4	.	.	NOUN
dpc-2669	159	5	13	13	NUM
dpc-2669	159	6	5	5	NUM
dpc-2669	159	7	0	0	NUM
dpc-2669	159	8	.	.	PUNCT
dpc-2669	159	9	00	00	NUM
dpc-2669	159	10	0	0	PUNCT
dpc-2669	160	1	to	to	ADP
dpc-2669	160	2	ta	ta	PROPN
dpc-2669	160	3	lc	lc	PROPN
dpc-2669	160	4	p	p	PROPN
dpc-2669	160	5	0	0	PROPN
dpc-2669	160	6	.	.	PUNCT
dpc-2669	160	7	00	00	NUM
dpc-2669	160	8	6	6	NUM
dpc-2669	160	9	0	0	NUM
dpc-2669	160	10	.	.	PUNCT
dpc-2669	161	1	46	46	NUM
dpc-2669	161	2	5	5	NUM
dpc-2669	161	3	0	0	NUM
dpc-2669	161	4	.	.	PUNCT
dpc-2669	162	1	74	74	NUM
dpc-2669	162	2	8	8	NUM
dpc-2669	162	3	0	0	NUM
dpc-2669	162	4	.	.	PUNCT
dpc-2669	162	5	00	00	NUM
dpc-2669	162	6	3	3	NUM
dpc-2669	162	7	1	1	NUM
dpc-2669	162	8	.	.	PUNCT
dpc-2669	162	9	00	00	NUM
dpc-2669	162	10	0	0	NUM
dpc-2669	163	1	r	r	NOUN
dpc-2669	163	2	0	0	NUM
dpc-2669	163	3	.	.	PUNCT
dpc-2669	163	4	32	32	NUM
dpc-2669	163	5	5	5	NUM
dpc-2669	163	6	0	0	NUM
dpc-2669	163	7	.	.	PUNCT
dpc-2669	163	8	08	08	NUM
dpc-2669	163	9	9	9	NUM
dpc-2669	163	10	-0	-0	SYM
dpc-2669	163	11	.0	.0	NUM
dpc-2669	163	12	39	39	NUM
dpc-2669	163	13	0	0	NUM
dpc-2669	163	14	.	.	PUNCT
dpc-2669	164	1	34	34	NUM
dpc-2669	164	2	5	5	NUM
dpc-2669	164	3	0	0	NUM
dpc-2669	164	4	.	.	PUNCT
dpc-2669	164	5	00	00	NUM
dpc-2669	164	6	0	0	NUM
dpc-2669	164	7	h	h	NOUN
dpc-2669	165	1	d	d	NOUN
dpc-2669	165	2	l	l	NOUN
dpc-2669	166	1	-c	-c	PUNCT
dpc-2669	166	2	p	p	NOUN
dpc-2669	166	3	0	0	NUM
dpc-2669	166	4	.	.	PUNCT
dpc-2669	166	5	65	65	NUM
dpc-2669	166	6	5	5	NUM
dpc-2669	166	7	0	0	NUM
dpc-2669	166	8	.	.	PUNCT
dpc-2669	166	9	57	57	NUM
dpc-2669	166	10	3	3	NUM
dpc-2669	166	11	0	0	NUM
dpc-2669	166	12	.	.	PUNCT
dpc-2669	167	1	01	01	NUM
dpc-2669	167	2	4	4	NUM
dpc-2669	167	3	0	0	NUM
dpc-2669	167	4	.	.	PUNCT
dpc-2669	167	5	00	00	NUM
dpc-2669	168	1	1	1	NUM
dpc-2669	168	2	0	0	NUM
dpc-2669	168	3	.	.	PUNCT
dpc-2669	169	1	90	90	NUM
dpc-2669	169	2	3	3	NUM
dpc-2669	169	3	1	1	NUM
dpc-2669	169	4	.	.	PUNCT
dpc-2669	169	5	00	00	NUM
dpc-2669	169	6	0	0	NUM
dpc-2669	170	1	r	r	NOUN
dpc-2669	170	2	0	0	NUM
dpc-2669	170	3	.	.	PUNCT
dpc-2669	171	1	05	05	NUM
dpc-2669	172	1	4	4	NUM
dpc-2669	172	2	-0	-0	SYM
dpc-2669	172	3	.0	.0	NUM
dpc-2669	172	4	69	69	NUM
dpc-2669	173	1	-0	-0	PUNCT
dpc-2669	173	2	.2	.2	NUM
dpc-2669	173	3	93	93	NUM
dpc-2669	173	4	-0	-0	SYM
dpc-2669	173	5	.3	.3	NUM
dpc-2669	173	6	87	87	NUM
dpc-2669	173	7	0	0	NUM
dpc-2669	173	8	.	.	PUNCT
dpc-2669	174	1	01	01	NUM
dpc-2669	174	2	5	5	NUM
dpc-2669	174	3	0	0	NUM
dpc-2669	174	4	.	.	PUNCT
dpc-2669	174	5	00	00	NUM
dpc-2669	174	6	0	0	NUM
dpc-2669	175	1	l	l	NOUN
dpc-2669	175	2	d	d	X
dpc-2669	175	3	l	l	NOUN
dpc-2669	175	4	-c	-c	PUNCT
dpc-2669	176	1	p	p	NOUN
dpc-2669	176	2	0	0	NUM
dpc-2669	176	3	.	.	PUNCT
dpc-2669	176	4	00	00	NUM
dpc-2669	177	1	3	3	NUM
dpc-2669	177	2	0	0	NUM
dpc-2669	177	3	.	.	PUNCT
dpc-2669	178	1	96	96	NUM
dpc-2669	178	2	0	0	NUM
dpc-2669	178	3	0	0	NUM
dpc-2669	178	4	.	.	NOUN
dpc-2669	179	1	80	80	NUM
dpc-2669	179	2	4	4	NUM
dpc-2669	179	3	0	0	NUM
dpc-2669	179	4	.	.	PUNCT
dpc-2669	179	5	83	83	NUM
dpc-2669	179	6	7	7	NUM
dpc-2669	179	7	<	<	SYM
dpc-2669	179	8	0	0	NUM
dpc-2669	179	9	.0	.0	NUM
dpc-2669	179	10	01	01	NUM
dpc-2669	179	11	0	0	NUM
dpc-2669	179	12	.	.	PUNCT
dpc-2669	180	1	55	55	NUM
dpc-2669	180	2	9	9	NUM
dpc-2669	180	3	1	1	NUM
dpc-2669	180	4	.	.	PUNCT
dpc-2669	180	5	00	00	NUM
dpc-2669	180	6	0	0	NUM
dpc-2669	181	1	r	r	NOUN
dpc-2669	181	2	0	0	NUM
dpc-2669	181	3	.	.	PUNCT
dpc-2669	182	1	34	34	NUM
dpc-2669	182	2	9	9	NUM
dpc-2669	182	3	-0	-0	SYM
dpc-2669	182	4	.0	.0	NUM
dpc-2669	182	5	06	06	NUM
dpc-2669	182	6	-0	-0	X
dpc-2669	182	7	.0	.0	NUM
dpc-2669	182	8	30	30	NUM
dpc-2669	182	9	0	0	NUM
dpc-2669	182	10	.	.	PUNCT
dpc-2669	183	1	02	02	NUM
dpc-2669	183	2	5	5	NUM
dpc-2669	183	3	0	0	NUM
dpc-2669	183	4	.	.	PUNCT
dpc-2669	184	1	91	91	NUM
dpc-2669	184	2	8	8	NUM
dpc-2669	184	3	-0	-0	SYM
dpc-2669	184	4	.0	.0	NUM
dpc-2669	184	5	71	71	NUM
dpc-2669	184	6	0	0	NUM
dpc-2669	184	7	.	.	PUNCT
dpc-2669	184	8	00	00	NUM
dpc-2669	184	9	0	0	NUM
dpc-2669	185	1	pa	pa	PROPN
dpc-2669	185	2	si	si	PROPN
dpc-2669	185	3	p	p	PROPN
dpc-2669	185	4	0	0	PROPN
dpc-2669	185	5	.	.	PUNCT
dpc-2669	186	1	58	58	NUM
dpc-2669	186	2	0	0	NUM
dpc-2669	186	3	0	0	NUM
dpc-2669	186	4	.	.	PUNCT
dpc-2669	187	1	28	28	NUM
dpc-2669	187	2	8	8	NUM
dpc-2669	187	3	0	0	NUM
dpc-2669	187	4	.	.	PUNCT
dpc-2669	188	1	61	61	NUM
dpc-2669	188	2	3	3	NUM
dpc-2669	188	3	0	0	NUM
dpc-2669	188	4	.	.	PUNCT
dpc-2669	189	1	38	38	NUM
dpc-2669	189	2	0	0	NUM
dpc-2669	189	3	0	0	NUM
dpc-2669	189	4	.	.	NOUN
dpc-2669	189	5	11	11	NUM
dpc-2669	189	6	4	4	NUM
dpc-2669	189	7	0	0	NUM
dpc-2669	189	8	.	.	PUNCT
dpc-2669	190	1	51	51	NUM
dpc-2669	190	2	1	1	NUM
dpc-2669	190	3	0	0	NUM
dpc-2669	190	4	.	.	PUNCT
dpc-2669	190	5	12	12	NUM
dpc-2669	190	6	9	9	NUM
dpc-2669	190	7	1	1	NUM
dpc-2669	190	8	.	.	PUNCT
dpc-2669	190	9	00	00	NUM
dpc-2669	190	10	0	0	NUM
dpc-2669	191	1	r	r	NOUN
dpc-2669	191	2	-0	-0	PUNCT
dpc-2669	191	3	.0	.0	NUM
dpc-2669	191	4	67	67	NUM
dpc-2669	191	5	-0	-0	SYM
dpc-2669	191	6	.1	.1	NUM
dpc-2669	191	7	29	29	NUM
dpc-2669	191	8	0	0	NUM
dpc-2669	191	9	.	.	X
dpc-2669	191	10	06	06	NUM
dpc-2669	191	11	2	2	NUM
dpc-2669	191	12	-0	-0	SYM
dpc-2669	191	13	.1	.1	NUM
dpc-2669	191	14	06	06	NUM
dpc-2669	192	1	-0	-0	SYM
dpc-2669	192	2	.1	.1	NUM
dpc-2669	192	3	91	91	NUM
dpc-2669	192	4	0	0	NUM
dpc-2669	192	5	.	.	PUNCT
dpc-2669	193	1	08	08	NUM
dpc-2669	193	2	0	0	NUM
dpc-2669	194	1	-0	-0	SYM
dpc-2669	194	2	.1	.1	NUM
dpc-2669	194	3	83	83	NUM
dpc-2669	194	4	0	0	NUM
dpc-2669	194	5	.	.	PUNCT
dpc-2669	194	6	00	00	NUM
dpc-2669	194	7	0	0	NUM
dpc-2669	195	1	l	l	NOUN
dpc-2669	195	2	ef	ef	PROPN
dpc-2669	195	3	t	t	PROPN
dpc-2669	195	4	an	an	DET
dpc-2669	195	5	t	t	NOUN
dpc-2669	195	6	c	c	PROPN
dpc-2669	196	1	i	i	PRON
dpc-2669	196	2	m	m	VERB
dpc-2669	196	3	t	t	NOUN
dpc-2669	196	4	p	p	X
dpc-2669	196	5	<	<	X
dpc-2669	196	6	0	0	PROPN
dpc-2669	196	7	.0	.0	NUM
dpc-2669	196	8	01	01	NUM
dpc-2669	196	9	0	0	NUM
dpc-2669	196	10	.	.	PUNCT
dpc-2669	197	1	34	34	NUM
dpc-2669	197	2	0	0	NUM
dpc-2669	197	3	0	0	NUM
dpc-2669	197	4	.	.	PUNCT
dpc-2669	198	1	54	54	NUM
dpc-2669	198	2	7	7	NUM
dpc-2669	198	3	0	0	NUM
dpc-2669	198	4	.	.	PUNCT
dpc-2669	199	1	47	47	NUM
dpc-2669	199	2	1	1	NUM
dpc-2669	199	3	0	0	NUM
dpc-2669	199	4	.	.	PUNCT
dpc-2669	200	1	14	14	NUM
dpc-2669	200	2	1	1	NUM
dpc-2669	200	3	0	0	NUM
dpc-2669	200	4	.	.	PUNCT
dpc-2669	201	1	07	07	NUM
dpc-2669	201	2	0	0	NUM
dpc-2669	201	3	0	0	NUM
dpc-2669	201	4	.	.	PUNCT
dpc-2669	202	1	10	10	NUM
dpc-2669	202	2	0	0	NUM
dpc-2669	202	3	0	0	NUM
dpc-2669	202	4	.	.	NUM
dpc-2669	202	5	21	21	NUM
dpc-2669	202	6	0	0	NUM
dpc-2669	202	7	1	1	NUM
dpc-2669	202	8	.	.	PUNCT
dpc-2669	202	9	00	00	NUM
dpc-2669	202	10	0	0	NUM
dpc-2669	203	1	r	r	NOUN
dpc-2669	203	2	0	0	NUM
dpc-2669	203	3	.	.	PUNCT
dpc-2669	204	1	45	45	NUM
dpc-2669	204	2	3	3	NUM
dpc-2669	204	3	0	0	NUM
dpc-2669	204	4	.	.	NOUN
dpc-2669	204	5	11	11	NUM
dpc-2669	204	6	6	6	NUM
dpc-2669	204	7	-0	-0	SYM
dpc-2669	204	8	.0	.0	NUM
dpc-2669	205	1	73	73	NUM
dpc-2669	205	2	0	0	NUM
dpc-2669	205	3	.	.	PUNCT
dpc-2669	206	1	08	08	NUM
dpc-2669	206	2	8	8	NUM
dpc-2669	206	3	0	0	NUM
dpc-2669	206	4	.	.	PUNCT
dpc-2669	206	5	17	17	NUM
dpc-2669	206	6	8	8	NUM
dpc-2669	206	7	-0	-0	SYM
dpc-2669	206	8	.2	.2	NUM
dpc-2669	206	9	18	18	NUM
dpc-2669	206	10	0	0	NUM
dpc-2669	206	11	.	.	PROPN
dpc-2669	206	12	19	19	NUM
dpc-2669	206	13	8	8	NUM
dpc-2669	206	14	-0	-0	SYM
dpc-2669	206	15	.1	.1	NUM
dpc-2669	206	16	52	52	NUM
dpc-2669	206	17	0	0	NUM
dpc-2669	206	18	.	.	PUNCT
dpc-2669	206	19	00	00	NUM
dpc-2669	206	20	0	0	NUM
dpc-2669	207	1	l	l	NOUN
dpc-2669	207	2	ef	ef	PROPN
dpc-2669	207	3	t	t	PROPN
dpc-2669	207	4	po	po	PROPN
dpc-2669	207	5	st	st	PROPN
dpc-2669	207	6	c	c	PROPN
dpc-2669	207	7	i	i	PRON
dpc-2669	207	8	m	m	VERB
dpc-2669	207	9	t	t	NOUN
dpc-2669	207	10	p	p	NOUN
dpc-2669	207	11	0	0	PROPN
dpc-2669	207	12	.	.	PUNCT
dpc-2669	207	13	77	77	NUM
dpc-2669	207	14	3	3	NUM
dpc-2669	207	15	0	0	NUM
dpc-2669	207	16	.	.	PUNCT
dpc-2669	207	17	36	36	NUM
dpc-2669	207	18	2	2	NUM
dpc-2669	207	19	0	0	NUM
dpc-2669	207	20	.	.	PUNCT
dpc-2669	207	21	23	23	NUM
dpc-2669	207	22	8	8	NUM
dpc-2669	207	23	0	0	NUM
dpc-2669	207	24	.	.	NOUN
dpc-2669	207	25	18	18	NUM
dpc-2669	207	26	9	9	NUM
dpc-2669	207	27	0	0	NUM
dpc-2669	207	28	.	.	PUNCT
dpc-2669	208	1	66	66	NUM
dpc-2669	208	2	1	1	NUM
dpc-2669	208	3	0	0	NUM
dpc-2669	208	4	.	.	PUNCT
dpc-2669	208	5	09	09	NUM
dpc-2669	208	6	5	5	NUM
dpc-2669	208	7	0	0	NUM
dpc-2669	208	8	.	.	PUNCT
dpc-2669	209	1	75	75	NUM
dpc-2669	209	2	8	8	NUM
dpc-2669	209	3	0	0	NUM
dpc-2669	209	4	.	.	PUNCT
dpc-2669	210	1	58	58	NUM
dpc-2669	210	2	3	3	NUM
dpc-2669	210	3	0	0	NUM
dpc-2669	210	4	.	.	PUNCT
dpc-2669	211	1	01	01	NUM
dpc-2669	211	2	9	9	NUM
dpc-2669	211	3	1	1	NUM
dpc-2669	211	4	.	.	PUNCT
dpc-2669	211	5	00	00	NUM
dpc-2669	211	6	0	0	NUM
dpc-2669	212	1	r	r	NOUN
dpc-2669	212	2	0	0	NUM
dpc-2669	212	3	.	.	NOUN
dpc-2669	212	4	03	03	NUM
dpc-2669	212	5	5	5	NUM
dpc-2669	212	6	0	0	NUM
dpc-2669	212	7	.	.	PUNCT
dpc-2669	212	8	11	11	NUM
dpc-2669	212	9	1	1	NUM
dpc-2669	212	10	0	0	NUM
dpc-2669	212	11	.	.	PUNCT
dpc-2669	212	12	04	04	NUM
dpc-2669	212	13	7	7	NUM
dpc-2669	212	14	0	0	NUM
dpc-2669	212	15	.	.	NOUN
dpc-2669	212	16	15	15	NUM
dpc-2669	212	17	9	9	NUM
dpc-2669	212	18	0	0	NUM
dpc-2669	212	19	.	.	PUNCT
dpc-2669	213	1	05	05	NUM
dpc-2669	213	2	3	3	NUM
dpc-2669	213	3	-0	-0	NOUN
dpc-2669	213	4	.2	.2	NUM
dpc-2669	213	5	01	01	NUM
dpc-2669	213	6	0	0	NUM
dpc-2669	213	7	.	.	X
dpc-2669	214	1	03	03	NUM
dpc-2669	214	2	8	8	NUM
dpc-2669	214	3	-0	-0	SYM
dpc-2669	214	4	.0	.0	NUM
dpc-2669	215	1	67	67	NUM
dpc-2669	215	2	0	0	NUM
dpc-2669	215	3	.	.	PUNCT
dpc-2669	216	1	28	28	NUM
dpc-2669	216	2	1	1	NUM
dpc-2669	216	3	0	0	NUM
dpc-2669	216	4	.	.	PUNCT
dpc-2669	216	5	00	00	NUM
dpc-2669	216	6	0	0	NUM
dpc-2669	217	1	r	r	NOUN
dpc-2669	217	2	ig	ig	PROPN
dpc-2669	218	1	ht	ht	INTJ
dpc-2669	218	2	a	a	PRON
dpc-2669	218	3	nt	not	PART
dpc-2669	218	4	c	c	NOUN
dpc-2669	219	1	i	i	PRON
dpc-2669	219	2	m	m	VERB
dpc-2669	219	3	t	t	NOUN
dpc-2669	219	4	p	p	NOUN
dpc-2669	219	5	0	0	NUM
dpc-2669	219	6	.	.	PUNCT
dpc-2669	220	1	94	94	NUM
dpc-2669	220	2	3	3	NUM
dpc-2669	220	3	0	0	NUM
dpc-2669	220	4	.	.	PUNCT
dpc-2669	220	5	06	06	NUM
dpc-2669	220	6	8	8	NUM
dpc-2669	220	7	0	0	NUM
dpc-2669	220	8	.	.	PUNCT
dpc-2669	221	1	48	48	NUM
dpc-2669	221	2	2	2	NUM
dpc-2669	221	3	0	0	NUM
dpc-2669	221	4	.	.	PUNCT
dpc-2669	221	5	61	61	NUM
dpc-2669	221	6	9	9	NUM
dpc-2669	221	7	0	0	NUM
dpc-2669	221	8	.	.	PUNCT
dpc-2669	222	1	74	74	NUM
dpc-2669	222	2	0	0	NUM
dpc-2669	222	3	0	0	NUM
dpc-2669	222	4	.	.	NUM
dpc-2669	222	5	08	08	NUM
dpc-2669	223	1	6	6	NUM
dpc-2669	223	2	0	0	NUM
dpc-2669	223	3	.	.	PUNCT
dpc-2669	224	1	46	46	NUM
dpc-2669	224	2	2	2	NUM
dpc-2669	224	3	0	0	NUM
dpc-2669	224	4	.	.	PUNCT
dpc-2669	225	1	42	42	NUM
dpc-2669	225	2	3	3	NUM
dpc-2669	225	3	0	0	NUM
dpc-2669	225	4	.	.	PUNCT
dpc-2669	225	5	00	00	NUM
dpc-2669	226	1	6	6	NUM
dpc-2669	226	2	0	0	NUM
dpc-2669	226	3	.	.	PUNCT
dpc-2669	226	4	03	03	NUM
dpc-2669	226	5	2	2	NUM
dpc-2669	226	6	1	1	NUM
dpc-2669	226	7	.	.	PUNCT
dpc-2669	226	8	00	00	NUM
dpc-2669	226	9	0	0	NUM
dpc-2669	226	10	r	r	NOUN
dpc-2669	226	11	0	0	NUM
dpc-2669	226	12	.	.	PUNCT
dpc-2669	226	13	00	00	NUM
dpc-2669	226	14	9	9	NUM
dpc-2669	226	15	0	0	NUM
dpc-2669	226	16	.	.	PUNCT
dpc-2669	226	17	21	21	NUM
dpc-2669	226	18	9	9	NUM
dpc-2669	226	19	0	0	NUM
dpc-2669	226	20	.	.	PUNCT
dpc-2669	226	21	08	08	NUM
dpc-2669	226	22	5	5	NUM
dpc-2669	226	23	0	0	NUM
dpc-2669	226	24	.	.	PUNCT
dpc-2669	226	25	06	06	NUM
dpc-2669	226	26	1	1	NUM
dpc-2669	226	27	0	0	NUM
dpc-2669	226	28	.	.	PUNCT
dpc-2669	226	29	04	04	NUM
dpc-2669	226	30	0	0	NUM
dpc-2669	226	31	-0	-0	INTJ
dpc-2669	226	32	.2	.2	NUM
dpc-2669	226	33	07	07	NUM
dpc-2669	226	34	0	0	NUM
dpc-2669	226	35	.	.	PUNCT
dpc-2669	226	36	08	08	NUM
dpc-2669	226	37	9	9	NUM
dpc-2669	226	38	-0	-0	SYM
dpc-2669	226	39	.0	.0	NUM
dpc-2669	226	40	97	97	NUM
dpc-2669	226	41	0	0	NUM
dpc-2669	226	42	.	.	PUNCT
dpc-2669	226	43	32	32	NUM
dpc-2669	226	44	7	7	NUM
dpc-2669	226	45	0	0	NUM
dpc-2669	226	46	.	.	PUNCT
dpc-2669	226	47	25	25	NUM
dpc-2669	226	48	6	6	NUM
dpc-2669	226	49	0	0	NUM
dpc-2669	226	50	.	.	PUNCT
dpc-2669	226	51	00	00	NUM
dpc-2669	226	52	0	0	NUM
dpc-2669	227	1	r	r	NOUN
dpc-2669	227	2	ig	ig	PROPN
dpc-2669	228	1	ht	ht	INTJ
dpc-2669	228	2	p	p	X
dpc-2669	228	3	os	os	NOUN
dpc-2669	228	4	t	t	PROPN
dpc-2669	228	5	c	c	PROPN
dpc-2669	229	1	i	i	PRON
dpc-2669	229	2	m	m	VERB
dpc-2669	229	3	t	t	NOUN
dpc-2669	229	4	p	p	NOUN
dpc-2669	229	5	0	0	PROPN
dpc-2669	229	6	.	.	NOUN
dpc-2669	229	7	03	03	NUM
dpc-2669	229	8	4	4	NUM
dpc-2669	229	9	0	0	NUM
dpc-2669	229	10	.	.	PUNCT
dpc-2669	229	11	15	15	NUM
dpc-2669	229	12	0	0	NUM
dpc-2669	229	13	0	0	NUM
dpc-2669	229	14	.	.	NOUN
dpc-2669	229	15	08	08	NUM
dpc-2669	229	16	4	4	NUM
dpc-2669	229	17	0	0	NUM
dpc-2669	229	18	.	.	NOUN
dpc-2669	229	19	20	20	NUM
dpc-2669	229	20	8	8	NUM
dpc-2669	229	21	0	0	NUM
dpc-2669	229	22	.	.	NOUN
dpc-2669	230	1	22	22	NUM
dpc-2669	230	2	6	6	NUM
dpc-2669	230	3	0	0	NUM
dpc-2669	230	4	.	.	PUNCT
dpc-2669	231	1	09	09	NUM
dpc-2669	231	2	4	4	NUM
dpc-2669	231	3	0	0	NUM
dpc-2669	231	4	.	.	PUNCT
dpc-2669	232	1	27	27	NUM
dpc-2669	232	2	2	2	NUM
dpc-2669	232	3	0	0	NUM
dpc-2669	232	4	.	.	PUNCT
dpc-2669	233	1	95	95	NUM
dpc-2669	233	2	1	1	NUM
dpc-2669	233	3	<	<	X
dpc-2669	233	4	0	0	NUM
dpc-2669	233	5	.0	.0	NUM
dpc-2669	233	6	01	01	NUM
dpc-2669	233	7	0	0	NUM
dpc-2669	233	8	.	.	PUNCT
dpc-2669	233	9	00	00	NUM
dpc-2669	234	1	4	4	NUM
dpc-2669	234	2	0	0	NUM
dpc-2669	234	3	.	.	PUNCT
dpc-2669	235	1	61	61	NUM
dpc-2669	235	2	3	3	NUM
dpc-2669	235	3	1	1	NUM
dpc-2669	235	4	.	.	PUNCT
dpc-2669	235	5	00	00	NUM
dpc-2669	235	6	0	0	NUM
dpc-2669	236	1	r	r	NOUN
dpc-2669	236	2	0	0	NUM
dpc-2669	236	3	.	.	NOUN
dpc-2669	236	4	25	25	NUM
dpc-2669	236	5	3	3	NUM
dpc-2669	236	6	0	0	NUM
dpc-2669	236	7	.	.	PUNCT
dpc-2669	236	8	17	17	NUM
dpc-2669	236	9	4	4	NUM
dpc-2669	236	10	0	0	NUM
dpc-2669	236	11	.	.	NOUN
dpc-2669	236	12	20	20	NUM
dpc-2669	236	13	8	8	NUM
dpc-2669	236	14	0	0	NUM
dpc-2669	236	15	.	.	NOUN
dpc-2669	236	16	15	15	NUM
dpc-2669	236	17	2	2	NUM
dpc-2669	236	18	0	0	NUM
dpc-2669	236	19	.	.	PUNCT
dpc-2669	236	20	14	14	NUM
dpc-2669	236	21	7	7	NUM
dpc-2669	236	22	-0	-0	PUNCT
dpc-2669	236	23	.2	.2	NUM
dpc-2669	236	24	02	02	NUM
dpc-2669	236	25	0	0	NUM
dpc-2669	236	26	.	.	NOUN
dpc-2669	236	27	13	13	NUM
dpc-2669	236	28	3	3	NUM
dpc-2669	236	29	-0	-0	SYM
dpc-2669	236	30	.0	.0	NUM
dpc-2669	236	31	08	08	NUM
dpc-2669	236	32	0	0	NUM
dpc-2669	236	33	.	.	PUNCT
dpc-2669	236	34	46	46	NUM
dpc-2669	236	35	1	1	NUM
dpc-2669	236	36	0	0	NUM
dpc-2669	236	37	.	.	PUNCT
dpc-2669	237	1	34	34	NUM
dpc-2669	237	2	3	3	NUM
dpc-2669	237	3	0	0	NUM
dpc-2669	237	4	.	.	PUNCT
dpc-2669	237	5	06	06	NUM
dpc-2669	237	6	1	1	NUM
dpc-2669	237	7	0	0	NUM
dpc-2669	237	8	.	.	PUNCT
dpc-2669	237	9	00	00	NUM
dpc-2669	237	10	0	0	PUNCT
dpc-2669	238	1	a	a	DET
dpc-2669	238	2	lt	lt	NOUN
dpc-2669	238	3	=	=	PUNCT
dpc-2669	238	4	a	a	X
dpc-2669	238	5	la	la	X
dpc-2669	238	6	ni	ni	PROPN
dpc-2669	238	7	ne	ne	PROPN
dpc-2669	238	8	a	a	PROPN
dpc-2669	238	9	m	m	NOUN
dpc-2669	238	10	in	in	ADP
dpc-2669	238	11	ot	ot	INTJ
dpc-2669	238	12	ra	ra	PROPN
dpc-2669	238	13	ns	ns	PROPN
dpc-2669	238	14	fe	fe	PROPN
dpc-2669	238	15	ra	ra	PROPN
dpc-2669	238	16	se	se	PROPN
dpc-2669	238	17	;	;	PUNCT
dpc-2669	238	18	a	a	DET
dpc-2669	238	19	st	st	PROPN
dpc-2669	238	20	=	=	PROPN
dpc-2669	238	21	a	a	PRON
dpc-2669	238	22	sp	sp	ADP
dpc-2669	238	23	ar	ar	NOUN
dpc-2669	238	24	ta	ta	PROPN
dpc-2669	238	25	te	te	PROPN
dpc-2669	238	26	a	a	DET
dpc-2669	238	27	m	m	NOUN
dpc-2669	238	28	in	in	ADP
dpc-2669	238	29	ot	ot	INTJ
dpc-2669	238	30	ra	ra	PROPN
dpc-2669	238	31	ns	ns	PROPN
dpc-2669	238	32	fe	fe	PROPN
dpc-2669	238	33	ra	ra	PROPN
dpc-2669	238	34	se	se	PROPN
dpc-2669	238	35	;	;	PUNCT
dpc-2669	238	36	b	b	X
dpc-2669	238	37	m	m	VERB
dpc-2669	238	38	i	i	NOUN
dpc-2669	238	39	=	=	PUNCT
dpc-2669	238	40	bo	bo	PROPN
dpc-2669	238	41	dy	dy	X
dpc-2669	238	42	m	m	NOUN
dpc-2669	238	43	as	as	ADP
dpc-2669	238	44	s	s	PRON
dpc-2669	238	45	in	in	ADP
dpc-2669	238	46	de	de	X
dpc-2669	238	47	x	x	X
dpc-2669	238	48	;	;	PUNCT
dpc-2669	238	49	c	c	PROPN
dpc-2669	239	1	i	i	PRON
dpc-2669	239	2	m	m	VERB
dpc-2669	239	3	t	t	NOUN
dpc-2669	239	4	=	=	SYM
dpc-2669	239	5	c	c	PROPN
dpc-2669	239	6	ar	ar	PROPN
dpc-2669	239	7	ot	ot	NOUN
dpc-2669	239	8	i	i	PROPN
dpc-2669	239	9	d	d	PROPN
dpc-2669	239	10	in	in	ADP
dpc-2669	239	11	ti	ti	PROPN
dpc-2669	239	12	m	m	VERB
dpc-2669	239	13	am	be	AUX
dpc-2669	239	14	ed	ed	PROPN
dpc-2669	239	15	ia	ia	PROPN
dpc-2669	239	16	t	t	PROPN
dpc-2669	239	17	hi	hi	INTJ
dpc-2669	239	18	ck	ck	PROPN
dpc-2669	239	19	ne	ne	PROPN
dpc-2669	239	20	ss	ss	PROPN
dpc-2669	239	21	;	;	PUNCT
dpc-2669	240	1	h	h	PROPN
dpc-2669	240	2	sc	sc	PROPN
dpc-2669	240	3	r	r	NOUN
dpc-2669	240	4	p	p	X
dpc-2669	240	5	=	=	X
dpc-2669	240	6	hi	hi	INTJ
dpc-2669	240	7	gh	gh	PROPN
dpc-2669	240	8	s	s	PROPN
dpc-2669	240	9	en	en	X
dpc-2669	240	10	si	si	X
dpc-2669	240	11	ti	ti	PROPN
dpc-2669	240	12	vi	vi	PROPN
dpc-2669	241	1	ty	ty	INTJ
dpc-2669	241	2	c	c	NOUN
dpc-2669	241	3	-r	-r	INTJ
dpc-2669	241	4	ea	ea	NOUN
dpc-2669	241	5	ct	ct	NUM
dpc-2669	241	6	iv	iv	NUM
dpc-2669	241	7	e	e	NOUN
dpc-2669	241	8	pr	pr	NOUN
dpc-2669	241	9	ot	ot	INTJ
dpc-2669	241	10	ei	ei	NOUN
dpc-2669	241	11	n	n	CCONJ
dpc-2669	241	12	;	;	PUNCT
dpc-2669	241	13	h	h	NOUN
dpc-2669	241	14	d	d	NOUN
dpc-2669	241	15	l	l	NOUN
dpc-2669	242	1	=	=	PUNCT
dpc-2669	242	2	h	h	NOUN
dpc-2669	243	1	ig	ig	PROPN
dpc-2669	243	2	h	h	NOUN
dpc-2669	243	3	de	de	PROPN
dpc-2669	243	4	ns	ns	INTJ
dpc-2669	243	5	it	it	PRON
dpc-2669	243	6	y	y	INTJ
dpc-2669	243	7	lip	lip	VERB
dpc-2669	243	8	op	op	NOUN
dpc-2669	243	9	ro	ro	X
dpc-2669	243	10	te	te	ADP
dpc-2669	243	11	in	in	ADV
dpc-2669	243	12	;	;	PUNCT
dpc-2669	244	1	l	l	PROPN
dpc-2669	244	2	d	d	X
dpc-2669	244	3	l	l	NOUN
dpc-2669	244	4	=	=	SYM
dpc-2669	244	5	lo	lo	PROPN
dpc-2669	244	6	w	w	NOUN
dpc-2669	244	7	d	d	PROPN
dpc-2669	244	8	en	en	ADP
dpc-2669	244	9	si	si	PROPN
dpc-2669	244	10	ty	ty	INTJ
dpc-2669	244	11	li	li	PROPN
dpc-2669	244	12	po	po	PROPN
dpc-2669	244	13	pr	pr	PROPN
dpc-2669	244	14	ot	ot	INTJ
dpc-2669	244	15	ei	ei	NOUN
dpc-2669	244	16	n	n	CCONJ
dpc-2669	244	17	;	;	PUNCT
dpc-2669	244	18	p	p	X
dpc-2669	244	19	a	a	DET
dpc-2669	244	20	si	si	X
dpc-2669	244	21	=	=	SYM
dpc-2669	244	22	p	p	NOUN
dpc-2669	244	23	so	so	ADV
dpc-2669	244	24	ri	ri	PROPN
dpc-2669	244	25	as	as	SCONJ
dpc-2669	244	26	is	be	AUX
dpc-2669	244	27	a	a	PRON
dpc-2669	244	28	re	re	NOUN
dpc-2669	244	29	a	a	DET
dpc-2669	244	30	an	an	PROPN
dpc-2669	244	31	d	d	X
dpc-2669	244	32	se	se	X
dpc-2669	244	33	ve	ve	VERB
dpc-2669	244	34	ri	ri	INTJ
dpc-2669	245	1	ty	ty	INTJ
dpc-2669	245	2	i	i	PRON
dpc-2669	245	3	nd	nd	ADV
dpc-2669	245	4	ex	ex	X
dpc-2669	245	5	;	;	PUNCT
dpc-2669	245	6	s	s	X
dpc-2669	245	7	d	d	NOUN
dpc-2669	245	8	=	=	SYM
dpc-2669	245	9	s	s	PROPN
dpc-2669	245	10	ta	ta	PROPN
dpc-2669	245	11	nd	nd	INTJ
dpc-2669	245	12	ar	ar	PROPN
dpc-2669	245	13	d	d	PROPN
dpc-2669	245	14	de	de	X
dpc-2669	245	15	vi	vi	PROPN
dpc-2669	245	16	at	at	ADP
dpc-2669	245	17	io	io	PROPN
dpc-2669	245	18	n	n	CCONJ
dpc-2669	245	19	;	;	PUNCT
dpc-2669	245	20	t	t	PROPN
dpc-2669	245	21	m	m	PROPN
dpc-2669	245	22	a	a	DET
dpc-2669	245	23	o	o	X
dpc-2669	245	24	=	=	SYM
dpc-2669	245	25	t	t	PROPN
dpc-2669	246	1	ri	ri	NOUN
dpc-2669	246	2	m	m	VERB
dpc-2669	246	3	et	et	NOUN
dpc-2669	246	4	hy	hy	NOUN
dpc-2669	246	5	la	la	PROPN
dpc-2669	246	6	m	m	VERB
dpc-2669	246	7	in	in	ADP
dpc-2669	246	8	e	e	NOUN
dpc-2669	246	9	  	  	SPACE
dpc-2669	246	10	nox	nox	NOUN
dpc-2669	246	11	i	i	PROPN
dpc-2669	246	12	d	d	PROPN
dpc-2669	246	13	e.	e.	PROPN
dpc-2669	246	14	8	8	NUM
dpc-2669	247	1	original	original	ADJ
dpc-2669	247	2	article	article	NOUN
dpc-2669	247	3	|	|	ADV
dpc-2669	247	4	dermatol	dermatol	ADJ
dpc-2669	247	5	pract	pract	NOUN
dpc-2669	247	6	concept	concept	NOUN
dpc-2669	247	7	.	.	PUNCT
dpc-2669	248	1	2023;13(2):e2023116	2023;13(2):e2023116	NUM
dpc-2669	248	2	table	table	NOUN
dpc-2669	248	3	5	5	NUM
dpc-2669	248	4	.	.	PUNCT
dpc-2669	248	5	multiple	multiple	ADJ
dpc-2669	248	6	linear	linear	PROPN
dpc-2669	248	7	regression	regression	NOUN
dpc-2669	248	8	model	model	NOUN
dpc-2669	248	9	adjusted	adjust	VERB
dpc-2669	248	10	for	for	ADP
dpc-2669	248	11	trimethylamine	trimethylamine	NOUN
dpc-2669	248	12	 	 	SPACE
dpc-2669	248	13	n	n	CCONJ
dpc-2669	248	14	-	-	PUNCT
dpc-2669	248	15	oxide	oxide	NOUN
dpc-2669	248	16	,	,	PUNCT
dpc-2669	248	17	psoriasis	psoriasis	NOUN
dpc-2669	248	18	area	area	NOUN
dpc-2669	248	19	and	and	CCONJ
dpc-2669	248	20	severity	severity	NOUN
dpc-2669	248	21	index	index	NOUN
dpc-2669	248	22	,	,	PUNCT
dpc-2669	248	23	disease	disease	NOUN
dpc-2669	248	24	duration	duration	NOUN
dpc-2669	248	25	,	,	PUNCT
dpc-2669	248	26	age	age	NOUN
dpc-2669	248	27	,	,	PUNCT
dpc-2669	248	28	oxlow	oxlow	ADJ
dpc-2669	248	29	density	density	NOUN
dpc-2669	248	30	lipoprotein	lipoprotein	ADJ
dpc-2669	248	31	,	,	PUNCT
dpc-2669	248	32	total	total	ADJ
dpc-2669	248	33	cholesterol	cholesterol	NOUN
dpc-2669	248	34	,	,	PUNCT
dpc-2669	248	35	triglyceride	triglyceride	ADJ
dpc-2669	248	36	,	,	PUNCT
dpc-2669	248	37	body	body	NOUN
dpc-2669	248	38	mass	mass	NOUN
dpc-2669	248	39	index	index	NOUN
dpc-2669	248	40	(	(	PUNCT
dpc-2669	248	41	dependent	dependent	ADJ
dpc-2669	248	42	variable	variable	NOUN
dpc-2669	248	43	:	:	PUNCT
dpc-2669	248	44	left	leave	VERB
dpc-2669	248	45	anterior	anterior	ADJ
dpc-2669	248	46	carotid	carotid	VERB
dpc-2669	248	47	intima	intima	ADJ
dpc-2669	248	48	-	-	PUNCT
dpc-2669	248	49	media	media	NOUN
dpc-2669	248	50	thickness	thickness	NOUN
dpc-2669	248	51	)	)	PUNCT
dpc-2669	248	52	.	.	PUNCT
dpc-2669	249	1	standardized	standardized	ADJ
dpc-2669	249	2	coefficients	coefficient	NOUN
dpc-2669	249	3	beta	beta	PROPN
dpc-2669	249	4	t	t	PROPN
dpc-2669	249	5	p	p	NOUN
dpc-2669	249	6	variance	variance	NOUN
dpc-2669	249	7	inflation	inflation	NOUN
dpc-2669	249	8	factor	factor	NOUN
dpc-2669	249	9	(	(	PUNCT
dpc-2669	249	10	vif	vif	PROPN
dpc-2669	249	11	)	)	PUNCT
dpc-2669	249	12	tmao	tmao	VERB
dpc-2669	249	13	0.371	0.371	NUM
dpc-2669	249	14	3,801	3,801	NUM
dpc-2669	249	15	<	<	NOUN
dpc-2669	249	16	0.001	0.001	NUM
dpc-2669	249	17	1.169	1.169	NUM
dpc-2669	249	18	age	age	NOUN
dpc-2669	249	19	0.618	0.618	NUM
dpc-2669	249	20	5.428	5.428	NUM
dpc-2669	249	21	<	<	NOUN
dpc-2669	249	22	0.001	0.001	NUM
dpc-2669	249	23	1.590	1.590	NUM
dpc-2669	249	24	oxidized	oxidize	VERB
dpc-2669	249	25	-	-	PUNCT
dpc-2669	249	26	ldl	ldl	NOUN
dpc-2669	249	27	0.047	0.047	NUM
dpc-2669	249	28	0.499	0.499	NUM
dpc-2669	249	29	0.620	0.620	NUM
dpc-2669	249	30	1.108	1.108	NUM
dpc-2669	249	31	hscrp	hscrp	X
dpc-2669	249	32	-0.040	-0.040	PUNCT
dpc-2669	249	33	-0.399	-0.399	NOUN
dpc-2669	249	34	0.691	0.691	NUM
dpc-2669	249	35	1.248	1.248	NUM
dpc-2669	249	36	triglyceride	triglyceride	ADP
dpc-2669	249	37	0.078	0.078	NUM
dpc-2669	249	38	0.705	0.705	NUM
dpc-2669	249	39	0.483	0.483	NUM
dpc-2669	249	40	1.503	1.503	NUM
dpc-2669	249	41	total	total	ADJ
dpc-2669	249	42	cholesterol	cholesterol	NOUN
dpc-2669	249	43	-0.023	-0.023	NUM
dpc-2669	249	44	-0.209	-0.209	NOUN
dpc-2669	249	45	0.835	0.835	NUM
dpc-2669	249	46	1.543	1.543	NUM
dpc-2669	249	47	pasi	pasi	NOUN
dpc-2669	249	48	-0.088	-0.088	NUM
dpc-2669	249	49	-0.943	-0.943	PUNCT
dpc-2669	249	50	0.350	0.350	NUM
dpc-2669	249	51	1.068	1.068	NUM
dpc-2669	249	52	disease	disease	NOUN
dpc-2669	249	53	duration	duration	NOUN
dpc-2669	249	54	-0.005	-0.005	PUNCT
dpc-2669	249	55	-0.047	-0.047	NOUN
dpc-2669	249	56	0.963	0.963	NUM
dpc-2669	249	57	1.420	1.420	NUM
dpc-2669	249	58	bmi	bmi	NOUN
dpc-2669	249	59	-0.079	-0.079	PUNCT
dpc-2669	249	60	-0.794	-0.794	NOUN
dpc-2669	249	61	0.430	0.430	NUM
dpc-2669	249	62	1.201	1.201	NUM
dpc-2669	249	63	bmi	bmi	NOUN
dpc-2669	249	64	=	=	PUNCT
dpc-2669	249	65	body	body	NOUN
dpc-2669	249	66	mass	mass	PROPN
dpc-2669	249	67	index	index	NOUN
dpc-2669	249	68	;	;	PUNCT
dpc-2669	249	69	hscrp	hscrp	NOUN
dpc-2669	249	70	=	=	PUNCT
dpc-2669	249	71	high	high	ADJ
dpc-2669	249	72	sensitivity	sensitivity	NOUN
dpc-2669	249	73	c	c	NOUN
dpc-2669	249	74	-	-	PUNCT
dpc-2669	249	75	reactive	reactive	ADJ
dpc-2669	249	76	protein	protein	NOUN
dpc-2669	249	77	;	;	PUNCT
dpc-2669	249	78	ldl	ldl	NOUN
dpc-2669	249	79	=	=	NOUN
dpc-2669	249	80	low	low	ADJ
dpc-2669	249	81	density	density	NOUN
dpc-2669	249	82	lipoprotein	lipoprotein	ADJ
dpc-2669	249	83	;	;	PUNCT
dpc-2669	249	84	pasi	pasi	NOUN
dpc-2669	249	85	=	=	SYM
dpc-2669	249	86	psoriasis	psoriasis	NOUN
dpc-2669	249	87	area	area	NOUN
dpc-2669	249	88	and	and	CCONJ
dpc-2669	249	89	severity	severity	NOUN
dpc-2669	249	90	index	index	NOUN
dpc-2669	249	91	table	table	NOUN
dpc-2669	249	92	3	3	NUM
dpc-2669	249	93	.	.	PUNCT
dpc-2669	250	1	correlations	correlation	NOUN
dpc-2669	250	2	between	between	ADP
dpc-2669	250	3	trimethylamine	trimethylamine	NOUN
dpc-2669	250	4	 	 	SPACE
dpc-2669	250	5	n	n	CCONJ
dpc-2669	250	6	-	-	PUNCT
dpc-2669	250	7	oxide	oxide	NOUN
dpc-2669	250	8	and	and	CCONJ
dpc-2669	250	9	carotid	carotid	NOUN
dpc-2669	250	10	intima	intima	ADJ
dpc-2669	250	11	-	-	PUNCT
dpc-2669	250	12	media	medium	NOUN
dpc-2669	250	13	thickness	thickness	NOUN
dpc-2669	250	14	levels	level	NOUN
dpc-2669	250	15	when	when	SCONJ
dpc-2669	250	16	age	age	NOUN
dpc-2669	250	17	,	,	PUNCT
dpc-2669	250	18	body	body	NOUN
dpc-2669	250	19	mass	mass	PROPN
dpc-2669	250	20	index	index	NOUN
dpc-2669	250	21	,	,	PUNCT
dpc-2669	250	22	disease	disease	NOUN
dpc-2669	250	23	duration	duration	NOUN
dpc-2669	250	24	,	,	PUNCT
dpc-2669	250	25	psoriasis	psoriasis	NOUN
dpc-2669	250	26	area	area	NOUN
dpc-2669	250	27	and	and	CCONJ
dpc-2669	250	28	severity	severity	NOUN
dpc-2669	250	29	index	index	NOUN
dpc-2669	250	30	score	score	NOUN
dpc-2669	250	31	,	,	PUNCT
dpc-2669	250	32	blood	blood	NOUN
dpc-2669	250	33	cholesterol	cholesterol	NOUN
dpc-2669	250	34	,	,	PUNCT
dpc-2669	250	35	high	high	ADJ
dpc-2669	250	36	sensitivity	sensitivity	NOUN
dpc-2669	250	37	c	c	NOUN
dpc-2669	250	38	-	-	PUNCT
dpc-2669	250	39	reactive	reactive	ADJ
dpc-2669	250	40	protein	protein	NOUN
dpc-2669	250	41	and	and	CCONJ
dpc-2669	250	42	oxidizedlow	oxidizedlow	NOUN
dpc-2669	250	43	density	density	NOUN
dpc-2669	250	44	lipoprotein	lipoprotein	NOUN
dpc-2669	250	45	were	be	AUX
dpc-2669	250	46	controlled	control	VERB
dpc-2669	250	47	.	.	PUNCT
dpc-2669	251	1	tmao	tmao	PROPN
dpc-2669	251	2	left	leave	VERB
dpc-2669	251	3	ant	ant	ADJ
dpc-2669	251	4	cimt	cimt	NOUN
dpc-2669	251	5	left	leave	VERB
dpc-2669	251	6	post	post	NOUN
dpc-2669	251	7	cimt	cimt	NOUN
dpc-2669	251	8	right	right	ADJ
dpc-2669	251	9	ant	ant	ADJ
dpc-2669	251	10	cimt	cimt	PROPN
dpc-2669	251	11	right	right	ADJ
dpc-2669	251	12	post	post	NOUN
dpc-2669	251	13	cimt	cimt	NOUN
dpc-2669	251	14	tmao	tmao	VERB
dpc-2669	252	1	p	p	NOUN
dpc-2669	252	2	1.000	1.000	NUM
dpc-2669	252	3	r	r	NOUN
dpc-2669	252	4	0.000	0.000	NUM
dpc-2669	252	5	left	leave	VERB
dpc-2669	252	6	ant	ant	ADJ
dpc-2669	252	7	cimt	cimt	NOUN
dpc-2669	252	8	p	p	NOUN
dpc-2669	252	9	<	<	X
dpc-2669	252	10	0.001	0.001	NUM
dpc-2669	252	11	1.000	1.000	NUM
dpc-2669	252	12	r	r	NOUN
dpc-2669	252	13	0.447	0.447	NUM
dpc-2669	252	14	0.000	0.000	NUM
dpc-2669	252	15	left	leave	VERB
dpc-2669	252	16	post	post	NOUN
dpc-2669	252	17	cimt	cimt	NOUN
dpc-2669	252	18	p	p	NOUN
dpc-2669	252	19	0.711	0.711	NUM
dpc-2669	252	20	0.028	0.028	NUM
dpc-2669	252	21	1.000	1.000	NUM
dpc-2669	252	22	r	r	NOUN
dpc-2669	252	23	0.048	0.048	NUM
dpc-2669	252	24	0.277	0.277	NUM
dpc-2669	252	25	0.000	0.000	NUM
dpc-2669	252	26	right	right	ADJ
dpc-2669	252	27	ant	ant	ADJ
dpc-2669	252	28	cimt	cimt	NOUN
dpc-2669	252	29	p	p	NOUN
dpc-2669	252	30	0.905	0.905	NUM
dpc-2669	252	31	0.004	0.004	NUM
dpc-2669	252	32	0.077	0.077	NUM
dpc-2669	252	33	1.000	1.000	NUM
dpc-2669	252	34	r	r	NOUN
dpc-2669	252	35	-0.015	-0.015	NUM
dpc-2669	252	36	0.358	0.358	NUM
dpc-2669	252	37	0.225	0.225	NUM
dpc-2669	252	38	0.000	0.000	NUM
dpc-2669	252	39	right	right	ADJ
dpc-2669	252	40	post	post	NOUN
dpc-2669	252	41	cimt	cimt	NOUN
dpc-2669	252	42	p	p	NOUN
dpc-2669	252	43	0.047	0.047	NUM
dpc-2669	252	44	<	<	X
dpc-2669	252	45	0.001	0.001	NUM
dpc-2669	252	46	0.025	0.025	NUM
dpc-2669	252	47	0.870	0.870	NUM
dpc-2669	252	48	1.000	1.000	NUM
dpc-2669	252	49	r	r	NOUN
dpc-2669	252	50	0.251	0.251	NUM
dpc-2669	252	51	0.439	0.439	NUM
dpc-2669	252	52	0.282	0.282	NUM
dpc-2669	252	53	0.021	0.021	NUM
dpc-2669	252	54	0.000	0.000	NUM
dpc-2669	252	55	cimt	cimt	NOUN
dpc-2669	252	56	=	=	SYM
dpc-2669	252	57	carotid	carotid	NOUN
dpc-2669	252	58	intima	intima	ADJ
dpc-2669	252	59	-	-	PUNCT
dpc-2669	252	60	media	medium	NOUN
dpc-2669	252	61	thickness	thickness	NOUN
dpc-2669	252	62	;	;	PUNCT
dpc-2669	252	63	tmao	tmao	PROPN
dpc-2669	252	64	=	=	PUNCT
dpc-2669	252	65	trimethylamine	trimethylamine	NOUN
dpc-2669	252	66	 	 	SPACE
dpc-2669	252	67	n	n	CCONJ
dpc-2669	252	68	-	-	PUNCT
dpc-2669	252	69	oxide	oxide	NOUN
dpc-2669	252	70	.	.	PUNCT
dpc-2669	252	71	table	table	NOUN
dpc-2669	252	72	4	4	NUM
dpc-2669	252	73	.	.	PUNCT
dpc-2669	252	74	simple	simple	ADJ
dpc-2669	252	75	linear	linear	PROPN
dpc-2669	252	76	regression	regression	NOUN
dpc-2669	252	77	model	model	NOUN
dpc-2669	252	78	,	,	PUNCT
dpc-2669	252	79	predictor	predictor	NOUN
dpc-2669	252	80	:	:	PUNCT
dpc-2669	252	81	trimethylamine	trimethylamine	NOUN
dpc-2669	252	82	 	 	SPACE
dpc-2669	252	83	n	n	CCONJ
dpc-2669	252	84	-	-	PUNCT
dpc-2669	252	85	oxide	oxide	NOUN
dpc-2669	252	86	,	,	PUNCT
dpc-2669	252	87	dependent	dependent	ADJ
dpc-2669	252	88	:	:	PUNCT
dpc-2669	252	89	left	leave	VERB
dpc-2669	252	90	anterior	anterior	ADJ
dpc-2669	252	91	and	and	CCONJ
dpc-2669	252	92	right	right	ADJ
dpc-2669	252	93	posterior	posterior	ADJ
dpc-2669	252	94	carotid	carotid	NOUN
dpc-2669	252	95	intima	intima	ADJ
dpc-2669	252	96	-	-	PUNCT
dpc-2669	252	97	media	medium	NOUN
dpc-2669	252	98	thickness	thickness	NOUN
dpc-2669	252	99	.	.	PUNCT
dpc-2669	253	1	r2	r2	PROPN
dpc-2669	253	2	standardized	standardize	VERB
dpc-2669	253	3	coefficients	coefficient	NOUN
dpc-2669	253	4	beta	beta	PROPN
dpc-2669	253	5	t	t	PROPN
dpc-2669	253	6	p	p	X
dpc-2669	253	7	f	f	PROPN
dpc-2669	253	8	predictor	predictor	NOUN
dpc-2669	253	9	:	:	PUNCT
dpc-2669	253	10	tmao	tmao	PROPN
dpc-2669	253	11	dependent	dependent	ADJ
dpc-2669	253	12	:	:	PUNCT
dpc-2669	253	13	left	leave	VERB
dpc-2669	253	14	ant	ant	ADJ
dpc-2669	253	15	cimt	cimt	VERB
dpc-2669	253	16	0.102	0.102	NUM
dpc-2669	253	17	0.320	0.320	NUM
dpc-2669	253	18	2.843	2.843	NUM
dpc-2669	253	19	0.006	0.006	NUM
dpc-2669	253	20	8.084	8.084	NUM
dpc-2669	253	21	predictor	predictor	NOUN
dpc-2669	253	22	:	:	PUNCT
dpc-2669	253	23	tmao	tmao	PROPN
dpc-2669	253	24	dependent	dependent	ADJ
dpc-2669	253	25	:	:	PUNCT
dpc-2669	253	26	right	right	ADJ
dpc-2669	253	27	post	post	NOUN
dpc-2669	253	28	cimt	cimt	NOUN
dpc-2669	253	29	0.020	0.020	NUM
dpc-2669	253	30	0.141	0.141	NUM
dpc-2669	253	31	1.199	1.199	NUM
dpc-2669	253	32	0.235	0.235	NUM
dpc-2669	253	33	1.199	1.199	NUM
dpc-2669	253	34	cimt	cimt	NOUN
dpc-2669	253	35	=	=	SYM
dpc-2669	253	36	carotid	carotid	NOUN
dpc-2669	253	37	intima	intima	ADJ
dpc-2669	253	38	-	-	PUNCT
dpc-2669	253	39	media	medium	NOUN
dpc-2669	253	40	thickness	thickness	NOUN
dpc-2669	253	41	;	;	PUNCT
dpc-2669	253	42	tmao	tmao	PROPN
dpc-2669	253	43	=	=	PUNCT
dpc-2669	253	44	trimethylamine	trimethylamine	NOUN
dpc-2669	253	45	 	 	SPACE
dpc-2669	253	46	n	n	CCONJ
dpc-2669	253	47	-	-	PUNCT
dpc-2669	253	48	oxide	oxide	NOUN
dpc-2669	253	49	.	.	PUNCT
dpc-2669	254	1	tmao	tmao	PROPN
dpc-2669	254	2	is	be	AUX
dpc-2669	254	3	a	a	DET
dpc-2669	254	4	metabolite	metabolite	NOUN
dpc-2669	254	5	originating	originate	VERB
dpc-2669	254	6	from	from	ADP
dpc-2669	254	7	the	the	DET
dpc-2669	254	8	gut	gut	NOUN
dpc-2669	254	9	microbiota	microbiota	NOUN
dpc-2669	254	10	that	that	PRON
dpc-2669	254	11	increases	increase	VERB
dpc-2669	254	12	the	the	DET
dpc-2669	254	13	risk	risk	NOUN
dpc-2669	254	14	of	of	ADP
dpc-2669	254	15	cardiometabolic	cardiometabolic	NOUN
dpc-2669	254	16	disease	disease	NOUN
dpc-2669	254	17	.	.	PUNCT
dpc-2669	255	1	in	in	ADP
dpc-2669	255	2	regression	regression	NOUN
dpc-2669	255	3	models	model	NOUN
dpc-2669	255	4	,	,	PUNCT
dpc-2669	255	5	tmao	tmao	PROPN
dpc-2669	255	6	levels	level	NOUN
dpc-2669	255	7	were	be	AUX
dpc-2669	255	8	found	find	VERB
dpc-2669	255	9	to	to	PART
dpc-2669	255	10	be	be	AUX
dpc-2669	255	11	a	a	DET
dpc-2669	255	12	positive	positive	ADJ
dpc-2669	255	13	predictor	predictor	NOUN
dpc-2669	255	14	of	of	ADP
dpc-2669	255	15	cardiovascular	cardiovascular	ADJ
dpc-2669	255	16	disease	disease	NOUN
dpc-2669	255	17	risk	risk	NOUN
dpc-2669	255	18	(	(	PUNCT
dpc-2669	255	19	figure	figure	NOUN
dpc-2669	255	20	4	4	NUM
dpc-2669	255	21	)	)	PUNCT
dpc-2669	255	22	.	.	PUNCT
dpc-2669	256	1	crp	crp	PROPN
dpc-2669	256	2	is	be	AUX
dpc-2669	256	3	a	a	DET
dpc-2669	256	4	circulating	circulate	VERB
dpc-2669	256	5	acute	acute	NOUN
dpc-2669	256	6	phase	phase	NOUN
dpc-2669	256	7	reactant	reactant	NOUN
dpc-2669	256	8	that	that	PRON
dpc-2669	256	9	reflects	reflect	VERB
dpc-2669	256	10	active	active	ADJ
dpc-2669	256	11	systemic	systemic	ADJ
dpc-2669	256	12	inflammation	inflammation	NOUN
dpc-2669	256	13	.	.	PUNCT
dpc-2669	257	1	increased	increase	VERB
dpc-2669	257	2	hs	hs	PROPN
dpc-2669	257	3	-	-	PROPN
dpc-2669	257	4	crp	crp	PROPN
dpc-2669	257	5	levels	level	NOUN
dpc-2669	257	6	are	be	AUX
dpc-2669	257	7	associated	associate	VERB
dpc-2669	257	8	with	with	ADP
dpc-2669	257	9	a	a	DET
dpc-2669	257	10	higher	high	ADJ
dpc-2669	257	11	risk	risk	NOUN
dpc-2669	257	12	of	of	ADP
dpc-2669	257	13	cardiovascular	cardiovascular	ADJ
dpc-2669	257	14	disease	disease	NOUN
dpc-2669	257	15	,	,	PUNCT
dpc-2669	257	16	even	even	ADV
dpc-2669	257	17	in	in	ADP
dpc-2669	257	18	individuals	individual	NOUN
dpc-2669	257	19	without	without	ADP
dpc-2669	257	20	clinical	clinical	ADJ
dpc-2669	257	21	manifestations	manifestation	NOUN
dpc-2669	257	22	of	of	ADP
dpc-2669	257	23	atherosclerotic	atherosclerotic	ADJ
dpc-2669	257	24	disease	disease	NOUN
dpc-2669	257	25	[	[	X
dpc-2669	257	26	25	25	NUM
dpc-2669	257	27	]	]	PUNCT
dpc-2669	257	28	.	.	PUNCT
dpc-2669	258	1	in	in	ADP
dpc-2669	258	2	psoriasis	psoriasis	NOUN
dpc-2669	258	3	patients	patient	NOUN
dpc-2669	258	4	,	,	PUNCT
dpc-2669	258	5	hs	hs	PROPN
dpc-2669	258	6	-	-	PUNCT
dpc-2669	258	7	crp	crp	PROPN
dpc-2669	258	8	levels	level	NOUN
dpc-2669	258	9	are	be	AUX
dpc-2669	258	10	higher	high	ADJ
dpc-2669	258	11	than	than	ADP
dpc-2669	258	12	in	in	ADP
dpc-2669	258	13	the	the	DET
dpc-2669	258	14	healthy	healthy	ADJ
dpc-2669	258	15	population	population	NOUN
dpc-2669	258	16	and	and	CCONJ
dpc-2669	258	17	correlated	correlate	VERB
dpc-2669	258	18	with	with	ADP
dpc-2669	258	19	the	the	DET
dpc-2669	258	20	risk	risk	NOUN
dpc-2669	258	21	of	of	ADP
dpc-2669	258	22	atherosclerotic	atherosclerotic	ADJ
dpc-2669	258	23	disease	disease	NOUN
dpc-2669	258	24	[	[	X
dpc-2669	258	25	26,27	26,27	NUM
dpc-2669	258	26	]	]	PUNCT
dpc-2669	258	27	.	.	PUNCT
dpc-2669	259	1	in	in	ADP
dpc-2669	259	2	this	this	DET
dpc-2669	259	3	study	study	NOUN
dpc-2669	259	4	,	,	PUNCT
dpc-2669	259	5	hs	hs	PROPN
dpc-2669	259	6	-	-	PUNCT
dpc-2669	259	7	crp	crp	PROPN
dpc-2669	259	8	levels	level	NOUN
dpc-2669	259	9	were	be	AUX
dpc-2669	259	10	found	find	VERB
dpc-2669	259	11	to	to	PART
dpc-2669	259	12	be	be	AUX
dpc-2669	259	13	higher	high	ADJ
dpc-2669	259	14	in	in	ADP
dpc-2669	259	15	the	the	DET
dpc-2669	259	16	patient	patient	NOUN
dpc-2669	259	17	group	group	NOUN
dpc-2669	259	18	compared	compare	VERB
dpc-2669	259	19	to	to	ADP
dpc-2669	259	20	healthy	healthy	ADJ
dpc-2669	259	21	controls	control	NOUN
dpc-2669	259	22	.	.	PUNCT
dpc-2669	260	1	in	in	ADP
dpc-2669	260	2	addition	addition	NOUN
dpc-2669	260	3	,	,	PUNCT
dpc-2669	260	4	positive	positive	ADJ
dpc-2669	260	5	correlation	correlation	NOUN
dpc-2669	260	6	between	between	ADP
dpc-2669	260	7	hs	hs	PROPN
dpc-2669	260	8	-	-	PROPN
dpc-2669	260	9	crp	crp	PROPN
dpc-2669	260	10	and	and	CCONJ
dpc-2669	260	11	triglyceride	triglyceride	ADJ
dpc-2669	260	12	levels	level	NOUN
dpc-2669	260	13	original	original	ADJ
dpc-2669	260	14	article	article	NOUN
dpc-2669	260	15	|	|	ADV
dpc-2669	260	16	dermatol	dermatol	ADJ
dpc-2669	260	17	pract	pract	NOUN
dpc-2669	260	18	concept	concept	NOUN
dpc-2669	260	19	.	.	PUNCT
dpc-2669	261	1	2023;13(2):e2023116	2023;13(2):e2023116	NUM
dpc-2669	261	2	9	9	NUM
dpc-2669	261	3	references	reference	NOUN
dpc-2669	261	4	1	1	NUM
dpc-2669	261	5	.	.	PUNCT
dpc-2669	261	6	hu	hu	PROPN
dpc-2669	261	7	sc	sc	PROPN
dpc-2669	261	8	-	-	PUNCT
dpc-2669	261	9	s	s	PROPN
dpc-2669	261	10	,	,	PUNCT
dpc-2669	261	11	lan	lan	PROPN
dpc-2669	261	12	c	c	PROPN
dpc-2669	261	13	-	-	PUNCT
dpc-2669	261	14	ce	ce	PROPN
dpc-2669	261	15	.	.	PUNCT
dpc-2669	262	1	psoriasis	psoriasis	NOUN
dpc-2669	262	2	and	and	CCONJ
dpc-2669	262	3	cardiovascular	cardiovascular	ADJ
dpc-2669	262	4	comorbidities	comorbiditie	NOUN
dpc-2669	262	5	:	:	PUNCT
dpc-2669	262	6	focusing	focus	VERB
dpc-2669	262	7	on	on	ADP
dpc-2669	262	8	severe	severe	ADJ
dpc-2669	262	9	vascular	vascular	ADJ
dpc-2669	262	10	events	event	NOUN
dpc-2669	262	11	,	,	PUNCT
dpc-2669	262	12	cardiovascular	cardiovascular	ADJ
dpc-2669	262	13	risk	risk	NOUN
dpc-2669	262	14	factors	factor	NOUN
dpc-2669	262	15	and	and	CCONJ
dpc-2669	262	16	implications	implication	NOUN
dpc-2669	262	17	for	for	ADP
dpc-2669	262	18	treatment	treatment	NOUN
dpc-2669	262	19	.	.	PUNCT
dpc-2669	263	1	int	int	PROPN
dpc-2669	263	2	j	j	PROPN
dpc-2669	263	3	mol	mol	ADP
dpc-2669	263	4	sci	sci	PROPN
dpc-2669	263	5	.	.	PUNCT
dpc-2669	264	1	2017;18(10):2211	2017;18(10):2211	X
dpc-2669	264	2	.	.	PUNCT
dpc-2669	265	1	doi	doi	NOUN
dpc-2669	265	2	:	:	PUNCT
dpc-2669	265	3	10.3390	10.3390	NUM
dpc-2669	265	4	/	/	SYM
dpc-2669	265	5	ijms18102211	ijms18102211	PROPN
dpc-2669	265	6	.	.	PUNCT
dpc-2669	266	1	pmid	pmid	NOUN
dpc-2669	266	2	:	:	PUNCT
dpc-2669	266	3	29065479	29065479	NUM
dpc-2669	266	4	.	.	PUNCT
dpc-2669	267	1	pmcid	pmcid	NOUN
dpc-2669	267	2	:	:	PUNCT
dpc-2669	267	3	pmc5666891	pmc5666891	ADJ
dpc-2669	267	4	.	.	PUNCT
dpc-2669	268	1	2	2	X
dpc-2669	268	2	.	.	X
dpc-2669	268	3	ghazizadeh	ghazizadeh	ADJ
dpc-2669	268	4	r	r	PROPN
dpc-2669	268	5	,	,	PUNCT
dpc-2669	268	6	shimizu	shimizu	PROPN
dpc-2669	268	7	h	h	PROPN
dpc-2669	268	8	,	,	PUNCT
dpc-2669	268	9	tosa	tosa	PROPN
dpc-2669	268	10	m	m	PROPN
dpc-2669	268	11	,	,	PUNCT
dpc-2669	268	12	ghazizadeh	ghazizadeh	ADJ
dpc-2669	268	13	m.	m.	NOUN
dpc-2669	268	14	pathogenic	pathogenic	ADJ
dpc-2669	268	15	mechanisms	mechanism	NOUN
dpc-2669	268	16	shared	share	VERB
dpc-2669	268	17	between	between	ADP
dpc-2669	268	18	psoriasis	psoriasis	NOUN
dpc-2669	268	19	and	and	CCONJ
dpc-2669	268	20	cardiovascular	cardiovascular	ADJ
dpc-2669	268	21	disease	disease	NOUN
dpc-2669	268	22	.	.	PUNCT
dpc-2669	269	1	int	int	PROPN
dpc-2669	269	2	j	j	PROPN
dpc-2669	269	3	med	med	PROPN
dpc-2669	269	4	sci	sci	PROPN
dpc-2669	269	5	.	.	PUNCT
dpc-2669	270	1	2010;7(5):284	2010;7(5):284	NUM
dpc-2669	270	2	-	-	SYM
dpc-2669	270	3	289	289	NUM
dpc-2669	270	4	.	.	PUNCT
dpc-2669	270	5	doi	doi	NOUN
dpc-2669	270	6	:	:	PUNCT
dpc-2669	270	7	10.7150	10.7150	NUM
dpc-2669	270	8	/	/	SYM
dpc-2669	270	9	ijms.7.284	ijms.7.284	NOUN
dpc-2669	270	10	.	.	PUNCT
dpc-2669	271	1	pmid	pmid	NOUN
dpc-2669	271	2	:	:	PUNCT
dpc-2669	271	3	20827428	20827428	NUM
dpc-2669	271	4	.	.	PUNCT
dpc-2669	272	1	pmcid	pmcid	NOUN
dpc-2669	272	2	:	:	PUNCT
dpc-2669	272	3	pmc2934727	pmc2934727	NOUN
dpc-2669	272	4	.	.	PUNCT
dpc-2669	273	1	3	3	X
dpc-2669	273	2	.	.	X
dpc-2669	273	3	subramaniam	subramaniam	PROPN
dpc-2669	273	4	s	s	PROPN
dpc-2669	273	5	,	,	PUNCT
dpc-2669	273	6	fletcher	fletcher	PROPN
dpc-2669	273	7	c.	c.	PROPN
dpc-2669	273	8	trimethylamine	trimethylamine	PROPN
dpc-2669	273	9	n	n	CCONJ
dpc-2669	273	10	-	-	PUNCT
dpc-2669	273	11	oxide	oxide	NOUN
dpc-2669	273	12	:	:	PUNCT
dpc-2669	273	13	breathe	breathe	VERB
dpc-2669	273	14	new	new	ADJ
dpc-2669	273	15	life	life	NOUN
dpc-2669	273	16	.	.	PUNCT
dpc-2669	274	1	br	br	PROPN
dpc-2669	275	1	j	j	PROPN
dpc-2669	275	2	pharmacol	pharmacol	PROPN
dpc-2669	275	3	.	.	PUNCT
dpc-2669	276	1	2018;175(8):1344	2018;175(8):1344	NUM
dpc-2669	276	2	-	-	SYM
dpc-2669	276	3	1353	1353	NUM
dpc-2669	276	4	.	.	PUNCT
dpc-2669	277	1	doi	doi	NOUN
dpc-2669	277	2	:	:	PUNCT
dpc-2669	277	3	10.1111	10.1111	NUM
dpc-2669	277	4	/	/	SYM
dpc-2669	277	5	bph.13959	bph.13959	PROPN
dpc-2669	277	6	.	.	PUNCT
dpc-2669	278	1	pmid	pmid	NOUN
dpc-2669	278	2	:	:	PUNCT
dpc-2669	278	3	28745401	28745401	NUM
dpc-2669	278	4	.	.	PUNCT
dpc-2669	279	1	pmcid	pmcid	NOUN
dpc-2669	279	2	:	:	PUNCT
dpc-2669	279	3	pmc5866995	pmc5866995	ADJ
dpc-2669	279	4	.	.	PUNCT
dpc-2669	280	1	4	4	X
dpc-2669	280	2	.	.	X
dpc-2669	280	3	cho	cho	PROPN
dpc-2669	280	4	ce	ce	PROPN
dpc-2669	280	5	,	,	PUNCT
dpc-2669	280	6	taesuwan	taesuwan	PROPN
dpc-2669	280	7	s	s	PROPN
dpc-2669	280	8	,	,	PUNCT
dpc-2669	280	9	malysheva	malysheva	NOUN
dpc-2669	280	10	ov	ov	PROPN
dpc-2669	280	11	,	,	PUNCT
dpc-2669	280	12	et	et	PROPN
dpc-2669	280	13	al	al	PROPN
dpc-2669	280	14	.	.	PROPN
dpc-2669	280	15	trimethylamine	trimethylamine	PROPN
dpc-2669	280	16	-	-	PUNCT
dpc-2669	280	17	n	n	NOUN
dpc-2669	280	18	oxide(tmao	oxide(tmao	ADJ
dpc-2669	280	19	)	)	PUNCT
dpc-2669	281	1	response	response	NOUN
dpc-2669	281	2	to	to	ADP
dpc-2669	281	3	animal	animal	NOUN
dpc-2669	281	4	source	source	NOUN
dpc-2669	281	5	foods	food	NOUN
dpc-2669	281	6	varies	vary	VERB
dpc-2669	281	7	among	among	ADP
dpc-2669	281	8	healthy	healthy	ADJ
dpc-2669	281	9	young	young	ADJ
dpc-2669	281	10	men	man	NOUN
dpc-2669	281	11	and	and	CCONJ
dpc-2669	281	12	is	be	AUX
dpc-2669	281	13	influenced	influence	VERB
dpc-2669	281	14	by	by	ADP
dpc-2669	281	15	their	their	PRON
dpc-2669	281	16	gut	gut	NOUN
dpc-2669	281	17	microbiota	microbiota	NOUN
dpc-2669	281	18	composition	composition	NOUN
dpc-2669	281	19	:	:	PUNCT
dpc-2669	281	20	a	a	DET
dpc-2669	281	21	randomized	randomized	ADJ
dpc-2669	281	22	controlled	control	VERB
dpc-2669	281	23	trial	trial	NOUN
dpc-2669	281	24	.	.	PUNCT
dpc-2669	282	1	mol	mol	ADP
dpc-2669	282	2	nutr	nutr	NOUN
dpc-2669	282	3	food	food	NOUN
dpc-2669	282	4	res	re	NOUN
dpc-2669	282	5	.	.	PUNCT
dpc-2669	283	1	2017;61(1	2017;61(1	NUM
dpc-2669	283	2	)	)	PUNCT
dpc-2669	283	3	.	.	PUNCT
dpc-2669	284	1	doi	doi	NOUN
dpc-2669	284	2	:	:	PUNCT
dpc-2669	284	3	10.1002	10.1002	NUM
dpc-2669	284	4	/	/	SYM
dpc-2669	284	5	mnfr.201600324	mnfr.201600324	PROPN
dpc-2669	284	6	.	.	PUNCT
dpc-2669	285	1	pmid	pmid	NOUN
dpc-2669	285	2	:	:	PUNCT
dpc-2669	285	3	27377678	27377678	NUM
dpc-2669	285	4	.	.	PUNCT
dpc-2669	286	1	5	5	X
dpc-2669	286	2	.	.	X
dpc-2669	286	3	scher	scher	PROPN
dpc-2669	286	4	ju	ju	PROPN
dpc-2669	286	5	,	,	PUNCT
dpc-2669	286	6	littman	littman	PROPN
dpc-2669	286	7	dr	dr	PROPN
dpc-2669	286	8	,	,	PUNCT
dpc-2669	286	9	abramson	abramson	PROPN
dpc-2669	286	10	sb	sb	PROPN
dpc-2669	286	11	.	.	PROPN
dpc-2669	286	12	microbiome	microbiome	PROPN
dpc-2669	286	13	in	in	ADP
dpc-2669	286	14	inflammatory	inflammatory	ADJ
dpc-2669	286	15	arthritis	arthritis	NOUN
dpc-2669	286	16	and	and	CCONJ
dpc-2669	286	17	human	human	ADJ
dpc-2669	286	18	rheumatic	rheumatic	ADJ
dpc-2669	286	19	diseases	disease	NOUN
dpc-2669	286	20	.	.	PUNCT
dpc-2669	287	1	arthritis	arthritis	NOUN
dpc-2669	287	2	rheumatol	rheumatol	NOUN
dpc-2669	287	3	.	.	PUNCT
dpc-2669	288	1	2016;68(1):35	2016;68(1):35	NUM
dpc-2669	288	2	-	-	SYM
dpc-2669	288	3	45	45	NUM
dpc-2669	288	4	.	.	PUNCT
dpc-2669	288	5	doi	doi	NOUN
dpc-2669	288	6	:	:	PUNCT
dpc-2669	288	7	10.1002	10.1002	NUM
dpc-2669	288	8	/	/	SYM
dpc-2669	288	9	art.39259	art.39259	NUM
dpc-2669	288	10	.	.	PUNCT
dpc-2669	289	1	pmid	pmid	NOUN
dpc-2669	289	2	:	:	PUNCT
dpc-2669	289	3	26331579	26331579	NUM
dpc-2669	289	4	.	.	PUNCT
dpc-2669	290	1	pmcid	pmcid	ADJ
dpc-2669	290	2	:	:	PUNCT
dpc-2669	290	3	pmc4789258	pmc4789258	NOUN
dpc-2669	290	4	.	.	PUNCT
dpc-2669	291	1	6	6	X
dpc-2669	291	2	.	.	X
dpc-2669	291	3	benhadou	benhadou	NOUN
dpc-2669	291	4	f	f	NOUN
dpc-2669	291	5	,	,	PUNCT
dpc-2669	291	6	mintoff	mintoff	PROPN
dpc-2669	291	7	d	d	PROPN
dpc-2669	291	8	,	,	PUNCT
dpc-2669	291	9	schnebert	schnebert	NOUN
dpc-2669	291	10	b	b	NOUN
dpc-2669	291	11	,	,	PUNCT
dpc-2669	291	12	thio	thio	ADJ
dpc-2669	291	13	hb	hb	X
dpc-2669	291	14	.	.	PUNCT
dpc-2669	292	1	psoriasis	psoriasis	NOUN
dpc-2669	292	2	and	and	CCONJ
dpc-2669	292	3	microbiota	microbiota	NOUN
dpc-2669	292	4	:	:	PUNCT
dpc-2669	292	5	a	a	DET
dpc-2669	292	6	systematic	systematic	ADJ
dpc-2669	292	7	review	review	NOUN
dpc-2669	292	8	.	.	PUNCT
dpc-2669	293	1	diseases	disease	NOUN
dpc-2669	293	2	.	.	PUNCT
dpc-2669	294	1	2018;6(2):47	2018;6(2):47	X
dpc-2669	294	2	.	.	PUNCT
dpc-2669	294	3	doi	doi	NOUN
dpc-2669	294	4	:	:	PUNCT
dpc-2669	294	5	10.3390	10.3390	NUM
dpc-2669	294	6	/	/	SYM
dpc-2669	294	7	diseases6020047	diseases6020047	PROPN
dpc-2669	294	8	.	.	PUNCT
dpc-2669	295	1	pmid	pmid	NOUN
dpc-2669	295	2	:	:	PUNCT
dpc-2669	295	3	29865237	29865237	NUM
dpc-2669	295	4	.	.	PUNCT
dpc-2669	296	1	pmcid	pmcid	NOUN
dpc-2669	296	2	:	:	PUNCT
dpc-2669	296	3	pmc6023392	pmc6023392	NOUN
dpc-2669	296	4	.	.	PUNCT
dpc-2669	297	1	7	7	X
dpc-2669	297	2	.	.	X
dpc-2669	297	3	janeiro	janeiro	PROPN
dpc-2669	297	4	mh	mh	PROPN
dpc-2669	297	5	,	,	PUNCT
dpc-2669	297	6	ramírez	ramírez	PROPN
dpc-2669	297	7	mj	mj	PROPN
dpc-2669	297	8	,	,	PUNCT
dpc-2669	297	9	milagro	milagro	PROPN
dpc-2669	297	10	fi	fi	PROPN
dpc-2669	297	11	,	,	PUNCT
dpc-2669	297	12	martínez	martínez	PROPN
dpc-2669	297	13	ja	ja	PROPN
dpc-2669	297	14	,	,	PUNCT
dpc-2669	297	15	solas	solas	PROPN
dpc-2669	297	16	m.	m.	NOUN
dpc-2669	297	17	implication	implication	NOUN
dpc-2669	297	18	of	of	ADP
dpc-2669	297	19	trimethylamine	trimethylamine	NOUN
dpc-2669	297	20	n	n	CCONJ
dpc-2669	297	21	-	-	PUNCT
dpc-2669	297	22	oxide	oxide	NOUN
dpc-2669	297	23	(	(	PUNCT
dpc-2669	297	24	tmao	tmao	PROPN
dpc-2669	297	25	)	)	PUNCT
dpc-2669	297	26	in	in	ADP
dpc-2669	297	27	disease	disease	NOUN
dpc-2669	297	28	:	:	PUNCT
dpc-2669	297	29	potential	potential	ADJ
dpc-2669	297	30	biomarker	biomarker	NOUN
dpc-2669	297	31	or	or	CCONJ
dpc-2669	297	32	new	new	ADJ
dpc-2669	297	33	therapeutic	therapeutic	ADJ
dpc-2669	297	34	target	target	NOUN
dpc-2669	297	35	.	.	PUNCT
dpc-2669	298	1	nutrients	nutrient	NOUN
dpc-2669	298	2	.	.	PUNCT
dpc-2669	299	1	2018;10(10):1398	2018;10(10):1398	X
dpc-2669	299	2	.	.	PUNCT
dpc-2669	300	1	doi	doi	NOUN
dpc-2669	300	2	:	:	PUNCT
dpc-2669	300	3	10.3390	10.3390	NUM
dpc-2669	300	4	/	/	SYM
dpc-2669	300	5	nu10101398	nu10101398	PROPN
dpc-2669	300	6	.	.	PUNCT
dpc-2669	301	1	pmid	pmid	NOUN
dpc-2669	301	2	:	:	PUNCT
dpc-2669	301	3	30275434	30275434	NUM
dpc-2669	301	4	.	.	PUNCT
dpc-2669	302	1	pmcid	pmcid	NOUN
dpc-2669	302	2	:	:	PUNCT
dpc-2669	302	3	pmc6213249	pmc6213249	NOUN
dpc-2669	302	4	.	.	PUNCT
dpc-2669	303	1	8	8	X
dpc-2669	303	2	.	.	PUNCT
dpc-2669	303	3	randrianarisoa	randrianarisoa	PROPN
dpc-2669	303	4	e	e	NOUN
dpc-2669	303	5	,	,	PUNCT
dpc-2669	303	6	lehn	lehn	PROPN
dpc-2669	303	7	-	-	PUNCT
dpc-2669	303	8	stefan	stefan	PROPN
dpc-2669	303	9	a	a	PROPN
dpc-2669	303	10	,	,	PUNCT
dpc-2669	303	11	wang	wang	PROPN
dpc-2669	303	12	x	x	PROPN
dpc-2669	303	13	,	,	PUNCT
dpc-2669	303	14	et	et	PROPN
dpc-2669	303	15	al	al	PROPN
dpc-2669	303	16	.	.	PROPN
dpc-2669	303	17	relationship	relationship	NOUN
dpc-2669	303	18	of	of	ADP
dpc-2669	303	19	serum	serum	NOUN
dpc-2669	303	20	trimethylamine	trimethylamine	NOUN
dpc-2669	303	21	n	n	CCONJ
dpc-2669	303	22	-	-	PUNCT
dpc-2669	303	23	oxide	oxide	NOUN
dpc-2669	303	24	(	(	PUNCT
dpc-2669	303	25	tmao	tmao	PROPN
dpc-2669	303	26	)	)	PUNCT
dpc-2669	303	27	levels	level	NOUN
dpc-2669	303	28	with	with	ADP
dpc-2669	303	29	early	early	ADJ
dpc-2669	303	30	atherosclerosis	atherosclerosis	NOUN
dpc-2669	303	31	in	in	ADP
dpc-2669	303	32	humans	human	NOUN
dpc-2669	303	33	.	.	PUNCT
dpc-2669	304	1	sci	sci	PROPN
dpc-2669	304	2	rep	rep	PROPN
dpc-2669	304	3	.	.	PROPN
dpc-2669	304	4	2016;6:26745	2016;6:26745	PROPN
dpc-2669	304	5	.	.	PUNCT
dpc-2669	305	1	doi	doi	NOUN
dpc-2669	305	2	:	:	PUNCT
dpc-2669	305	3	10.1038	10.1038	NUM
dpc-2669	305	4	/srep26745	/srep26745	PUNCT
dpc-2669	305	5	.	.	PUNCT
dpc-2669	306	1	pmid	pmid	NOUN
dpc-2669	306	2	:	:	PUNCT
dpc-2669	306	3	27228955	27228955	NUM
dpc-2669	306	4	.	.	PUNCT
dpc-2669	307	1	pmcid	pmcid	NOUN
dpc-2669	307	2	:	:	PUNCT
dpc-2669	307	3	pmc4882652	pmc4882652	ADJ
dpc-2669	307	4	.	.	PUNCT
dpc-2669	308	1	9	9	X
dpc-2669	308	2	.	.	X
dpc-2669	309	1	jadhav	jadhav	PROPN
dpc-2669	309	2	um	um	INTJ
dpc-2669	309	3	,	,	PUNCT
dpc-2669	309	4	kadam	kadam	PROPN
dpc-2669	309	5	nn	nn	PROPN
dpc-2669	309	6	.	.	PROPN
dpc-2669	309	7	carotid	carotid	NOUN
dpc-2669	309	8	intima	intima	ADJ
dpc-2669	309	9	-	-	PUNCT
dpc-2669	309	10	media	media	NOUN
dpc-2669	309	11	thickness	thickness	NOUN
dpc-2669	309	12	as	as	ADP
dpc-2669	309	13	an	an	DET
dpc-2669	309	14	independent	independent	ADJ
dpc-2669	309	15	predictor	predictor	NOUN
dpc-2669	309	16	of	of	ADP
dpc-2669	309	17	coronary	coronary	ADJ
dpc-2669	309	18	artery	artery	NOUN
dpc-2669	309	19	disease	disease	NOUN
dpc-2669	309	20	.	.	PUNCT
dpc-2669	310	1	indian	indian	ADJ
dpc-2669	310	2	heart	heart	NOUN
dpc-2669	310	3	j.	j.	PROPN
dpc-2669	310	4	2001;53(4):458	2001;53(4):458	PROPN
dpc-2669	310	5	-	-	PUNCT
dpc-2669	310	6	462	462	PROPN
dpc-2669	310	7	.	.	PUNCT
dpc-2669	311	1	pmid	pmid	NOUN
dpc-2669	311	2	:	:	PUNCT
dpc-2669	311	3	11759935	11759935	NUM
dpc-2669	311	4	.	.	PUNCT
dpc-2669	312	1	and	and	CCONJ
dpc-2669	312	2	bmi	bmi	PROPN
dpc-2669	312	3	,	,	PUNCT
dpc-2669	312	4	negative	negative	ADJ
dpc-2669	312	5	correlation	correlation	NOUN
dpc-2669	312	6	between	between	ADP
dpc-2669	312	7	hs	hs	PROPN
dpc-2669	312	8	-	-	PROPN
dpc-2669	312	9	crp	crp	PROPN
dpc-2669	312	10	and	and	CCONJ
dpc-2669	312	11	hdl	hdl	PROPN
dpc-2669	312	12	-	-	PUNCT
dpc-2669	312	13	c	c	NOUN
dpc-2669	312	14	in	in	ADP
dpc-2669	312	15	psoriasis	psoriasis	NOUN
dpc-2669	312	16	patients	patient	NOUN
dpc-2669	312	17	shows	show	VERB
dpc-2669	312	18	that	that	SCONJ
dpc-2669	312	19	obesity	obesity	NOUN
dpc-2669	312	20	and	and	CCONJ
dpc-2669	312	21	metabolic	metabolic	NOUN
dpc-2669	312	22	syndrome	syndrome	NOUN
dpc-2669	312	23	actually	actually	ADV
dpc-2669	312	24	cause	cause	VERB
dpc-2669	312	25	systemic	systemic	ADJ
dpc-2669	312	26	inflammatory	inflammatory	ADJ
dpc-2669	312	27	response	response	NOUN
dpc-2669	312	28	.	.	PUNCT
dpc-2669	313	1	cytokine	cytokine	NOUN
dpc-2669	313	2	profile	profile	NOUN
dpc-2669	313	3	observed	observe	VERB
dpc-2669	313	4	in	in	ADP
dpc-2669	313	5	psoriasis	psoriasis	NOUN
dpc-2669	313	6	patients	patient	NOUN
dpc-2669	313	7	contributes	contribute	VERB
dpc-2669	313	8	to	to	ADP
dpc-2669	313	9	the	the	DET
dpc-2669	313	10	formation	formation	NOUN
dpc-2669	313	11	of	of	ADP
dpc-2669	313	12	dyslipidemia	dyslipidemia	NOUN
dpc-2669	313	13	and	and	CCONJ
dpc-2669	313	14	atherosclerosis	atherosclerosis	NOUN
dpc-2669	313	15	through	through	ADP
dpc-2669	313	16	mechanisms	mechanism	NOUN
dpc-2669	313	17	such	such	ADJ
dpc-2669	313	18	as	as	ADP
dpc-2669	313	19	irregularities	irregularity	NOUN
dpc-2669	313	20	in	in	ADP
dpc-2669	313	21	membrane	membrane	NOUN
dpc-2669	313	22	protein	protein	NOUN
dpc-2669	313	23	synthesis	synthesis	NOUN
dpc-2669	313	24	of	of	ADP
dpc-2669	313	25	lipoproteins	lipoprotein	NOUN
dpc-2669	313	26	in	in	ADP
dpc-2669	313	27	the	the	DET
dpc-2669	313	28	liver	liver	NOUN
dpc-2669	313	29	,	,	PUNCT
dpc-2669	313	30	impaired	impaired	ADJ
dpc-2669	313	31	reverse	reverse	ADJ
dpc-2669	313	32	cholesterol	cholesterol	NOUN
dpc-2669	313	33	transport	transport	NOUN
dpc-2669	313	34	via	via	ADP
dpc-2669	313	35	hdl	hdl	PROPN
dpc-2669	313	36	-	-	PUNCT
dpc-2669	313	37	c	c	PROPN
dpc-2669	313	38	,	,	PUNCT
dpc-2669	313	39	the	the	DET
dpc-2669	313	40	effect	effect	NOUN
dpc-2669	313	41	of	of	ADP
dpc-2669	313	42	chylomicron	chylomicron	NOUN
dpc-2669	313	43	residues	residue	NOUN
dpc-2669	313	44	on	on	ADP
dpc-2669	313	45	atherosclerosis	atherosclerosis	NOUN
dpc-2669	313	46	and	and	CCONJ
dpc-2669	313	47	paradoxical	paradoxical	ADJ
dpc-2669	313	48	ldl	ldl	NOUN
dpc-2669	313	49	-	-	PUNCT
dpc-2669	313	50	c	c	NOUN
dpc-2669	313	51	increase	increase	NOUN
dpc-2669	313	52	[	[	X
dpc-2669	313	53	28	28	NUM
dpc-2669	313	54	]	]	PUNCT
dpc-2669	313	55	.	.	PUNCT
dpc-2669	314	1	in	in	ADP
dpc-2669	314	2	this	this	DET
dpc-2669	314	3	study	study	NOUN
dpc-2669	314	4	,	,	PUNCT
dpc-2669	314	5	oxidized	oxidize	VERB
dpc-2669	314	6	-	-	PUNCT
dpc-2669	314	7	ldl	ldl	NOUN
dpc-2669	314	8	and	and	CCONJ
dpc-2669	314	9	triglyceride	triglyceride	ADJ
dpc-2669	314	10	levels	level	NOUN
dpc-2669	314	11	were	be	AUX
dpc-2669	314	12	higher	high	ADJ
dpc-2669	314	13	and	and	CCONJ
dpc-2669	314	14	hdl	hdl	PROPN
dpc-2669	314	15	-	-	PUNCT
dpc-2669	314	16	c	c	PROPN
dpc-2669	314	17	levels	level	NOUN
dpc-2669	314	18	were	be	AUX
dpc-2669	314	19	lower	low	ADJ
dpc-2669	314	20	in	in	ADP
dpc-2669	314	21	the	the	DET
dpc-2669	314	22	patient	patient	NOUN
dpc-2669	314	23	group	group	NOUN
dpc-2669	314	24	compared	compare	VERB
dpc-2669	314	25	to	to	ADP
dpc-2669	314	26	healthy	healthy	ADJ
dpc-2669	314	27	controls	control	NOUN
dpc-2669	314	28	.	.	PUNCT
dpc-2669	315	1	there	there	PRON
dpc-2669	315	2	was	be	VERB
dpc-2669	315	3	no	no	DET
dpc-2669	315	4	statistically	statistically	ADJ
dpc-2669	315	5	difference	difference	NOUN
dpc-2669	315	6	between	between	ADP
dpc-2669	315	7	the	the	DET
dpc-2669	315	8	two	two	NUM
dpc-2669	315	9	groups	group	NOUN
dpc-2669	315	10	in	in	ADP
dpc-2669	315	11	terms	term	NOUN
dpc-2669	315	12	of	of	ADP
dpc-2669	315	13	total	total	ADJ
dpc-2669	315	14	cholesterol	cholesterol	NOUN
dpc-2669	315	15	and	and	CCONJ
dpc-2669	315	16	ldl	ldl	NOUN
dpc-2669	315	17	-	-	PUNCT
dpc-2669	315	18	c.	c.	NOUN
dpc-2669	315	19	limitations	limitation	NOUN
dpc-2669	315	20	of	of	ADP
dpc-2669	315	21	the	the	DET
dpc-2669	315	22	study	study	NOUN
dpc-2669	315	23	:	:	PUNCT
dpc-2669	315	24	this	this	PRON
dpc-2669	315	25	was	be	AUX
dpc-2669	315	26	a	a	DET
dpc-2669	315	27	cross	cross	ADJ
dpc-2669	315	28	-	-	ADJ
dpc-2669	315	29	sectional	sectional	ADJ
dpc-2669	315	30	study	study	NOUN
dpc-2669	315	31	and	and	CCONJ
dpc-2669	315	32	was	be	AUX
dpc-2669	315	33	conducted	conduct	VERB
dpc-2669	315	34	in	in	ADP
dpc-2669	315	35	a	a	DET
dpc-2669	315	36	limited	limited	ADJ
dpc-2669	315	37	population	population	NOUN
dpc-2669	315	38	.	.	PUNCT
dpc-2669	316	1	psoriasis	psoriasis	NOUN
dpc-2669	316	2	is	be	AUX
dpc-2669	316	3	a	a	DET
dpc-2669	316	4	chronic	chronic	ADJ
dpc-2669	316	5	systemic	systemic	ADJ
dpc-2669	316	6	inflammatory	inflammatory	ADJ
dpc-2669	316	7	disease	disease	NOUN
dpc-2669	316	8	and	and	CCONJ
dpc-2669	316	9	has	have	AUX
dpc-2669	316	10	been	be	AUX
dpc-2669	316	11	associated	associate	VERB
dpc-2669	316	12	with	with	ADP
dpc-2669	316	13	an	an	DET
dpc-2669	316	14	increased	increase	VERB
dpc-2669	316	15	risk	risk	NOUN
dpc-2669	316	16	of	of	ADP
dpc-2669	316	17	cardiovascular	cardiovascular	ADJ
dpc-2669	316	18	mortality	mortality	NOUN
dpc-2669	316	19	and	and	CCONJ
dpc-2669	316	20	morbidity	morbidity	NOUN
dpc-2669	316	21	in	in	ADP
dpc-2669	316	22	many	many	ADJ
dpc-2669	316	23	studies	study	NOUN
dpc-2669	316	24	.	.	PUNCT
dpc-2669	317	1	the	the	DET
dpc-2669	317	2	data	datum	NOUN
dpc-2669	317	3	obtained	obtain	VERB
dpc-2669	317	4	in	in	ADP
dpc-2669	317	5	this	this	DET
dpc-2669	317	6	study	study	NOUN
dpc-2669	317	7	also	also	ADV
dpc-2669	317	8	showed	show	VERB
dpc-2669	317	9	that	that	SCONJ
dpc-2669	317	10	psoriasis	psoriasis	NOUN
dpc-2669	317	11	is	be	AUX
dpc-2669	317	12	a	a	DET
dpc-2669	317	13	risk	risk	NOUN
dpc-2669	317	14	factor	factor	NOUN
dpc-2669	317	15	for	for	ADP
dpc-2669	317	16	cardiovascular	cardiovascular	ADJ
dpc-2669	317	17	disease	disease	NOUN
dpc-2669	317	18	.	.	PUNCT
dpc-2669	318	1	although	although	SCONJ
dpc-2669	318	2	tmao	tmao	PROPN
dpc-2669	318	3	has	have	AUX
dpc-2669	318	4	been	be	AUX
dpc-2669	318	5	recognized	recognize	VERB
dpc-2669	318	6	in	in	ADP
dpc-2669	318	7	recent	recent	ADJ
dpc-2669	318	8	years	year	NOUN
dpc-2669	318	9	as	as	ADP
dpc-2669	318	10	an	an	DET
dpc-2669	318	11	intestinal	intestinal	ADJ
dpc-2669	318	12	microbiota	microbiota	NOUN
dpc-2669	318	13	and	and	CCONJ
dpc-2669	318	14	diet	diet	NOUN
dpc-2669	318	15	-	-	PUNCT
dpc-2669	318	16	related	relate	VERB
dpc-2669	318	17	molecule	molecule	NOUN
dpc-2669	318	18	that	that	PRON
dpc-2669	318	19	triggers	trigger	VERB
dpc-2669	318	20	atherosclerosis	atherosclerosis	NOUN
dpc-2669	318	21	in	in	ADP
dpc-2669	318	22	the	the	DET
dpc-2669	318	23	vessel	vessel	NOUN
dpc-2669	318	24	wall	wall	NOUN
dpc-2669	318	25	,	,	PUNCT
dpc-2669	318	26	there	there	PRON
dpc-2669	318	27	are	be	VERB
dpc-2669	318	28	conflicting	conflicting	ADJ
dpc-2669	318	29	results	result	NOUN
dpc-2669	318	30	in	in	ADP
dpc-2669	318	31	studies	study	NOUN
dpc-2669	318	32	.	.	PUNCT
dpc-2669	319	1	in	in	ADP
dpc-2669	319	2	this	this	DET
dpc-2669	319	3	study	study	NOUN
dpc-2669	319	4	,	,	PUNCT
dpc-2669	319	5	serum	serum	PROPN
dpc-2669	319	6	tmao	tmao	PROPN
dpc-2669	319	7	levels	level	NOUN
dpc-2669	319	8	were	be	AUX
dpc-2669	319	9	significantly	significantly	ADV
dpc-2669	319	10	higher	high	ADJ
dpc-2669	319	11	in	in	ADP
dpc-2669	319	12	psoriasis	psoriasis	NOUN
dpc-2669	319	13	patients	patient	NOUN
dpc-2669	319	14	,	,	PUNCT
dpc-2669	319	15	indicating	indicate	VERB
dpc-2669	319	16	intestinal	intestinal	ADJ
dpc-2669	319	17	dysbiosis	dysbiosis	NOUN
dpc-2669	319	18	,	,	PUNCT
dpc-2669	319	19	in	in	ADP
dpc-2669	319	20	addition	addition	NOUN
dpc-2669	319	21	tmao	tmao	VERB
dpc-2669	319	22	level	level	NOUN
dpc-2669	319	23	is	be	AUX
dpc-2669	319	24	an	an	DET
dpc-2669	319	25	independent	independent	ADJ
dpc-2669	319	26	positive	positive	ADJ
dpc-2669	319	27	predictor	predictor	NOUN
dpc-2669	319	28	for	for	ADP
dpc-2669	319	29	cardiovascular	cardiovascular	ADJ
dpc-2669	319	30	disease	disease	NOUN
dpc-2669	319	31	risk	risk	NOUN
dpc-2669	319	32	status	status	NOUN
dpc-2669	319	33	.	.	PUNCT
dpc-2669	320	1	further	further	ADJ
dpc-2669	320	2	studies	study	NOUN
dpc-2669	320	3	are	be	AUX
dpc-2669	320	4	needed	need	VERB
dpc-2669	320	5	to	to	PART
dpc-2669	320	6	determine	determine	VERB
dpc-2669	320	7	the	the	DET
dpc-2669	320	8	diversity	diversity	NOUN
dpc-2669	320	9	of	of	ADP
dpc-2669	320	10	gut	gut	ADJ
dpc-2669	320	11	bacterial	bacterial	ADJ
dpc-2669	320	12	colonization	colonization	NOUN
dpc-2669	320	13	in	in	ADP
dpc-2669	320	14	psoriasis	psoriasis	NOUN
dpc-2669	320	15	patients	patient	NOUN
dpc-2669	320	16	,	,	PUNCT
dpc-2669	320	17	genetic	genetic	ADJ
dpc-2669	320	18	factors	factor	NOUN
dpc-2669	320	19	,	,	PUNCT
dpc-2669	320	20	molecular	molecular	ADJ
dpc-2669	320	21	mechanisms	mechanism	NOUN
dpc-2669	320	22	controlling	control	VERB
dpc-2669	320	23	gut	gut	NOUN
dpc-2669	320	24	wall	wall	NOUN
dpc-2669	320	25	permeability	permeability	NOUN
dpc-2669	320	26	,	,	PUNCT
dpc-2669	320	27	and	and	CCONJ
dpc-2669	320	28	the	the	DET
dpc-2669	320	29	role	role	NOUN
dpc-2669	320	30	of	of	ADP
dpc-2669	320	31	probiotics	probiotic	NOUN
dpc-2669	320	32	,	,	PUNCT
dpc-2669	320	33	prebiotics	prebiotic	NOUN
dpc-2669	320	34	,	,	PUNCT
dpc-2669	320	35	and	and	CCONJ
dpc-2669	320	36	perhaps	perhaps	ADV
dpc-2669	320	37	antibiotics	antibiotic	NOUN
dpc-2669	320	38	to	to	PART
dpc-2669	320	39	reduce	reduce	VERB
dpc-2669	320	40	cardiovascular	cardiovascular	ADJ
dpc-2669	320	41	disease	disease	NOUN
dpc-2669	320	42	risk	risk	NOUN
dpc-2669	320	43	.	.	PUNCT
dpc-2669	321	1	1.20	1.20	NUM
dpc-2669	321	2	1.00	1.00	NUM
dpc-2669	321	3	0.80	0.80	NUM
dpc-2669	321	4	0.60	0.60	NUM
dpc-2669	321	5	0.40	0.40	NUM
dpc-2669	321	6	0.20	0.20	NUM
dpc-2669	321	7	0.00	0.00	NUM
dpc-2669	321	8	0.00	0.00	NUM
dpc-2669	321	9	200.00	200.00	NUM
dpc-2669	321	10	400.00	400.00	NUM
dpc-2669	321	11	600.00	600.00	NUM
dpc-2669	321	12	800.00	800.00	NUM
dpc-2669	321	13	1000.00	1000.00	NUM
dpc-2669	321	14	1200.00	1200.00	NUM
dpc-2669	321	15	1400.00	1400.00	NUM
dpc-2669	321	16	tmao	tmao	NOUN
dpc-2669	321	17	(	(	PUNCT
dpc-2669	321	18	ng	ng	PROPN
dpc-2669	321	19	/	/	SYM
dpc-2669	321	20	ml	ml	PROPN
dpc-2669	321	21	)	)	PUNCT
dpc-2669	321	22	le	le	X
dpc-2669	322	1	ft	ft	PROPN
dpc-2669	322	2	a	a	PRON
dpc-2669	322	3	nt	not	PART
dpc-2669	322	4	er	er	INTJ
dpc-2669	322	5	io	io	NOUN
dpc-2669	322	6	r	r	NOUN
dpc-2669	322	7	c	c	PROPN
dpc-2669	323	1	i	i	PRON
dpc-2669	323	2	m	m	VERB
dpc-2669	323	3	t	t	PROPN
dpc-2669	323	4	(	(	PUNCT
dpc-2669	323	5	m	m	PROPN
dpc-2669	323	6	m	m	VERB
dpc-2669	323	7	)	)	PUNCT
dpc-2669	323	8	figure	figure	NOUN
dpc-2669	323	9	4	4	NUM
dpc-2669	323	10	.	.	PUNCT
dpc-2669	323	11	relationship	relationship	NOUN
dpc-2669	323	12	between	between	ADP
dpc-2669	323	13	trimethylamine	trimethylamine	NOUN
dpc-2669	323	14	 	 	SPACE
dpc-2669	323	15	n	n	CCONJ
dpc-2669	323	16	-	-	PUNCT
dpc-2669	323	17	oxide	oxide	NOUN
dpc-2669	323	18	and	and	CCONJ
dpc-2669	323	19	left	leave	VERB
dpc-2669	323	20	anterior	anterior	ADJ
dpc-2669	323	21	carotid	carotid	NOUN
dpc-2669	323	22	intima	intima	ADJ
dpc-2669	323	23	-	-	PUNCT
dpc-2669	323	24	media	medium	NOUN
dpc-2669	323	25	thickness	thickness	NOUN
dpc-2669	323	26	.	.	PUNCT
dpc-2669	324	1	10	10	NUM
dpc-2669	324	2	original	original	ADJ
dpc-2669	324	3	article	article	NOUN
dpc-2669	324	4	|	|	ADV
dpc-2669	324	5	dermatol	dermatol	ADJ
dpc-2669	324	6	pract	pract	NOUN
dpc-2669	324	7	concept	concept	NOUN
dpc-2669	324	8	.	.	PUNCT
dpc-2669	325	1	2023;13(2):e2023116	2023;13(2):e2023116	NUM
dpc-2669	325	2	20	20	NUM
dpc-2669	325	3	.	.	PUNCT
dpc-2669	326	1	geng	geng	PROPN
dpc-2669	326	2	j	j	PROPN
dpc-2669	326	3	,	,	PUNCT
dpc-2669	326	4	yang	yang	PROPN
dpc-2669	326	5	c	c	PROPN
dpc-2669	326	6	,	,	PUNCT
dpc-2669	326	7	wang	wang	PROPN
dpc-2669	326	8	b	b	PROPN
dpc-2669	326	9	,	,	PUNCT
dpc-2669	326	10	et	et	PROPN
dpc-2669	326	11	al	al	PROPN
dpc-2669	326	12	.	.	PROPN
dpc-2669	326	13	trimethylamine	trimethylamine	PROPN
dpc-2669	326	14	n	n	CCONJ
dpc-2669	326	15	-	-	PUNCT
dpc-2669	326	16	oxide	oxide	NOUN
dpc-2669	326	17	promotes	promote	VERB
dpc-2669	326	18	atherosclerosis	atherosclerosis	NOUN
dpc-2669	326	19	via	via	ADP
dpc-2669	326	20	cd36	cd36	PROPN
dpc-2669	326	21	-	-	PUNCT
dpc-2669	326	22	dependent	dependent	ADJ
dpc-2669	326	23	mapk	mapk	PROPN
dpc-2669	326	24	/	/	SYM
dpc-2669	326	25	jnk	jnk	PROPN
dpc-2669	326	26	pathway	pathway	NOUN
dpc-2669	326	27	.	.	PUNCT
dpc-2669	327	1	biomed	biome	VERB
dpc-2669	327	2	pharmacother	pharmacother	ADJ
dpc-2669	327	3	.	.	PUNCT
dpc-2669	328	1	2018;97:941	2018;97:941	NUM
dpc-2669	328	2	-	-	SYM
dpc-2669	328	3	947	947	NUM
dpc-2669	328	4	.	.	PUNCT
dpc-2669	329	1	doi	doi	NOUN
dpc-2669	329	2	:	:	PUNCT
dpc-2669	329	3	10.1016	10.1016	NUM
dpc-2669	329	4	/	/	SYM
dpc-2669	329	5	j	j	PROPN
dpc-2669	329	6	.biopha.2017.11.016	.biopha.2017.11.016	PROPN
dpc-2669	329	7	.	.	PUNCT
dpc-2669	330	1	pmid	pmid	NOUN
dpc-2669	330	2	:	:	PUNCT
dpc-2669	330	3	29136772	29136772	NUM
dpc-2669	330	4	.	.	PUNCT
dpc-2669	331	1	21	21	NUM
dpc-2669	331	2	.	.	PUNCT
dpc-2669	331	3	mohammadi	mohammadi	PROPN
dpc-2669	331	4	a	a	PRON
dpc-2669	331	5	,	,	PUNCT
dpc-2669	331	6	najar	najar	PROPN
dpc-2669	331	7	ag	ag	PROPN
dpc-2669	331	8	,	,	PUNCT
dpc-2669	331	9	yaghoobi	yaghoobi	PROPN
dpc-2669	331	10	mm	mm	PROPN
dpc-2669	331	11	,	,	PUNCT
dpc-2669	331	12	jahani	jahani	PROPN
dpc-2669	331	13	y	y	PROPN
dpc-2669	331	14	,	,	PUNCT
dpc-2669	331	15	vahabzadeh	vahabzadeh	PROPN
dpc-2669	331	16	z.	z.	PROPN
dpc-2669	331	17	trimethylamine	trimethylamine	PROPN
dpc-2669	331	18	-	-	PUNCT
dpc-2669	331	19	n	n	CCONJ
dpc-2669	331	20	-	-	PUNCT
dpc-2669	331	21	oxide	oxide	NOUN
dpc-2669	331	22	treatment	treatment	NOUN
dpc-2669	331	23	induces	induce	VERB
dpc-2669	331	24	changes	change	NOUN
dpc-2669	331	25	in	in	ADP
dpc-2669	331	26	the	the	DET
dpc-2669	331	27	atp	atp	NOUN
dpc-2669	331	28	-	-	PUNCT
dpc-2669	331	29	binding	bind	VERB
dpc-2669	331	30	cassette	cassette	NOUN
dpc-2669	331	31	transporter	transporter	NOUN
dpc-2669	331	32	a1	a1	NOUN
dpc-2669	331	33	and	and	CCONJ
dpc-2669	331	34	scavenger	scavenger	NOUN
dpc-2669	331	35	receptor	receptor	NOUN
dpc-2669	331	36	a1	a1	NOUN
dpc-2669	331	37	in	in	ADP
dpc-2669	331	38	murine	murine	ADJ
dpc-2669	331	39	macrophage	macrophage	ADJ
dpc-2669	331	40	j774a	j774a	PROPN
dpc-2669	331	41	.	.	PUNCT
dpc-2669	332	1	1	1	NUM
dpc-2669	332	2	cells	cell	NOUN
dpc-2669	332	3	.	.	PUNCT
dpc-2669	333	1	inflammation	inflammation	NOUN
dpc-2669	333	2	.	.	PUNCT
dpc-2669	334	1	2016;39(1):393	2016;39(1):393	NUM
dpc-2669	334	2	-	-	PUNCT
dpc-2669	334	3	404	404	NUM
dpc-2669	334	4	.	.	PUNCT
dpc-2669	335	1	doi	doi	NOUN
dpc-2669	335	2	:	:	PUNCT
dpc-2669	335	3	10.1007	10.1007	NUM
dpc-2669	335	4	/	/	SYM
dpc-2669	335	5	s10753	s10753	NOUN
dpc-2669	335	6	-	-	NUM
dpc-2669	335	7	015	015	NUM
dpc-2669	335	8	-	-	PUNCT
dpc-2669	335	9	0261	0261	NUM
dpc-2669	335	10	-	-	SYM
dpc-2669	335	11	7	7	NUM
dpc-2669	335	12	.	.	PUNCT
dpc-2669	336	1	pmid	pmid	NOUN
dpc-2669	336	2	:	:	PUNCT
dpc-2669	336	3	26412259	26412259	NUM
dpc-2669	336	4	.	.	PUNCT
dpc-2669	337	1	22	22	NUM
dpc-2669	337	2	.	.	PUNCT
dpc-2669	338	1	seldin	seldin	PROPN
dpc-2669	338	2	mm	mm	PROPN
dpc-2669	338	3	,	,	PUNCT
dpc-2669	338	4	meng	meng	PROPN
dpc-2669	338	5	y	y	PROPN
dpc-2669	338	6	,	,	PUNCT
dpc-2669	338	7	qi	qi	PROPN
dpc-2669	338	8	h	h	NOUN
dpc-2669	338	9	,	,	PUNCT
dpc-2669	338	10	et	et	PROPN
dpc-2669	338	11	al	al	PROPN
dpc-2669	338	12	.	.	PROPN
dpc-2669	338	13	trimethylamine	trimethylamine	PROPN
dpc-2669	338	14	n‐oxide	n‐oxide	PUNCT
dpc-2669	338	15	promotes	promote	VERB
dpc-2669	338	16	vascular	vascular	ADJ
dpc-2669	338	17	inflammation	inflammation	NOUN
dpc-2669	338	18	through	through	ADP
dpc-2669	338	19	signaling	signal	VERB
dpc-2669	338	20	of	of	ADP
dpc-2669	338	21	mitogen‐activated	mitogen‐activate	VERB
dpc-2669	338	22	protein	protein	NOUN
dpc-2669	338	23	kinase	kinase	NOUN
dpc-2669	338	24	and	and	CCONJ
dpc-2669	338	25	nuclear	nuclear	ADJ
dpc-2669	338	26	factor‐κb	factor‐κb	PROPN
dpc-2669	338	27	.	.	PUNCT
dpc-2669	339	1	j	j	PROPN
dpc-2669	339	2	am	be	AUX
dpc-2669	339	3	heart	heart	NOUN
dpc-2669	339	4	assoc	assoc	NOUN
dpc-2669	339	5	.	.	PUNCT
dpc-2669	340	1	2016;5(2):e002767	2016;5(2):e002767	NOUN
dpc-2669	340	2	.	.	PUNCT
dpc-2669	341	1	doi	doi	NOUN
dpc-2669	341	2	:	:	PUNCT
dpc-2669	341	3	10.1161	10.1161	NUM
dpc-2669	341	4	/	/	SYM
dpc-2669	341	5	jaha.115.002767	jaha.115.002767	NOUN
dpc-2669	341	6	.	.	PUNCT
dpc-2669	342	1	pmid	pmid	NOUN
dpc-2669	342	2	:	:	PUNCT
dpc-2669	342	3	26903003	26903003	NUM
dpc-2669	342	4	.	.	PUNCT
dpc-2669	343	1	pmcid	pmcid	ADJ
dpc-2669	343	2	:	:	PUNCT
dpc-2669	343	3	pmc4802459	pmc4802459	NOUN
dpc-2669	343	4	.	.	PUNCT
dpc-2669	344	1	23	23	NUM
dpc-2669	344	2	.	.	PUNCT
dpc-2669	345	1	chen	chen	PROPN
dpc-2669	345	2	h	h	PROPN
dpc-2669	345	3	,	,	PUNCT
dpc-2669	345	4	li	li	PROPN
dpc-2669	345	5	j	j	PROPN
dpc-2669	345	6	,	,	PUNCT
dpc-2669	345	7	li	li	PROPN
dpc-2669	345	8	n	n	PROPN
dpc-2669	345	9	,	,	PUNCT
dpc-2669	345	10	liu	liu	PROPN
dpc-2669	345	11	h	h	PROPN
dpc-2669	345	12	,	,	PUNCT
dpc-2669	345	13	tang	tang	PROPN
dpc-2669	345	14	j.	j.	PROPN
dpc-2669	345	15	increased	increase	VERB
dpc-2669	345	16	circulating	circulate	VERB
dpc-2669	345	17	trimethylamine	trimethylamine	NOUN
dpc-2669	345	18	n	n	CCONJ
dpc-2669	345	19	-	-	PUNCT
dpc-2669	345	20	oxide	oxide	NOUN
dpc-2669	345	21	plays	play	VERB
dpc-2669	345	22	a	a	DET
dpc-2669	345	23	contributory	contributory	ADJ
dpc-2669	345	24	role	role	NOUN
dpc-2669	345	25	in	in	ADP
dpc-2669	345	26	the	the	DET
dpc-2669	345	27	development	development	NOUN
dpc-2669	345	28	of	of	ADP
dpc-2669	345	29	endothelial	endothelial	ADJ
dpc-2669	345	30	dysfunction	dysfunction	NOUN
dpc-2669	345	31	and	and	CCONJ
dpc-2669	345	32	hypertension	hypertension	NOUN
dpc-2669	345	33	in	in	ADP
dpc-2669	345	34	the	the	DET
dpc-2669	345	35	rupp	rupp	NOUN
dpc-2669	345	36	rat	rat	NOUN
dpc-2669	345	37	model	model	NOUN
dpc-2669	345	38	of	of	ADP
dpc-2669	345	39	preeclampsia	preeclampsia	NOUN
dpc-2669	345	40	.	.	PUNCT
dpc-2669	346	1	hypertens	hyperten	NOUN
dpc-2669	346	2	pregnancy	pregnancy	NOUN
dpc-2669	346	3	.	.	PUNCT
dpc-2669	347	1	2019;38(2):96	2019;38(2):96	PROPN
dpc-2669	347	2	-	-	SYM
dpc-2669	347	3	104.doi	104.doi	NUM
dpc-2669	347	4	:	:	PUNCT
dpc-2669	347	5	10.1080/10641955.2019.1584630	10.1080/10641955.2019.1584630	NUM
dpc-2669	347	6	.	.	PUNCT
dpc-2669	348	1	pmid	pmid	NOUN
dpc-2669	348	2	:	:	PUNCT
dpc-2669	348	3	30821524	30821524	NUM
dpc-2669	348	4	.	.	PUNCT
dpc-2669	349	1	24	24	NUM
dpc-2669	349	2	.	.	PUNCT
dpc-2669	350	1	sikora	sikora	PROPN
dpc-2669	350	2	m	m	PROPN
dpc-2669	350	3	,	,	PUNCT
dpc-2669	350	4	kiss	kiss	VERB
dpc-2669	350	5	n	n	SYM
dpc-2669	350	6	,	,	PUNCT
dpc-2669	350	7	stec	stec	ADJ
dpc-2669	350	8	a	a	PRON
dpc-2669	350	9	,	,	PUNCT
dpc-2669	350	10	et	et	PROPN
dpc-2669	350	11	al	al	PROPN
dpc-2669	350	12	.	.	PROPN
dpc-2669	350	13	trimethylamine	trimethylamine	NOUN
dpc-2669	350	14	n	n	CCONJ
dpc-2669	350	15	-	-	PUNCT
dpc-2669	350	16	oxide	oxide	NOUN
dpc-2669	350	17	,	,	PUNCT
dpc-2669	350	18	a	a	DET
dpc-2669	350	19	gut	gut	NOUN
dpc-2669	350	20	microbiota	microbiota	NOUN
dpc-2669	350	21	-	-	PUNCT
dpc-2669	350	22	derived	derive	VERB
dpc-2669	350	23	metabolite	metabolite	NOUN
dpc-2669	350	24	,	,	PUNCT
dpc-2669	350	25	is	be	AUX
dpc-2669	350	26	associated	associate	VERB
dpc-2669	350	27	with	with	ADP
dpc-2669	350	28	cardiovascular	cardiovascular	ADJ
dpc-2669	350	29	risk	risk	NOUN
dpc-2669	350	30	in	in	ADP
dpc-2669	350	31	psoriasis	psoriasis	NOUN
dpc-2669	350	32	:	:	PUNCT
dpc-2669	350	33	a	a	DET
dpc-2669	350	34	cross	cross	ADJ
dpc-2669	350	35	-	-	ADJ
dpc-2669	350	36	sectional	sectional	ADJ
dpc-2669	350	37	pilot	pilot	NOUN
dpc-2669	350	38	study	study	NOUN
dpc-2669	350	39	.	.	PUNCT
dpc-2669	351	1	dermatol	dermatol	NOUN
dpc-2669	351	2	ther	ther	ADV
dpc-2669	351	3	(	(	PUNCT
dpc-2669	351	4	heidelb	heidelb	NOUN
dpc-2669	351	5	)	)	PUNCT
dpc-2669	351	6	.	.	PUNCT
dpc-2669	352	1	2021;11(4):1277	2021;11(4):1277	NUM
dpc-2669	352	2	-	-	SYM
dpc-2669	352	3	1289	1289	NUM
dpc-2669	352	4	.	.	PUNCT
dpc-2669	353	1	doi	doi	NOUN
dpc-2669	353	2	:	:	PUNCT
dpc-2669	353	3	10.1007	10.1007	NUM
dpc-2669	353	4	/	/	SYM
dpc-2669	353	5	s13555	s13555	PROPN
dpc-2669	353	6	-	-	PUNCT
dpc-2669	353	7	021	021	NUM
dpc-2669	353	8	-	-	PUNCT
dpc-2669	353	9	00547	00547	NUM
dpc-2669	353	10	-	-	SYM
dpc-2669	353	11	3	3	NUM
dpc-2669	353	12	.	.	PUNCT
dpc-2669	354	1	pmid	pmid	NOUN
dpc-2669	354	2	:	:	PUNCT
dpc-2669	354	3	33983475.pmcid	33983475.pmcid	NUM
dpc-2669	354	4	:	:	PUNCT
dpc-2669	354	5	pmc8322249	pmc8322249	NOUN
dpc-2669	354	6	.	.	PUNCT
dpc-2669	355	1	25	25	NUM
dpc-2669	355	2	.	.	X
dpc-2669	355	3	yu	yu	PROPN
dpc-2669	355	4	h	h	PROPN
dpc-2669	355	5	,	,	PUNCT
dpc-2669	355	6	rifai	rifai	VERB
dpc-2669	355	7	n.	n.	PROPN
dpc-2669	355	8	high	high	ADJ
dpc-2669	355	9	-	-	PUNCT
dpc-2669	355	10	sensitivity	sensitivity	NOUN
dpc-2669	355	11	c	c	NOUN
dpc-2669	355	12	-	-	PUNCT
dpc-2669	355	13	reactive	reactive	ADJ
dpc-2669	355	14	protein	protein	NOUN
dpc-2669	355	15	and	and	CCONJ
dpc-2669	355	16	atherosclerosis	atherosclerosis	NOUN
dpc-2669	355	17	:	:	PUNCT
dpc-2669	355	18	from	from	ADP
dpc-2669	355	19	theory	theory	NOUN
dpc-2669	355	20	to	to	ADP
dpc-2669	355	21	therapy	therapy	NOUN
dpc-2669	355	22	.	.	PUNCT
dpc-2669	356	1	clin	clin	PROPN
dpc-2669	356	2	biochem	biochem	PROPN
dpc-2669	356	3	.	.	PUNCT
dpc-2669	357	1	2000;33(8):601	2000;33(8):601	NUM
dpc-2669	357	2	-	-	PUNCT
dpc-2669	357	3	610	610	NUM
dpc-2669	357	4	.	.	PUNCT
dpc-2669	358	1	doi	doi	NOUN
dpc-2669	358	2	:	:	PUNCT
dpc-2669	358	3	10.1016	10.1016	NUM
dpc-2669	358	4	/	/	SYM
dpc-2669	358	5	s0009	s0009	PROPN
dpc-2669	358	6	-	-	PUNCT
dpc-2669	358	7	9120(00)00186	9120(00)00186	NUM
dpc-2669	358	8	-	-	PUNCT
dpc-2669	358	9	7	7	NUM
dpc-2669	358	10	.	.	PUNCT
dpc-2669	359	1	pmid	pmid	NOUN
dpc-2669	359	2	:	:	PUNCT
dpc-2669	359	3	11166006	11166006	NUM
dpc-2669	359	4	.	.	PUNCT
dpc-2669	360	1	26	26	NUM
dpc-2669	360	2	.	.	PUNCT
dpc-2669	361	1	niknezhad	niknezhad	PROPN
dpc-2669	361	2	n	n	NUM
dpc-2669	361	3	,	,	PUNCT
dpc-2669	361	4	haghighatkhah	haghighatkhah	PROPN
dpc-2669	361	5	hr	hr	NOUN
dpc-2669	361	6	,	,	PUNCT
dpc-2669	361	7	zargari	zargari	ADJ
dpc-2669	361	8	o	o	NOUN
dpc-2669	361	9	,	,	PUNCT
dpc-2669	361	10	et	et	PROPN
dpc-2669	361	11	al	al	PROPN
dpc-2669	361	12	.	.	PROPN
dpc-2669	361	13	high	high	ADJ
dpc-2669	361	14	-	-	PUNCT
dpc-2669	361	15	sensitivity	sensitivity	NOUN
dpc-2669	361	16	c	c	NOUN
dpc-2669	361	17	-	-	PUNCT
dpc-2669	361	18	reactive	reactive	ADJ
dpc-2669	361	19	protein	protein	NOUN
dpc-2669	361	20	as	as	ADP
dpc-2669	361	21	a	a	DET
dpc-2669	361	22	biomarker	biomarker	NOUN
dpc-2669	361	23	in	in	ADP
dpc-2669	361	24	detecting	detect	VERB
dpc-2669	361	25	subclinical	subclinical	ADJ
dpc-2669	361	26	atherosclerosis	atherosclerosis	NOUN
dpc-2669	361	27	in	in	ADP
dpc-2669	361	28	psoriasis	psoriasis	NOUN
dpc-2669	361	29	.	.	PUNCT
dpc-2669	362	1	dermatol	dermatol	NOUN
dpc-2669	362	2	ther	ther	ADV
dpc-2669	362	3	.	.	PUNCT
dpc-2669	363	1	2020;33(4):e13628	2020;33(4):e13628	X
dpc-2669	363	2	.	.	PUNCT
dpc-2669	364	1	doi	doi	NOUN
dpc-2669	364	2	:	:	PUNCT
dpc-2669	364	3	10.1111	10.1111	NUM
dpc-2669	364	4	/	/	SYM
dpc-2669	364	5	dth.13628	dth.13628	X
dpc-2669	364	6	.	.	PUNCT
dpc-2669	365	1	pmid	pmid	NOUN
dpc-2669	365	2	:	:	PUNCT
dpc-2669	365	3	32431027	32431027	NUM
dpc-2669	365	4	.	.	PUNCT
dpc-2669	366	1	27	27	NUM
dpc-2669	366	2	.	.	X
dpc-2669	367	1	yiu	yiu	PROPN
dpc-2669	367	2	k	k	PROPN
dpc-2669	367	3	-	-	PROPN
dpc-2669	367	4	h	h	PROPN
dpc-2669	367	5	,	,	PUNCT
dpc-2669	367	6	yeung	yeung	PROPN
dpc-2669	367	7	c	c	PROPN
dpc-2669	367	8	-	-	PUNCT
dpc-2669	367	9	k	k	PROPN
dpc-2669	367	10	,	,	PUNCT
dpc-2669	367	11	chan	chan	PROPN
dpc-2669	367	12	h	h	PROPN
dpc-2669	367	13	-	-	PUNCT
dpc-2669	367	14	t	t	PROPN
dpc-2669	367	15	,	,	PUNCT
dpc-2669	367	16	et	et	PROPN
dpc-2669	367	17	al	al	PROPN
dpc-2669	367	18	.	.	PROPN
dpc-2669	367	19	increased	increase	VERB
dpc-2669	367	20	arterial	arterial	ADJ
dpc-2669	367	21	stiffness	stiffness	NOUN
dpc-2669	367	22	in	in	ADP
dpc-2669	367	23	patients	patient	NOUN
dpc-2669	367	24	with	with	ADP
dpc-2669	367	25	psoriasis	psoriasis	NOUN
dpc-2669	367	26	is	be	AUX
dpc-2669	367	27	associated	associate	VERB
dpc-2669	367	28	with	with	ADP
dpc-2669	367	29	active	active	ADJ
dpc-2669	367	30	systemic	systemic	ADJ
dpc-2669	367	31	inflammation	inflammation	NOUN
dpc-2669	367	32	.	.	PUNCT
dpc-2669	368	1	br	br	PROPN
dpc-2669	368	2	j	j	PROPN
dpc-2669	368	3	dermatol	dermatol	NOUN
dpc-2669	368	4	.	.	PUNCT
dpc-2669	369	1	2011;164(3):514	2011;164(3):514	NUM
dpc-2669	369	2	-	-	SYM
dpc-2669	369	3	520	520	NUM
dpc-2669	369	4	.	.	PUNCT
dpc-2669	370	1	doi	doi	NOUN
dpc-2669	370	2	:	:	PUNCT
dpc-2669	370	3	10.1111	10.1111	NUM
dpc-2669	370	4	/	/	SYM
dpc-2669	370	5	j.1365	j.1365	NOUN
dpc-2669	370	6	-	-	PUNCT
dpc-2669	370	7	2133.2010.10107.x	2133.2010.10107.x	NUM
dpc-2669	370	8	.	.	PUNCT
dpc-2669	371	1	pmid	pmid	NOUN
dpc-2669	371	2	:	:	PUNCT
dpc-2669	371	3	21039409	21039409	NUM
dpc-2669	371	4	.	.	PUNCT
dpc-2669	372	1	28	28	NUM
dpc-2669	372	2	.	.	PUNCT
dpc-2669	373	1	armstrong	armstrong	PROPN
dpc-2669	373	2	ej	ej	PROPN
dpc-2669	373	3	,	,	PUNCT
dpc-2669	373	4	krueger	krueger	PROPN
dpc-2669	373	5	jg	jg	PROPN
dpc-2669	373	6	.	.	PUNCT
dpc-2669	373	7	lipoprotein	lipoprotein	ADJ
dpc-2669	373	8	metabolism	metabolism	NOUN
dpc-2669	373	9	and	and	CCONJ
dpc-2669	373	10	inflammation	inflammation	NOUN
dpc-2669	373	11	in	in	ADP
dpc-2669	373	12	patients	patient	NOUN
dpc-2669	373	13	with	with	ADP
dpc-2669	373	14	psoriasis	psoriasis	NOUN
dpc-2669	373	15	.	.	PUNCT
dpc-2669	374	1	am	be	AUX
dpc-2669	374	2	j	j	PROPN
dpc-2669	374	3	cardiol	cardiol	NOUN
dpc-2669	374	4	.	.	PUNCT
dpc-2669	375	1	2016	2016	NUM
dpc-2669	375	2	;	;	PUNCT
dpc-2669	375	3	118(4):603	118(4):603	NOUN
dpc-2669	375	4	-	-	SYM
dpc-2669	375	5	609	609	NUM
dpc-2669	375	6	.	.	PUNCT
dpc-2669	376	1	doi	doi	NOUN
dpc-2669	376	2	:	:	PUNCT
dpc-2669	376	3	10.1016	10.1016	NUM
dpc-2669	376	4	/	/	SYM
dpc-2669	376	5	j.amjcard.2016.05.060	j.amjcard.2016.05.060	PROPN
dpc-2669	376	6	.	.	PUNCT
dpc-2669	377	1	pmid	pmid	NOUN
dpc-2669	377	2	:	:	PUNCT
dpc-2669	377	3	27392508.bmi	27392508.bmi	NUM
dpc-2669	377	4	=	=	SYM
dpc-2669	377	5	body	body	PROPN
dpc-2669	377	6	mass	mass	PROPN
dpc-2669	377	7	index	index	NOUN
dpc-2669	377	8	;	;	PUNCT
dpc-2669	377	9	crp	crp	PROPN
dpc-2669	377	10	=	=	SYM
dpc-2669	377	11	high	high	ADJ
dpc-2669	377	12	sensitivity	sensitivity	NOUN
dpc-2669	377	13	10	10	NUM
dpc-2669	377	14	.	.	PUNCT
dpc-2669	378	1	mukherjee	mukherjee	PROPN
dpc-2669	378	2	d	d	PROPN
dpc-2669	378	3	,	,	PUNCT
dpc-2669	378	4	yadav	yadav	PROPN
dpc-2669	378	5	js	js	PROPN
dpc-2669	378	6	.	.	PUNCT
dpc-2669	379	1	carotid	carotid	NOUN
dpc-2669	379	2	artery	artery	NOUN
dpc-2669	379	3	intimal	intimal	ADJ
dpc-2669	379	4	-	-	PUNCT
dpc-2669	379	5	medial	medial	ADJ
dpc-2669	379	6	thickness	thickness	NOUN
dpc-2669	379	7	:	:	PUNCT
dpc-2669	379	8	indicator	indicator	NOUN
dpc-2669	379	9	of	of	ADP
dpc-2669	379	10	atherosclerotic	atherosclerotic	ADJ
dpc-2669	379	11	burden	burden	NOUN
dpc-2669	379	12	and	and	CCONJ
dpc-2669	379	13	response	response	NOUN
dpc-2669	379	14	to	to	ADP
dpc-2669	379	15	risk	risk	NOUN
dpc-2669	379	16	factor	factor	NOUN
dpc-2669	379	17	modification	modification	NOUN
dpc-2669	379	18	.	.	PUNCT
dpc-2669	380	1	am	be	AUX
dpc-2669	380	2	heart	heart	NOUN
dpc-2669	380	3	j.	j.	PROPN
dpc-2669	380	4	2002;144(5):753	2002;144(5):753	PROPN
dpc-2669	380	5	-	-	SYM
dpc-2669	380	6	759	759	NUM
dpc-2669	380	7	.	.	PUNCT
dpc-2669	381	1	doi	doi	NOUN
dpc-2669	381	2	:	:	PUNCT
dpc-2669	381	3	10.1067	10.1067	NUM
dpc-2669	381	4	/mhj.2002.124865	/mhj.2002.124865	NUM
dpc-2669	381	5	.	.	PUNCT
dpc-2669	382	1	pmid	pmid	NOUN
dpc-2669	382	2	:	:	PUNCT
dpc-2669	382	3	12422142	12422142	NUM
dpc-2669	382	4	.	.	PUNCT
dpc-2669	383	1	11	11	NUM
dpc-2669	383	2	.	.	X
dpc-2669	383	3	hu	hu	PROPN
dpc-2669	383	4	sc	sc	PROPN
dpc-2669	383	5	-	-	PUNCT
dpc-2669	383	6	s	s	PROPN
dpc-2669	383	7	,	,	PUNCT
dpc-2669	383	8	lan	lan	PROPN
dpc-2669	383	9	c	c	PROPN
dpc-2669	383	10	-	-	PUNCT
dpc-2669	383	11	ce	ce	PROPN
dpc-2669	383	12	.	.	PUNCT
dpc-2669	383	13	psoriasis	psoriasis	NOUN
dpc-2669	383	14	and	and	CCONJ
dpc-2669	383	15	cardiovascular	cardiovascular	ADJ
dpc-2669	383	16	comorbidities	comorbiditie	NOUN
dpc-2669	383	17	:	:	PUNCT
dpc-2669	383	18	focusing	focus	VERB
dpc-2669	383	19	on	on	ADP
dpc-2669	383	20	severe	severe	ADJ
dpc-2669	383	21	vascular	vascular	ADJ
dpc-2669	383	22	events	event	NOUN
dpc-2669	383	23	,	,	PUNCT
dpc-2669	383	24	cardiovascular	cardiovascular	ADJ
dpc-2669	383	25	risk	risk	NOUN
dpc-2669	383	26	factors	factor	NOUN
dpc-2669	383	27	and	and	CCONJ
dpc-2669	383	28	implications	implication	NOUN
dpc-2669	383	29	for	for	ADP
dpc-2669	383	30	treatment	treatment	NOUN
dpc-2669	383	31	.	.	PUNCT
dpc-2669	384	1	int	int	PROPN
dpc-2669	384	2	j	j	PROPN
dpc-2669	384	3	mol	mol	ADP
dpc-2669	384	4	sci	sci	PROPN
dpc-2669	384	5	.	.	PUNCT
dpc-2669	385	1	2017;18(10):2211	2017;18(10):2211	X
dpc-2669	385	2	.	.	PUNCT
dpc-2669	386	1	doi	doi	NOUN
dpc-2669	386	2	:	:	PUNCT
dpc-2669	386	3	10.3390	10.3390	NUM
dpc-2669	386	4	/	/	SYM
dpc-2669	386	5	ijms18102211	ijms18102211	PROPN
dpc-2669	386	6	.	.	PUNCT
dpc-2669	387	1	pmid	pmid	NOUN
dpc-2669	387	2	:	:	PUNCT
dpc-2669	387	3	29065479	29065479	NUM
dpc-2669	387	4	.	.	PUNCT
dpc-2669	388	1	pmcid	pmcid	NOUN
dpc-2669	388	2	:	:	PUNCT
dpc-2669	388	3	pmc5666891	pmc5666891	ADJ
dpc-2669	388	4	.	.	PUNCT
dpc-2669	389	1	12	12	NUM
dpc-2669	389	2	.	.	PUNCT
dpc-2669	390	1	gisondi	gisondi	PROPN
dpc-2669	390	2	p	p	NOUN
dpc-2669	390	3	,	,	PUNCT
dpc-2669	390	4	fantin	fantin	NOUN
dpc-2669	390	5	f	f	X
dpc-2669	390	6	,	,	PUNCT
dpc-2669	390	7	del	del	PROPN
dpc-2669	390	8	giglio	giglio	PROPN
dpc-2669	390	9	m	m	PROPN
dpc-2669	390	10	,	,	PUNCT
dpc-2669	390	11	et	et	PROPN
dpc-2669	390	12	al	al	PROPN
dpc-2669	390	13	.	.	PROPN
dpc-2669	390	14	chronic	chronic	ADJ
dpc-2669	390	15	plaque	plaque	NOUN
dpc-2669	390	16	psoriasis	psoriasis	NOUN
dpc-2669	390	17	is	be	AUX
dpc-2669	390	18	associated	associate	VERB
dpc-2669	390	19	with	with	ADP
dpc-2669	390	20	increased	increase	VERB
dpc-2669	390	21	arterial	arterial	ADJ
dpc-2669	390	22	stiffness	stiffness	NOUN
dpc-2669	390	23	.	.	PUNCT
dpc-2669	391	1	dermatology	dermatology	NOUN
dpc-2669	391	2	.	.	PUNCT
dpc-2669	392	1	2009;218(2):110	2009;218(2):110	NUM
dpc-2669	392	2	-	-	SYM
dpc-2669	392	3	113	113	NUM
dpc-2669	392	4	.	.	PUNCT
dpc-2669	393	1	doi	doi	NOUN
dpc-2669	393	2	:	:	PUNCT
dpc-2669	393	3	10.1159/000182256	10.1159/000182256	NUM
dpc-2669	393	4	.	.	PUNCT
dpc-2669	394	1	pmid	pmid	NOUN
dpc-2669	394	2	:	:	PUNCT
dpc-2669	394	3	19060461	19060461	NUM
dpc-2669	394	4	.	.	PUNCT
dpc-2669	395	1	13	13	NUM
dpc-2669	395	2	.	.	X
dpc-2669	395	3	dey	dey	PROPN
dpc-2669	395	4	ak	ak	PROPN
dpc-2669	395	5	,	,	PUNCT
dpc-2669	395	6	joshi	joshi	PROPN
dpc-2669	395	7	aa	aa	PROPN
dpc-2669	395	8	,	,	PUNCT
dpc-2669	395	9	chaturvedi	chaturvedi	PROPN
dpc-2669	395	10	a	a	PROPN
dpc-2669	395	11	,	,	PUNCT
dpc-2669	395	12	et	et	PROPN
dpc-2669	395	13	al	al	PROPN
dpc-2669	395	14	.	.	PROPN
dpc-2669	395	15	association	association	PROPN
dpc-2669	395	16	between	between	ADP
dpc-2669	395	17	skin	skin	NOUN
dpc-2669	395	18	and	and	CCONJ
dpc-2669	395	19	aortic	aortic	ADJ
dpc-2669	395	20	vascular	vascular	ADJ
dpc-2669	395	21	inflammation	inflammation	NOUN
dpc-2669	395	22	in	in	ADP
dpc-2669	395	23	patients	patient	NOUN
dpc-2669	395	24	with	with	ADP
dpc-2669	395	25	psoriasis	psoriasis	NOUN
dpc-2669	395	26	:	:	PUNCT
dpc-2669	395	27	a	a	DET
dpc-2669	395	28	case	case	NOUN
dpc-2669	395	29	-	-	PUNCT
dpc-2669	395	30	cohort	cohort	NOUN
dpc-2669	395	31	study	study	NOUN
dpc-2669	395	32	using	use	VERB
dpc-2669	395	33	positron	positron	NOUN
dpc-2669	395	34	emission	emission	NOUN
dpc-2669	395	35	tomography/	tomography/	NUM
dpc-2669	395	36	computed	compute	VERB
dpc-2669	395	37	tomography	tomography	NOUN
dpc-2669	395	38	.	.	PUNCT
dpc-2669	396	1	jama	jama	PROPN
dpc-2669	396	2	cardiol	cardiol	PROPN
dpc-2669	396	3	.	.	PUNCT
dpc-2669	397	1	2017;2(9):1013	2017;2(9):1013	NUM
dpc-2669	397	2	-	-	SYM
dpc-2669	397	3	1018	1018	NUM
dpc-2669	397	4	.	.	PUNCT
dpc-2669	398	1	doi	doi	NOUN
dpc-2669	398	2	:	:	PUNCT
dpc-2669	398	3	10.1001	10.1001	NUM
dpc-2669	398	4	/	/	SYM
dpc-2669	398	5	jamacardio.2017.1213	jamacardio.2017.1213	PROPN
dpc-2669	398	6	.	.	PUNCT
dpc-2669	399	1	pmid	pmid	NOUN
dpc-2669	399	2	:	:	PUNCT
dpc-2669	399	3	28564678	28564678	NUM
dpc-2669	399	4	.	.	PUNCT
dpc-2669	400	1	pmcid	pmcid	NOUN
dpc-2669	400	2	:	:	PUNCT
dpc-2669	400	3	pmc5815046	pmc5815046	NOUN
dpc-2669	400	4	.	.	PUNCT
dpc-2669	401	1	14	14	NUM
dpc-2669	401	2	.	.	PUNCT
dpc-2669	402	1	evensen	evensen	PROPN
dpc-2669	402	2	k	k	PROPN
dpc-2669	402	3	,	,	PUNCT
dpc-2669	402	4	slevolden	slevolden	ADJ
dpc-2669	402	5	e	e	NOUN
dpc-2669	402	6	,	,	PUNCT
dpc-2669	402	7	skagen	skagen	PROPN
dpc-2669	402	8	k	k	PROPN
dpc-2669	402	9	,	,	PUNCT
dpc-2669	402	10	et	et	PROPN
dpc-2669	402	11	al	al	PROPN
dpc-2669	402	12	.	.	PROPN
dpc-2669	402	13	increased	increase	VERB
dpc-2669	402	14	subclinical	subclinical	ADJ
dpc-2669	402	15	atherosclerosis	atherosclerosis	NOUN
dpc-2669	402	16	in	in	ADP
dpc-2669	402	17	patients	patient	NOUN
dpc-2669	402	18	with	with	ADP
dpc-2669	402	19	chronic	chronic	ADJ
dpc-2669	402	20	plaque	plaque	NOUN
dpc-2669	402	21	psoriasis	psoriasis	NOUN
dpc-2669	402	22	.	.	PUNCT
dpc-2669	403	1	atherosclerosis	atherosclerosis	NOUN
dpc-2669	403	2	.	.	PUNCT
dpc-2669	404	1	2014;237(2):499	2014;237(2):499	NUM
dpc-2669	404	2	-	-	SYM
dpc-2669	404	3	503	503	NUM
dpc-2669	404	4	.	.	PUNCT
dpc-2669	405	1	doi	doi	NOUN
dpc-2669	405	2	:	:	PUNCT
dpc-2669	405	3	10.1016	10.1016	NUM
dpc-2669	405	4	/	/	SYM
dpc-2669	405	5	j.atherosclerosis.2014.10.008	j.atherosclerosis.2014.10.008	PROPN
dpc-2669	405	6	.	.	PUNCT
dpc-2669	406	1	pmid	pmid	NOUN
dpc-2669	406	2	:	:	PUNCT
dpc-2669	406	3	25463081	25463081	NUM
dpc-2669	406	4	.	.	PUNCT
dpc-2669	407	1	15	15	NUM
dpc-2669	407	2	.	.	X
dpc-2669	407	3	santilli	santilli	PROPN
dpc-2669	407	4	s	s	PROPN
dpc-2669	407	5	,	,	PUNCT
dpc-2669	407	6	kast	kast	PROPN
dpc-2669	407	7	dr	dr	PROPN
dpc-2669	407	8	,	,	PUNCT
dpc-2669	407	9	grozdev	grozdev	VERB
dpc-2669	407	10	i	i	PRON
dpc-2669	407	11	,	,	PUNCT
dpc-2669	407	12	et	et	PROPN
dpc-2669	407	13	al	al	PROPN
dpc-2669	407	14	.	.	PUNCT
dpc-2669	407	15	visualization	visualization	NOUN
dpc-2669	407	16	of	of	ADP
dpc-2669	407	17	atherosclerosis	atherosclerosis	NOUN
dpc-2669	407	18	as	as	SCONJ
dpc-2669	407	19	detected	detect	VERB
dpc-2669	407	20	by	by	ADP
dpc-2669	407	21	coronary	coronary	ADJ
dpc-2669	407	22	artery	artery	NOUN
dpc-2669	407	23	calcium	calcium	NOUN
dpc-2669	407	24	and	and	CCONJ
dpc-2669	407	25	carotid	carotid	NOUN
dpc-2669	407	26	intima	intima	ADJ
dpc-2669	407	27	-	-	PUNCT
dpc-2669	407	28	media	medium	NOUN
dpc-2669	407	29	thickness	thickness	NOUN
dpc-2669	407	30	reveals	reveal	VERB
dpc-2669	407	31	significant	significant	ADJ
dpc-2669	407	32	atherosclerosis	atherosclerosis	NOUN
dpc-2669	407	33	in	in	ADP
dpc-2669	407	34	a	a	DET
dpc-2669	407	35	cross	cross	ADJ
dpc-2669	407	36	-	-	ADJ
dpc-2669	407	37	sectional	sectional	ADJ
dpc-2669	407	38	study	study	NOUN
dpc-2669	407	39	of	of	ADP
dpc-2669	407	40	psoriasis	psoriasis	NOUN
dpc-2669	407	41	patients	patient	NOUN
dpc-2669	407	42	in	in	ADP
dpc-2669	407	43	a	a	DET
dpc-2669	407	44	tertiary	tertiary	ADJ
dpc-2669	407	45	care	care	NOUN
dpc-2669	407	46	center	center	NOUN
dpc-2669	407	47	.	.	PUNCT
dpc-2669	408	1	j	j	PROPN
dpc-2669	408	2	transl	transl	PROPN
dpc-2669	408	3	med	med	PROPN
dpc-2669	408	4	.	.	PUNCT
dpc-2669	409	1	2016;14(1):217	2016;14(1):217	PROPN
dpc-2669	409	2	.	.	PUNCT
dpc-2669	410	1	doi	doi	NOUN
dpc-2669	410	2	:	:	PUNCT
dpc-2669	410	3	10.1186	10.1186	NUM
dpc-2669	410	4	/	/	SYM
dpc-2669	410	5	s12967	s12967	NOUN
dpc-2669	410	6	-	-	PUNCT
dpc-2669	410	7	016	016	NUM
dpc-2669	410	8	-	-	PUNCT
dpc-2669	410	9	0947	0947	NUM
dpc-2669	410	10	-0	-0	PUNCT
dpc-2669	410	11	.	.	PUNCT
dpc-2669	411	1	pmid	pmid	NOUN
dpc-2669	411	2	:	:	PUNCT
dpc-2669	411	3	27448600	27448600	NUM
dpc-2669	411	4	.	.	PUNCT
dpc-2669	412	1	pmcid	pmcid	ADJ
dpc-2669	412	2	:	:	PUNCT
dpc-2669	412	3	pmc4957305	pmc4957305	NOUN
dpc-2669	412	4	.	.	PUNCT
dpc-2669	413	1	16	16	NUM
dpc-2669	413	2	.	.	PUNCT
dpc-2669	414	1	shaharyar	shaharyar	PROPN
dpc-2669	414	2	s	s	PROPN
dpc-2669	414	3	,	,	PUNCT
dpc-2669	414	4	warraich	warraich	ADJ
dpc-2669	414	5	h	h	NOUN
dpc-2669	414	6	,	,	PUNCT
dpc-2669	414	7	mcevoy	mcevoy	PROPN
dpc-2669	414	8	jw	jw	PROPN
dpc-2669	414	9	,	,	PUNCT
dpc-2669	414	10	et	et	PROPN
dpc-2669	414	11	al	al	PROPN
dpc-2669	414	12	.	.	PUNCT
dpc-2669	415	1	subclinical	subclinical	ADJ
dpc-2669	415	2	cardiovascular	cardiovascular	ADJ
dpc-2669	415	3	disease	disease	NOUN
dpc-2669	415	4	in	in	ADP
dpc-2669	415	5	plaque	plaque	NOUN
dpc-2669	415	6	psoriasis	psoriasis	NOUN
dpc-2669	415	7	:	:	PUNCT
dpc-2669	415	8	association	association	NOUN
dpc-2669	415	9	or	or	CCONJ
dpc-2669	415	10	causal	causal	NOUN
dpc-2669	415	11	link	link	NOUN
dpc-2669	415	12	?	?	PUNCT
dpc-2669	416	1	atherosclerosis	atherosclerosis	NOUN
dpc-2669	416	2	.	.	PUNCT
dpc-2669	417	1	2014;232(1):72	2014;232(1):72	NUM
dpc-2669	417	2	-	-	SYM
dpc-2669	417	3	78	78	NUM
dpc-2669	417	4	.	.	PUNCT
dpc-2669	418	1	doi	doi	NOUN
dpc-2669	418	2	:	:	PUNCT
dpc-2669	418	3	10.1016	10.1016	NUM
dpc-2669	418	4	/	/	SYM
dpc-2669	418	5	j.atherosclerosis	j.atherosclerosis	NOUN
dpc-2669	418	6	.	.	PUNCT
dpc-2669	419	1	2013.10.023	2013.10.023	NUM
dpc-2669	419	2	.	.	PUNCT
dpc-2669	420	1	pmid	pmid	NOUN
dpc-2669	420	2	:	:	PUNCT
dpc-2669	420	3	24401219	24401219	NUM
dpc-2669	420	4	.	.	PUNCT
dpc-2669	421	1	17	17	NUM
dpc-2669	421	2	.	.	PUNCT
dpc-2669	422	1	masallat	masallat	PROPN
dpc-2669	422	2	d	d	PROPN
dpc-2669	422	3	,	,	PUNCT
dpc-2669	422	4	moemen	moemen	PROPN
dpc-2669	422	5	d	d	PROPN
dpc-2669	422	6	,	,	PUNCT
dpc-2669	422	7	ahmed	ahmed	PROPN
dpc-2669	422	8	f.	f.	PROPN
dpc-2669	422	9	gut	gut	PROPN
dpc-2669	422	10	bacterial	bacterial	ADJ
dpc-2669	422	11	microbiota	microbiota	NOUN
dpc-2669	422	12	in	in	ADP
dpc-2669	422	13	psoriasis	psoriasis	NOUN
dpc-2669	422	14	:	:	PUNCT
dpc-2669	422	15	a	a	DET
dpc-2669	422	16	case	case	NOUN
dpc-2669	422	17	control	control	NOUN
dpc-2669	422	18	study	study	NOUN
dpc-2669	422	19	.	.	PUNCT
dpc-2669	423	1	afr	afr	PROPN
dpc-2669	423	2	j	j	PROPN
dpc-2669	423	3	microbiol	microbiol	PROPN
dpc-2669	423	4	res	re	NOUN
dpc-2669	423	5	.	.	PUNCT
dpc-2669	424	1	2016;10:1337	2016;10:1337	NUM
dpc-2669	424	2	-	-	SYM
dpc-2669	424	3	1343	1343	NUM
dpc-2669	424	4	.	.	PUNCT
dpc-2669	425	1	doi	doi	NOUN
dpc-2669	425	2	:	:	PUNCT
dpc-2669	425	3	10.5897	10.5897	NUM
dpc-2669	425	4	/	/	SYM
dpc-2669	425	5	ajmr2016.8046	ajmr2016.8046	PROPN
dpc-2669	425	6	18	18	NUM
dpc-2669	425	7	.	.	PUNCT
dpc-2669	426	1	durack	durack	PROPN
dpc-2669	426	2	j	j	PROPN
dpc-2669	426	3	,	,	PUNCT
dpc-2669	426	4	lynch	lynch	PROPN
dpc-2669	426	5	sv	sv	PROPN
dpc-2669	426	6	.	.	PUNCT
dpc-2669	427	1	the	the	DET
dpc-2669	427	2	gut	gut	NOUN
dpc-2669	427	3	microbiome	microbiome	NOUN
dpc-2669	427	4	:	:	PUNCT
dpc-2669	427	5	relationships	relationship	NOUN
dpc-2669	427	6	with	with	ADP
dpc-2669	427	7	disease	disease	NOUN
dpc-2669	427	8	and	and	CCONJ
dpc-2669	427	9	opportunities	opportunity	NOUN
dpc-2669	427	10	for	for	ADP
dpc-2669	427	11	therapy	therapy	NOUN
dpc-2669	427	12	.	.	PUNCT
dpc-2669	428	1	j	j	PROPN
dpc-2669	428	2	exp	exp	NOUN
dpc-2669	428	3	med	med	PROPN
dpc-2669	428	4	.	.	PUNCT
dpc-2669	429	1	2019;216(1):20	2019;216(1):20	PROPN
dpc-2669	429	2	-	-	PUNCT
dpc-2669	429	3	40	40	NUM
dpc-2669	429	4	.	.	PUNCT
dpc-2669	430	1	doi	doi	NOUN
dpc-2669	430	2	:	:	PUNCT
dpc-2669	430	3	10.1084	10.1084	NUM
dpc-2669	430	4	/	/	SYM
dpc-2669	430	5	jem.20180448	jem.20180448	X
dpc-2669	430	6	.	.	PUNCT
dpc-2669	431	1	pmid	pmid	NOUN
dpc-2669	431	2	:	:	PUNCT
dpc-2669	431	3	30322864	30322864	NUM
dpc-2669	431	4	;	;	PUNCT
dpc-2669	431	5	pmcid	pmcid	PROPN
dpc-2669	431	6	:	:	PUNCT
dpc-2669	431	7	pmc6314516	pmc6314516	PROPN
dpc-2669	431	8	.	.	PUNCT
dpc-2669	432	1	19	19	NUM
dpc-2669	432	2	.	.	PUNCT
dpc-2669	432	3	ellis	ellis	PROPN
dpc-2669	432	4	sr	sr	PROPN
dpc-2669	432	5	,	,	PUNCT
dpc-2669	432	6	nguyen	nguyen	PROPN
dpc-2669	432	7	m	m	PROPN
dpc-2669	432	8	,	,	PUNCT
dpc-2669	432	9	vaughn	vaughn	PROPN
dpc-2669	432	10	ar	ar	PROPN
dpc-2669	432	11	,	,	PUNCT
dpc-2669	432	12	et	et	PROPN
dpc-2669	432	13	al	al	PROPN
dpc-2669	432	14	.	.	PUNCT
dpc-2669	433	1	the	the	DET
dpc-2669	433	2	skin	skin	NOUN
dpc-2669	433	3	and	and	CCONJ
dpc-2669	433	4	gut	gut	NOUN
dpc-2669	433	5	microbiome	microbiome	NOUN
dpc-2669	433	6	and	and	CCONJ
dpc-2669	433	7	its	its	PRON
dpc-2669	433	8	role	role	NOUN
dpc-2669	433	9	in	in	ADP
dpc-2669	433	10	common	common	ADJ
dpc-2669	433	11	dermatologic	dermatologic	ADJ
dpc-2669	433	12	conditions	condition	NOUN
dpc-2669	433	13	.	.	PUNCT
dpc-2669	434	1	microorganisms	microorganism	NOUN
dpc-2669	434	2	.	.	PUNCT
dpc-2669	435	1	2019;7(11):550	2019;7(11):550	X
dpc-2669	435	2	.	.	PUNCT
dpc-2669	436	1	doi	doi	NOUN
dpc-2669	436	2	:	:	PUNCT
dpc-2669	436	3	10.3390	10.3390	NUM
dpc-2669	436	4	/	/	SYM
dpc-2669	436	5	microorganisms7110550	microorganisms7110550	PROPN
dpc-2669	436	6	.	.	PUNCT
dpc-2669	437	1	pmid	pmid	NOUN
dpc-2669	437	2	:	:	PUNCT
dpc-2669	437	3	31717915	31717915	NUM
dpc-2669	437	4	.	.	PUNCT
dpc-2669	438	1	pmcid	pmcid	NOUN
dpc-2669	438	2	:	:	PUNCT
dpc-2669	438	3	pmc6920876	pmc6920876	NOUN
dpc-2669	438	4	.	.	PUNCT